"YearStart","YearEnd","LocationAbbr","LocationDesc","DataSource","Topic","Question","DataValueUnit","DataValueType","DataValue","DataValueAlt","DataValueFootnoteSymbol","DatavalueFootnote","LowConfidenceLimit","HighConfidenceLimit","StratificationCategory1","Stratification1","GeoLocation","LocationID","TopicID","QuestionID","DataValueTypeID","StratificationCategoryID1","StratificationID1"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.5",78.5,NA,NA,76,80.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.8",75.8,NA,NA,73.6,77.9,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.8",75.8,NA,NA,73.5,77.9,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70",70,NA,NA,67.8,72.1,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.4",68.4,NA,NA,64.6,72.1,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","68.8",68.8,NA,NA,65.1,72.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.1",66.1,NA,NA,62,69.9,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,62.3,70.1,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.7",76.7,NA,NA,64.6,85.5,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.6",76.6,NA,NA,65.7,84.9,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.4",83.4,NA,NA,75.2,89.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.9",82.9,NA,NA,74.2,89,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.5",78.5,NA,NA,67.7,86.4,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77",77,NA,NA,65.1,85.7,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77",77,NA,NA,74.8,79,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,74.3,78.6,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.3",76.3,NA,NA,73.8,78.6,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.9",75.9,NA,NA,73.3,78.2,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.9",81.9,NA,NA,77.8,85.4,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,76.5,84.5,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.1",68.1,NA,NA,64.8,71.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.1",67.1,NA,NA,63.6,70.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.2",68.2,NA,NA,64.6,71.6,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.8",66.8,NA,NA,63,70.4,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.1",74.1,NA,NA,64.5,81.8,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.1",75.1,NA,NA,67.2,81.7,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.3",76.3,NA,NA,74.3,78.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.8",75.8,NA,NA,73.7,77.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.3",76.3,NA,NA,74.3,78.1,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,73.5,77.7,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.2",85.2,NA,NA,73.1,92.5,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.9",84.9,NA,NA,74.5,91.5,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.7",74.7,NA,NA,67.7,80.6,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,67.7,80.4,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.5",76.5,NA,NA,65.1,85,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,66,85.4,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.8",82.8,NA,NA,80.5,85,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,80.2,84.8,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,78,83.7,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.6",80.6,NA,NA,77.4,83.4,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","91.4",91.4,NA,NA,79.9,96.6,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","92.1",92.1,NA,NA,82.6,96.6,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,75.2,85.9,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,74.6,85.9,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.4",89.4,NA,NA,82.6,93.7,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.7",88.7,NA,NA,80.8,93.7,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.1",74.1,NA,NA,72.2,75.8,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.9",73.9,NA,NA,72.1,75.7,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.1",74.1,NA,NA,72.1,76,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74",74,NA,NA,72,75.9,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.4",85.4,NA,NA,73.2,92.6,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.2",85.2,NA,NA,73.2,92.4,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.9",74.9,NA,NA,68.7,80.3,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,67.3,79.1,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.4",72.4,NA,NA,55,84.9,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,68.9,87.1,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","56.9",56.9,NA,NA,40.4,72,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","60.9",60.9,NA,NA,43.9,75.6,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.5",83.5,NA,NA,81.4,85.5,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,81.6,85.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.8",83.8,NA,NA,81.4,85.9,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,81.5,86,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.6",88.6,NA,NA,82.1,92.9,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,81.2,92.3,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.5",78.5,NA,NA,68.4,86.1,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.8",78.8,NA,NA,69.5,85.8,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.2",81.2,NA,NA,78.1,83.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.1",81.1,NA,NA,78,83.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.9",78.9,NA,NA,74.1,83.1,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,74.7,83.6,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84",84,NA,NA,79.7,87.6,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,79.4,87.6,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.5",85.5,NA,NA,83,87.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,82.8,87.6,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.5",84.5,NA,NA,81.5,87.1,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,81.3,87.1,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.5",88.5,NA,NA,81.5,93,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.6",88.6,NA,NA,82.1,93,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.8",86.8,NA,NA,82.3,90.2,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.3",76.3,NA,NA,64.5,85.1,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,67.4,85.1,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.5",77.5,NA,NA,75.5,79.5,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,75.1,79.2,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.1",76.1,NA,NA,74.1,77.9,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.3",75.3,NA,NA,73.1,77.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.8",85.8,NA,NA,79.6,90.3,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,81.1,90.2,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.5",77.5,NA,NA,68.9,84.2,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,68.8,83.5,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","65.3",65.3,NA,NA,50.2,77.8,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","65.6",65.6,NA,NA,53.4,76,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.6",70.6,NA,NA,49.8,85.3,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.6",67.6,NA,NA,53.5,79.1,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.4",78.4,NA,NA,76.3,80.3,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,75.6,79.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,76.1,80.4,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,74.6,79.4,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.8",87.8,NA,NA,81.7,92.1,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.7",88.7,NA,NA,83.3,92.5,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.4",72.4,NA,NA,64.6,79.1,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.4",73.4,NA,NA,65.8,79.7,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.8",80.8,NA,NA,78.8,82.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.9",80.9,NA,NA,78.6,82.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81",81,NA,NA,78.8,83.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.4",80.4,NA,NA,77.7,82.9,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,77.8,83,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.9",83.9,NA,NA,79.5,87.6,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.1",84.1,NA,NA,79.8,87.7,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.9",79.9,NA,NA,77.5,82.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80",80,NA,NA,77.5,82.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.2,80.8,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.7",77.7,NA,NA,74.7,80.6,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,78.4,82.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.1",87.1,NA,NA,82.7,90.6,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.6",72.6,NA,NA,65.6,78.7,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.2",72.2,NA,NA,65.3,78.1,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.7",70.7,NA,NA,62,78.1,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.7",70.7,NA,NA,62.2,77.9,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85",85,NA,NA,82.6,87.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.1",85.1,NA,NA,82.7,87.3,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82",82,NA,NA,77.8,85.5,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.1",82.1,NA,NA,77.4,86,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.4",82.4,NA,NA,71.9,89.6,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,71.4,88.6,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.6",87.6,NA,NA,83.7,90.8,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,83.6,90.9,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.2",83.2,NA,NA,77.5,87.7,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83",83,NA,NA,77.5,87.5,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.5",83.5,NA,NA,80.9,85.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,80.7,85.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.3",80.3,NA,NA,76.4,83.7,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,77.5,84.6,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.5",79.5,NA,NA,67.9,87.7,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,69.7,87.8,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.6",84.6,NA,NA,80,88.4,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,79.4,88.1,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.6",85.6,NA,NA,81,89.2,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.7",85.7,NA,NA,81,89.4,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,79,83,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,78.7,82.8,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.6",68.6,NA,NA,65.4,71.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","68.4",68.4,NA,NA,65.1,71.6,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.4",69.4,NA,NA,66.1,72.5,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,65.7,72.4,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.3,80.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,75.4,80.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,74.1,80,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,74.1,80.1,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.5",84.5,NA,NA,76.7,90.1,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,76.6,89.9,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78",78,NA,NA,63.6,87.8,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,68.6,89.1,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.5",72.5,NA,NA,70.5,74.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,70.4,74.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.9",71.9,NA,NA,69.9,73.9,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.9",71.9,NA,NA,69.8,73.9,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.6",80.6,NA,NA,72.6,86.8,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,73.2,87.3,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.4",76.4,NA,NA,74.7,77.9,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.1",76.1,NA,NA,74.4,77.7,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,75.2,78.5,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,74.7,78.2,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.6",78.6,NA,NA,69.5,85.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.3",78.3,NA,NA,69.5,85,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68",68,NA,NA,55.6,78.3,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.1",69.1,NA,NA,58,78.4,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.2",71.2,NA,NA,56.3,82.6,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,51.2,80.9,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","59.7",59.7,NA,NA,44.1,73.5,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","63.5",63.5,NA,NA,48.8,76,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.6",79.6,NA,NA,77.5,81.6,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.2",79.2,NA,NA,77,81.2,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.6",79.6,NA,NA,77.4,81.7,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.1",79.1,NA,NA,76.7,81.2,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.8",84.8,NA,NA,76.3,90.7,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.4",87.4,NA,NA,81.2,91.7,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","60.9",60.9,NA,NA,49,71.6,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.5",79.5,NA,NA,77.4,81.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.2",79.2,NA,NA,77,81.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,75.6,80.8,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,75,80.4,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,77,84.5,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,77.1,84.6,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88",88,NA,NA,86.4,89.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,86.3,89.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.9",87.9,NA,NA,86.1,89.4,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,85.9,89.3,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.2",86.2,NA,NA,76.9,92.2,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.8",86.8,NA,NA,78.5,92.2,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88",88,NA,NA,79.8,93.2,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,79.3,92.5,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","94.9",94.9,NA,NA,89.2,97.7,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","94.7",94.7,NA,NA,88.8,97.6,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.4",88.4,NA,NA,69.7,96.2,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.6",88.6,NA,NA,74.2,95.4,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.6",83.6,NA,NA,81.7,85.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,81.6,85.2,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.4",81.4,NA,NA,79.3,83.4,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,79.1,83.3,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89",89,NA,NA,84.9,92,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.9",88.9,NA,NA,85,91.9,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","90.6",90.6,NA,NA,78.4,96.2,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","90.5",90.5,NA,NA,78.6,96.1,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.1",77.1,NA,NA,62.4,87.3,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,63.3,84.9,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.9",82.9,NA,NA,63.7,93,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.1",82.1,NA,NA,63.7,92.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83",83,NA,NA,81.2,84.7,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.9",82.9,NA,NA,81.1,84.6,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.1",83.1,NA,NA,81.3,84.8,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83",83,NA,NA,81.1,84.7,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.9",81.9,NA,NA,79.9,83.7,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.9,83.7,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.7",81.7,NA,NA,79.6,83.6,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.8",81.8,NA,NA,79.7,83.7,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.8",84.8,NA,NA,78.2,89.6,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,77.8,89.4,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.6",81.6,NA,NA,80.2,83,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,80,82.9,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.7",81.7,NA,NA,80.2,83.1,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,80.1,83,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.4",87.4,NA,NA,76.7,93.6,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,78.1,93.6,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.3",69.3,NA,NA,54.2,81.1,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.9",74.9,NA,NA,62.4,84.3,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,61.8,88.7,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,61.1,86.1,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.6",72.6,NA,NA,69.8,75.3,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,69.7,75.3,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.1",72.1,NA,NA,69.1,74.9,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72",72,NA,NA,68.9,74.9,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,66.6,84.8,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,67.8,84.8,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.6",69.6,NA,NA,66.2,72.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,66.1,72.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.6",68.6,NA,NA,64.3,72.7,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,64.2,72.9,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74",74,NA,NA,68.2,79,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.9",73.9,NA,NA,68.4,78.7,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.9",72.9,NA,NA,70.1,75.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72",72,NA,NA,69,74.7,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.3",73.3,NA,NA,70.4,76,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.3",72.3,NA,NA,69.1,75.2,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.9",68.9,NA,NA,56.8,78.8,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.1",70.1,NA,NA,59.4,78.9,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.7",80.7,NA,NA,78.6,82.7,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,78.7,82.9,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81",81,NA,NA,78.5,83.3,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,78.6,83.6,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.3",81.3,NA,NA,76.3,85.4,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,76.2,85.4,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.1",70.1,NA,NA,56.6,80.8,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.4",74.4,NA,NA,58.7,85.6,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76",76,NA,NA,73.3,78.5,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.6",75.6,NA,NA,72.9,78.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.6",76.6,NA,NA,73.9,79.1,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,73.4,78.8,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.1",67.1,NA,NA,48.5,81.5,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72",72,NA,NA,56.3,83.7,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.9",75.9,NA,NA,74.3,77.4,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.1",76.1,NA,NA,74.5,77.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.3",76.3,NA,NA,74.6,77.8,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,74.8,78,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.7",82.7,NA,NA,68.2,91.4,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,71.4,90.8,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.5",66.5,NA,NA,54.4,76.8,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,53.6,76.1,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","61.2",61.2,NA,NA,43.4,76.4,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","63.3",63.3,NA,NA,51.7,73.6,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.1",83.1,NA,NA,80.8,85.1,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,81.2,85.5,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.1",83.1,NA,NA,80.8,85.2,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,81.1,85.5,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,75.9,80.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,75.9,80.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77",77,NA,NA,74.6,79.3,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,74.3,79,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,75,88.1,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.1",82.1,NA,NA,75,87.5,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.9",78.9,NA,NA,69.1,86.2,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.6",80.6,NA,NA,72.9,86.5,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.8",81.8,NA,NA,64.7,91.7,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,69.3,91.8,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72",72,NA,NA,69.5,74.4,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,69,74.1,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.8",70.8,NA,NA,67.5,74,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.2",70.2,NA,NA,66.7,73.5,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.2",74.2,NA,NA,69.6,78.4,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.6",73.6,NA,NA,68.8,77.8,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73",73,NA,NA,62,81.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.7",72.7,NA,NA,62.8,80.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.2",72.2,NA,NA,67.9,76.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,67.1,75.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.5",71.5,NA,NA,66.9,75.7,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70",70,NA,NA,65.1,74.5,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75",75,NA,NA,60.3,85.6,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.4",73.4,NA,NA,61.2,82.8,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,75.9,80.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.3,80.8,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.4",78.4,NA,NA,75.5,81,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82",82,NA,NA,75,87.4,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,75.7,87.3,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86",86,NA,NA,79.3,90.8,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,78.2,90.4,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.9",67.9,NA,NA,50.7,81.2,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,45,71,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.3",74.3,NA,NA,71.9,76.6,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74",74,NA,NA,71.6,76.4,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.9",83.9,NA,NA,75.3,89.9,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.2",85.2,NA,NA,78.6,90,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.7",69.7,NA,NA,67.4,71.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.3",70.3,NA,NA,67.8,72.6,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.8",69.8,NA,NA,67.2,72.2,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.1",71.1,NA,NA,61,79.5,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,57.7,77.8,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","57.5",57.5,NA,NA,42,71.6,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","53.5",53.5,NA,NA,39.5,67,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.5",68.5,NA,NA,59.4,76.4,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,58.8,75.5,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.1",74.1,NA,NA,63.9,82.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,65.4,82,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,74.1,79.5,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,73.5,79.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.2",76.2,NA,NA,73.2,78.9,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,72.5,78.7,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78",78,NA,NA,66.2,86.5,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,64.1,85.6,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.3",77.3,NA,NA,75.3,79.1,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,75,79,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77",77,NA,NA,74.9,79,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.8",76.8,NA,NA,74.6,78.8,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.2",81.2,NA,NA,72.7,87.5,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,73.4,87.3,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.4",82.4,NA,NA,79.9,84.6,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.2",82.2,NA,NA,79.7,84.5,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,80,84.7,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.2",82.2,NA,NA,79.7,84.5,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.1",85.1,NA,NA,83,87,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.9",84.9,NA,NA,82.7,86.9,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.4",85.4,NA,NA,83.2,87.3,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.2",85.2,NA,NA,82.9,87.2,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.5",76.5,NA,NA,50.9,91.1,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.1",73.1,NA,NA,51.1,87.6,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.3",83.3,NA,NA,72.6,90.3,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,70,89.4,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.7",76.7,NA,NA,74.8,78.6,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,74.2,78.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.2",75.2,NA,NA,72.8,77.4,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,71.9,76.8,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.6",81.6,NA,NA,77.7,84.9,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.4",81.4,NA,NA,77.3,84.9,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.2",80.2,NA,NA,76.9,83.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,77.6,83.5,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.3",80.3,NA,NA,76.9,83.3,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,77.7,83.8,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79",79,NA,NA,63.4,89.1,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.7",78.7,NA,NA,64.5,88.3,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.8",76.8,NA,NA,73.9,79.4,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,73.9,79.5,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.2",76.2,NA,NA,73.1,79.1,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,72.9,79.1,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.2",83.2,NA,NA,75.7,88.8,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,77.8,89.4,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.8",78.8,NA,NA,76,81.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.8",78.8,NA,NA,75.9,81.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.9",78.9,NA,NA,76,81.6,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.9",78.9,NA,NA,75.9,81.7,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,68.4,85.7,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,68.9,85.3,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","57.7",57.7,NA,NA,33.6,78.5,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.7",76.7,NA,NA,74.4,78.9,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,74.5,79.1,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.4",75.4,NA,NA,72.4,78.2,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.6",75.6,NA,NA,72.5,78.3,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,73.3,89.1,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,74.8,89.2,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.2",78.2,NA,NA,73.8,82.1,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,74.1,82.3,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","53.7",53.7,NA,NA,41.4,65.6,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.9",80.9,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",76.8,85,"Overall","Overall",NA,"59","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81",81,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",76.9,85.1,"Overall","Overall",NA,"59","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,"*","50 States + DC: US Median",76.4,79.6,"Overall","Overall",NA,"59","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.8",77.8,"*","50 States + DC: US Median",76.1,79.2,"Overall","Overall",NA,"59","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.2",73.2,NA,NA,71.3,75.1,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.1",73.1,NA,NA,71.1,75,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.5",73.5,NA,NA,71.5,75.5,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.4",73.4,NA,NA,71.3,75.3,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.1",73.1,NA,NA,62.9,81.3,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.5",72.5,NA,NA,62.6,80.5,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","63.6",63.6,NA,NA,46.5,77.8,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","60.8",60.8,NA,NA,45.2,74.5,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.2",80.2,NA,NA,78.1,82.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,78,82,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.7,80.3,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.9",77.9,NA,NA,75.5,80.2,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.7",87.7,NA,NA,83.2,91.2,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.6",87.6,NA,NA,83.1,91,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.4",73.4,NA,NA,57.2,85.1,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,63.6,86.1,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.6",78.6,NA,NA,76.4,80.7,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.6",78.6,NA,NA,76.3,80.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.5",79.5,NA,NA,77.3,81.6,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.6",79.6,NA,NA,77.3,81.7,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.4",77.4,NA,NA,75.4,79.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.5",77.5,NA,NA,75.4,79.4,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.1",77.1,NA,NA,75,79.2,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,74.9,79.3,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75",75,NA,NA,60.9,85.3,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,69.3,88.6,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.2",79.2,NA,NA,69.7,86.4,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,69,85.2,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.2",75.2,NA,NA,59.6,86.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,62.1,87.1,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80",80,NA,NA,77.2,82.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,77.2,82.7,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.3",81.3,NA,NA,78.7,83.6,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.4",81.4,NA,NA,78.8,83.8,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","60.9",60.9,NA,NA,32.8,83.3,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,49.3,83.4,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.6",75.6,NA,NA,73.2,77.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.9",74.9,NA,NA,72.3,77.3,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.8",75.8,NA,NA,73.4,78.2,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.2",75.2,NA,NA,72.6,77.7,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","WHT"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","BLK"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","HIS"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","OTH"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","MRC"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.6",69.6,NA,NA,66.9,72.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,66.5,72,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.5",69.5,NA,NA,66.7,72.2,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,66.3,72,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.5",68.5,NA,NA,54.1,80.1,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,53.1,79.6,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.2",78.2,NA,NA,74.9,81.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,75.2,81.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.2",82.2,NA,NA,78.8,85.2,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,79.3,85.6,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","65.7",65.7,NA,NA,57,73.4,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","65.6",65.6,NA,NA,56.9,73.3,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.8",68.8,NA,NA,44.2,85.9,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.6",78.6,NA,NA,66.1,87.4,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.2",83.2,NA,NA,81,85.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83",83,NA,NA,80.8,84.9,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.7",80.7,NA,NA,77.8,83.4,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81",81,NA,NA,78,83.6,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.7",88.7,NA,NA,85.6,91.2,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,84.5,90.3,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.7",73.7,NA,NA,55.8,86.2,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.2",68.2,NA,NA,53.9,79.8,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.3",79.3,NA,NA,68.9,86.8,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79",79,NA,NA,69.2,86.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,68.2,89.4,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.1",81.1,NA,NA,69.5,89,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.1",78.1,NA,NA,74.2,81.5,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,74.1,81,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.4",76.4,NA,NA,71.8,80.4,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,72.2,80.3,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.9",87.9,NA,NA,79.3,93.2,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.9",86.9,NA,NA,79.4,92,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.7",79.7,NA,NA,77.5,81.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.8",79.8,NA,NA,77.7,81.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.3",80.3,NA,NA,77.8,82.6,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,77.6,82.8,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83",83,NA,NA,66.4,92.4,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.7",84.7,NA,NA,71.2,92.6,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.5",80.5,NA,NA,75.1,84.9,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.6",80.6,NA,NA,76,84.4,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.6",72.6,NA,NA,64.5,79.4,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","73.2",73.2,NA,NA,65.7,79.7,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.1",83.1,NA,NA,81,85.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,81.6,85.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.6",83.6,NA,NA,80.6,86.2,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,79.9,86,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.6",83.6,NA,NA,73.4,90.4,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85",85,NA,NA,75.5,91.2,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,83.6,89.5,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,84.2,89.8,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.1",73.1,NA,NA,64.6,80.1,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.5",75.5,NA,NA,68,81.7,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.6",84.6,NA,NA,83,86.1,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.8",84.8,NA,NA,83.2,86.2,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.8",84.8,NA,NA,83,86.4,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85",85,NA,NA,83.3,86.7,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.5",72.5,NA,NA,57.7,83.7,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,60.5,84.6,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.8",85.8,NA,NA,81.4,89.2,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,82.7,89.4,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81",81,NA,NA,69.2,89,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,73.9,90,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,85,88.9,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.6",87.6,NA,NA,85.5,89.4,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.8",87.8,NA,NA,85.4,89.9,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.7",88.7,NA,NA,86.1,90.9,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.9",87.9,NA,NA,80.6,92.7,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.3",88.3,NA,NA,81.6,92.7,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.6",85.6,NA,NA,79.3,90.3,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.7",85.7,NA,NA,79.6,90.1,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.7",88.7,NA,NA,78.2,94.5,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,77,94.4,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.8",89.8,NA,NA,81.2,94.7,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85",85,NA,NA,81.1,88.2,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.7",85.7,NA,NA,82.3,88.6,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.9",84.9,NA,NA,78.8,89.4,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.2",86.2,NA,NA,81.4,89.9,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,81.8,91,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,83.9,91.5,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.5",83.5,NA,NA,60.4,94.3,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90",90,NA,NA,76.1,96.2,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.7",84.7,NA,NA,65.5,94.1,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68",68,NA,NA,63.6,72.1,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,71.5,94.3,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.3",86.3,NA,NA,83.3,88.9,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.8",86.8,NA,NA,84,89.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.5",87.5,NA,NA,84.1,90.3,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,84.2,90.6,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.9",82.9,NA,NA,73.5,89.4,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,79,90.8,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.2",91.2,NA,NA,83.8,95.4,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","94",94,NA,NA,85.8,97.6,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","96",96,NA,NA,90.6,98.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.5",79.5,NA,NA,77.3,81.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,77.7,82,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,78.2,83.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.8",81.8,NA,NA,79,84.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.4",79.4,NA,NA,71.9,85.3,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,72.8,85.6,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.6",78.6,NA,NA,73.4,83,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,73.1,82.6,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","62.3",62.3,NA,NA,48.8,74.2,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","66",66,NA,NA,53,77,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.7",79.7,NA,NA,77.8,81.5,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80",80,NA,NA,78,81.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80",80,NA,NA,78,81.9,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,78.7,82.8,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.2",79.2,NA,NA,72.6,84.5,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,73.4,84.5,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.3",80.3,NA,NA,75,84.8,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,75.5,85.1,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","64.7",64.7,NA,NA,50.2,76.9,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,52.3,76.1,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","57.5",57.5,NA,NA,39.2,74,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","56.5",56.5,NA,NA,40.8,71,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.5",84.5,NA,NA,82.1,86.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,82.2,86.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.1",84.1,NA,NA,81,86.8,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,81.4,87.2,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87",87,NA,NA,82.4,90.5,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,82,90,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.9",83.9,NA,NA,73.2,90.9,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,69.6,89.1,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.1",84.1,NA,NA,82,86.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,82.1,86.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.8",83.8,NA,NA,81,86.3,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,80.8,86.3,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,83.8,90.3,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.5",87.5,NA,NA,84,90.3,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.1",77.1,NA,NA,67.2,84.7,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,67.3,84.7,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.2",77.2,NA,NA,55.9,90.1,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,55.8,87.3,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","67.9",67.9,NA,NA,63.5,72,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.9",89.9,NA,NA,75.7,96.2,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.9",90.9,NA,NA,78.3,96.5,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.6",73.6,NA,NA,58,84.9,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.5",70.5,NA,NA,56,81.8,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","63.6",63.6,NA,NA,58.3,68.6,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","63.4",63.4,NA,NA,58.2,68.4,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,68.8,88.7,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,69.1,87.1,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.4,80.6,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.9",77.9,NA,NA,75.2,80.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.1",86.1,NA,NA,81.8,89.4,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,81.7,89.3,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,70.5,87.5,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,73.1,87.8,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.3",72.3,NA,NA,67.3,76.8,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,65.1,75.2,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.5",79.5,NA,NA,74.5,83.7,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,75.2,84.3,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,NA,NA,79.9,84.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,79.8,84.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.9",86.9,NA,NA,82.8,90.1,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,82.2,90.2,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.2",85.2,NA,NA,74.5,91.9,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,81.3,92.4,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.9",78.9,NA,NA,74.5,82.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,73.4,82.2,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,78.1,87.7,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,78.6,87.8,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.4",84.4,NA,NA,82.2,86.4,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85",85,NA,NA,83,86.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.7",84.7,NA,NA,82.5,86.7,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.1",85.1,NA,NA,83,87,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.3",91.3,NA,NA,76.9,97.1,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","92.2",92.2,NA,NA,81.3,97,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.1",76.1,NA,NA,73,79,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,73.1,78.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.7",76.7,NA,NA,73.5,79.6,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,73.8,79.7,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.1",77.1,NA,NA,62.8,87,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,59.2,81.3,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,78.6,84,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,78.8,84,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.5",80.5,NA,NA,77.2,83.4,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,77.1,83.6,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.6",86.6,NA,NA,78.2,92.1,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,78.7,91.6,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,79.1,92.7,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,78.3,92.1,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","59.9",59.9,NA,NA,39.1,77.7,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,57.8,80.5,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.9",77.9,NA,NA,75.9,79.9,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.6",78.6,NA,NA,76.7,80.4,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.8,80.2,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79",79,NA,NA,76.8,81,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,73.1,87.6,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,74.8,88,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.7",76.7,NA,NA,67.7,83.8,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.6",77.6,NA,NA,68.4,84.8,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","55.9",55.9,NA,NA,38.6,71.9,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,48,73.9,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.9",81.9,NA,NA,80.2,83.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,80.8,83.9,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.6",82.6,NA,NA,80.8,84.3,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,81.5,84.9,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,71.9,88.2,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,74.4,87.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.3",80.3,NA,NA,74.3,85.1,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,74.2,85,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","71.9",71.9,NA,NA,59.2,81.9,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,61.3,82,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.8",79.8,NA,NA,67.2,88.4,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,60.9,84.8,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.3",81.3,NA,NA,79,83.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,78.9,83.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.4",82.4,NA,NA,80.1,84.4,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.5",82.5,NA,NA,80.2,84.6,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.1",75.1,NA,NA,59.5,86.1,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.2",75.2,NA,NA,62.7,84.6,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.1",84.1,NA,NA,81.8,86.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84",84,NA,NA,81.8,85.9,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.9",83.9,NA,NA,81,86.4,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.8",83.8,NA,NA,80.9,86.3,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,83.4,90.5,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,82.9,89.7,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","71.3",71.3,NA,NA,55.6,83.1,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,58.3,83.4,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88",88,NA,NA,86.4,89.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,86.3,89.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90",90,NA,NA,88.4,91.4,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.3",90.3,NA,NA,88.6,91.7,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,78.7,92.1,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,78.8,91.6,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.6",83.6,NA,NA,76.2,89,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,75.8,88.8,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.3",75.3,NA,NA,65.8,82.8,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.5",77.5,NA,NA,69.8,83.8,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89",89,NA,NA,77.6,95,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.4",91.4,NA,NA,83.4,95.8,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.7",86.7,NA,NA,84.3,88.8,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,84.3,88.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.7",85.7,NA,NA,82.5,88.3,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,81.9,88.4,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.3",91.3,NA,NA,87.1,94.3,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.6",91.6,NA,NA,87.8,94.3,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.1",89.1,NA,NA,77.7,95,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.7",89.7,NA,NA,80.3,94.9,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72",72,NA,NA,57.2,83.2,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","69.6",69.6,NA,NA,59.4,78.2,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.4",91.4,NA,NA,78.5,96.8,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.3",89.3,NA,NA,75.6,95.8,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85",85,NA,NA,83,86.8,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.6",85.6,NA,NA,83.5,87.4,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.6",85.6,NA,NA,83.6,87.4,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.2",86.2,NA,NA,84.1,88,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,81.4,85.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,81.6,85.4,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.9",83.9,NA,NA,81.7,85.9,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84",84,NA,NA,81.7,86.1,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.9",84.9,NA,NA,79,89.3,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.2",85.2,NA,NA,79.6,89.4,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,73.2,92.6,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,67.8,92.2,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","67.7",67.7,NA,NA,53,79.6,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,60.3,82.7,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.5",68.5,NA,NA,51.2,81.9,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.3",68.3,NA,NA,53.4,80.1,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.1",86.1,NA,NA,84.9,87.2,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.2",86.2,NA,NA,85,87.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,86.2,88.5,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.5",87.5,NA,NA,86.3,88.7,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.4",78.4,NA,NA,70.2,84.8,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,72.6,85.9,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.6",84.6,NA,NA,76.9,90.1,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,75.1,89.2,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.6",73.6,NA,NA,64.6,81,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.8",74.8,NA,NA,65.9,82,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.8",80.8,NA,NA,78.1,83.2,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.1",81.1,NA,NA,78.5,83.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,77.7,83.2,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,77.7,83.3,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.6",83.6,NA,NA,74.4,89.9,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,76.2,90.1,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,80.3,86.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,79.6,85.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.6",83.6,NA,NA,79.2,87.2,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.1",83.1,NA,NA,78.8,86.7,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.5",85.5,NA,NA,80.9,89.1,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,79.8,88.1,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.1",81.1,NA,NA,78.4,83.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.7",81.7,NA,NA,79.1,84.1,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.3",82.3,NA,NA,79.4,84.8,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.9",82.9,NA,NA,80.1,85.4,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.8",78.8,NA,NA,69,86.2,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.7",77.7,NA,NA,68.1,85.1,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.9",85.9,NA,NA,84,87.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,84.1,87.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.7",87.7,NA,NA,85.5,89.7,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,85.6,89.8,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.3",85.3,NA,NA,80.9,88.8,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85",85,NA,NA,80.5,88.6,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,73.6,85.7,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,72.6,86.3,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.1",78.1,NA,NA,64.4,87.5,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,71.2,89.8,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.5",81.5,NA,NA,78.5,84.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,80,85,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,80.4,86,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,82,86.8,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","66.3",66.3,NA,NA,50.4,79.1,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,55.4,79.5,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.7",81.7,NA,NA,80,83.3,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,80.3,83.4,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,NA,NA,80.7,84.1,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.9",82.9,NA,NA,81.2,84.4,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.9",79.9,NA,NA,67.2,88.5,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,66.1,87.3,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.1",80.1,NA,NA,72.9,85.8,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79",79,NA,NA,71.8,84.8,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.3",74.3,NA,NA,59.7,84.9,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.6",78.6,NA,NA,68.6,86.1,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","69.4",69.4,NA,NA,50.8,83.3,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","72.2",72.2,NA,NA,56.8,83.7,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.6,87.7,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.5",85.5,NA,NA,82.6,87.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.5,87.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,82.4,88,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.7",83.7,NA,NA,81.9,85.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,81.8,85.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.1",85.1,NA,NA,83,86.9,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,83.5,87.8,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,82.9,90.5,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,82.3,90.1,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,81.5,88.6,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84",84,NA,NA,79.8,87.5,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68",68,NA,NA,58.2,76.4,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","67.9",67.9,NA,NA,59.4,75.4,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.1",79.1,NA,NA,76.5,81.4,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,77.1,81.8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.1",81.1,NA,NA,77.9,84,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82",82,NA,NA,78.5,85,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.6",79.6,NA,NA,75.2,83.3,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,76.5,83.6,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.3",74.3,NA,NA,66.7,80.6,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.8",74.8,NA,NA,67.6,80.9,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.3",78.3,NA,NA,73.9,82.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.7",78.7,NA,NA,74.5,82.4,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.9",81.9,NA,NA,77.5,85.5,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.9",82.9,NA,NA,78.7,86.5,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78",78,NA,NA,68.9,85,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,69.2,84,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","63.8",63.8,NA,NA,44.1,79.7,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,47.2,81.4,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.7",82.7,NA,NA,80.4,84.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83",83,NA,NA,80.8,85,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.8",84.8,NA,NA,82,87.2,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,82.6,87.8,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.2",87.2,NA,NA,82,91.1,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.4",87.4,NA,NA,82.3,91.1,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.9",85.9,NA,NA,80.7,89.9,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,80.2,89.4,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","62.9",62.9,NA,NA,51.6,72.9,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","67.6",67.6,NA,NA,57.5,76.3,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.5",81.5,NA,NA,79.3,83.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82",82,NA,NA,79.8,83.9,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.3",81.3,NA,NA,79,83.4,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.6,84,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.7",81.7,NA,NA,72.5,88.3,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.4",81.4,NA,NA,72.4,88,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,72.7,94.2,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.1",86.1,NA,NA,73.2,93.4,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","71.8",71.8,NA,NA,53.4,84.9,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.5",70.5,NA,NA,55.2,82.3,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77",77,NA,NA,74.6,79.3,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,75.1,79.5,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.5",76.5,NA,NA,73.6,79.1,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.8",76.8,NA,NA,74,79.5,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.6",79.6,NA,NA,69.9,86.7,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.3",78.3,NA,NA,69.7,85,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.9",81.9,NA,NA,73.8,87.9,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,77.8,89.3,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.8",76.8,NA,NA,69.6,82.7,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.7",77.7,NA,NA,71.2,83.1,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.9",70.9,NA,NA,51,85.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,65.6,85.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83",83,NA,NA,80.3,85.4,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,80.6,85.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.6",81.6,NA,NA,78.6,84.2,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.1",82.1,NA,NA,79.1,84.7,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.1",91.1,NA,NA,81.8,95.9,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","93.7",93.7,NA,NA,87.6,97,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.5",86.5,NA,NA,74,93.6,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.2",85.2,NA,NA,73.2,92.3,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,78.4,82.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,79.3,83.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.5",81.5,NA,NA,79.2,83.6,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82",82,NA,NA,79.6,84.2,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.4",82.4,NA,NA,75.3,87.8,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,78.1,88.8,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.6",79.6,NA,NA,61.7,90.4,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89",89,NA,NA,82.9,93.1,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","54.7",54.7,NA,NA,39.1,69.5,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,50.3,75.9,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.4",77.4,NA,NA,75,79.6,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,75.9,80.4,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.4",77.4,NA,NA,75,79.6,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,75.9,80.4,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.3,88,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,84.1,88.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.9",85.9,NA,NA,83.1,88.3,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,83.9,89.1,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,63.4,91.1,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.7",85.7,NA,NA,76.2,91.8,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88",88,NA,NA,79.7,93.3,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.7",89.7,NA,NA,83.9,93.6,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.8",81.8,NA,NA,63.5,92.1,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.6",85.6,NA,NA,73.5,92.7,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.3",82.3,NA,NA,80.3,84.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,80.3,84.1,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.2",80.2,NA,NA,77.4,82.7,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,77.6,82.8,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.2",86.2,NA,NA,82.9,89,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,82.6,88.6,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.6",90.6,NA,NA,77.4,96.5,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.9",90.9,NA,NA,81.2,95.9,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.5",72.5,NA,NA,56.2,84.4,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,55.8,83.2,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.5",84.5,NA,NA,81.4,87.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.1",85.1,NA,NA,82.2,87.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.4,88,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,82.9,88.4,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.7",83.7,NA,NA,80.3,86.7,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.9",78.9,NA,NA,65.4,88.1,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.9",78.9,NA,NA,68.8,86.3,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.5,87.9,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.5",85.5,NA,NA,82.7,87.9,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,80.1,86.5,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","92.2",92.2,NA,NA,85.7,95.9,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.3",90.3,NA,NA,82.4,94.9,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.8",84.8,NA,NA,82.2,87.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.9",84.9,NA,NA,82.3,87.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.2",82.2,NA,NA,79,85,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,79,85.2,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","93.1",93.1,NA,NA,88.7,95.9,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","92.9",92.9,NA,NA,88.7,95.6,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.7",77.7,NA,NA,75.5,79.7,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.9",77.9,NA,NA,75.7,79.9,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,77.8,83.2,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.6",80.6,NA,NA,77.7,83.2,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.8",80.8,NA,NA,73.6,86.4,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,72.9,86,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.6",75.6,NA,NA,71.9,78.9,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.5",75.5,NA,NA,71.8,78.9,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","69.9",69.9,NA,NA,54,82.1,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.6",75.6,NA,NA,66.5,82.9,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.7",82.7,"*","50 States + DC: US Median",81.3,84.1,"Overall","Overall",NA,"59","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,"*","50 States + DC: US Median",81.5,84,"Overall","Overall",NA,"59","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",79.3,84.8,"Overall","Overall",NA,"59","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.4",82.4,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",79,84.9,"Overall","Overall",NA,"59","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.3",77.3,NA,NA,75.6,78.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,76.3,79.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.2",78.2,NA,NA,76.4,79.9,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.8",78.8,NA,NA,77.2,80.3,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.8",76.8,NA,NA,71.2,81.5,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.8",75.8,NA,NA,69.8,81,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","67",67,NA,NA,56.4,76.1,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,58.6,77.3,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.2",85.2,NA,NA,83.2,87,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,83.4,87.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.2",85.2,NA,NA,82.9,87.2,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,83.7,87.8,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86",86,NA,NA,80.5,90.1,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.1",86.1,NA,NA,80.9,90,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89",89,NA,NA,81.6,93.6,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90",90,NA,NA,83,94.4,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.4",73.4,NA,NA,61,83,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,62.5,82.4,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.7",85.7,NA,NA,83.7,87.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,84.4,88,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.4",86.4,NA,NA,84.5,88.2,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.8",86.8,NA,NA,84.8,88.6,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81",81,NA,NA,78.7,83,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,79,83.2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.3",83.3,NA,NA,81.1,85.2,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,81.2,85.5,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,NA,NA,75.1,88,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,77.6,89.2,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","71.2",71.2,NA,NA,60.7,79.8,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.2",75.2,NA,NA,66.6,82.2,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.1",68.1,NA,NA,52.1,80.8,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,52.7,78.6,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.6",86.6,NA,NA,84.2,88.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.8",86.8,NA,NA,84.6,88.7,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.2",87.2,NA,NA,84.9,89.1,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.5",87.5,NA,NA,85.2,89.4,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.2",86.2,NA,NA,65.2,95.4,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,74.4,94.7,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.7",89.7,NA,NA,77.2,95.8,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.5",91.5,NA,NA,81.3,96.4,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.3",68.3,NA,NA,48.1,83.4,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.8",71.8,NA,NA,54.7,84.3,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.3",80.3,NA,NA,78,82.5,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,78.7,83,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,78.2,82.8,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,78.8,83.3,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81",81,NA,NA,77.8,83.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.4",80.4,NA,NA,77.3,83.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.2",80.2,NA,NA,76.6,83.3,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.8",79.8,NA,NA,76.3,82.9,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.3",89.3,NA,NA,79.3,94.8,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.1",85.1,NA,NA,74.6,91.7,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","WHT"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","BLK"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","HIS"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","OTH"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","MRC"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.3",79.3,NA,NA,74.6,83.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.2",84.2,NA,NA,79,88.4,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","65.7",65.7,NA,NA,54.1,75.6,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,83.3,88.9,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,77.4,85.7,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","93.2",93.2,NA,NA,89.7,95.6,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.4",79.4,NA,NA,64.8,89,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.8",80.8,NA,NA,75.3,85.4,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.7",78.7,NA,NA,71.6,84.3,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.5",89.5,NA,NA,77.8,95.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.3",80.3,NA,NA,76.8,83.3,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,76.8,84.8,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,73.5,86.3,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","74.8",74.8,NA,NA,63.4,83.5,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,78.8,84.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,76,85.3,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.9",84.9,NA,NA,71.2,92.8,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.3",87.3,NA,NA,83.2,90.5,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","69.2",69.2,NA,NA,58.3,78.4,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.5,87.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.4",87.4,NA,NA,84.8,89.6,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,80.2,90,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","74.8",74.8,NA,NA,58.6,86.2,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.3",88.3,NA,NA,84.9,91,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.8",89.8,NA,NA,85.2,93.2,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.3",85.3,NA,NA,74.4,92.1,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.9",85.9,NA,NA,78,91.3,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.7",84.7,NA,NA,79.2,89,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.8",83.8,NA,NA,75.5,89.7,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.4",90.4,NA,NA,82,95.1,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.1",84.1,NA,NA,79.1,88,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.5",87.5,NA,NA,81.6,91.7,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.5",76.5,NA,NA,63.5,85.9,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","92.6",92.6,NA,NA,83.9,96.8,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,77.3,83.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.4",83.4,NA,NA,78.9,87,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.7",76.7,NA,NA,66.3,84.6,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.4",81.4,NA,NA,74.8,86.6,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.2",81.2,NA,NA,78.4,83.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.3",83.3,NA,NA,80.2,86,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.1",80.1,NA,NA,71.5,86.6,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.1",79.1,NA,NA,71.7,85,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","60.2",60.2,NA,NA,42,76,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","68.7",68.7,NA,NA,44.6,85.6,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.6",86.6,NA,NA,83.3,89.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.1",86.1,NA,NA,81.3,89.8,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.3",88.3,NA,NA,82.1,92.6,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.7",84.7,NA,NA,81.5,87.3,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.1",83.1,NA,NA,78.7,86.8,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.9",89.9,NA,NA,85.2,93.3,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.8",78.8,NA,NA,67.2,87.1,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","67.3",67.3,NA,NA,61.6,72.6,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","61.2",61.2,NA,NA,54.2,67.8,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,66.8,91,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.8",75.8,NA,NA,71.6,79.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.9",87.9,NA,NA,80.1,92.9,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.8",79.8,NA,NA,66.8,88.6,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","65.4",65.4,NA,NA,57.3,72.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.7",77.7,NA,NA,70.9,83.4,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.5",81.5,NA,NA,77.7,84.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.2",86.2,NA,NA,78.9,91.3,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.2",82.2,NA,NA,68.1,90.9,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.1",76.1,NA,NA,69.2,81.9,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85",85,NA,NA,77.8,90.1,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.1",85.1,NA,NA,81.7,88,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.9",85.9,NA,NA,82.4,88.8,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.8",90.8,NA,NA,74.3,97.1,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.2",79.2,NA,NA,74.9,82.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.7",79.7,NA,NA,75.3,83.5,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.5",81.5,NA,NA,63.7,91.7,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.2",82.2,NA,NA,77.8,85.9,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.1",82.1,NA,NA,76.7,86.5,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.4",86.4,NA,NA,73.5,93.6,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.9",88.9,NA,NA,78.5,94.6,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.3",79.3,NA,NA,76.2,82.1,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.2",80.2,NA,NA,76.6,83.3,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.4",79.4,NA,NA,68,87.4,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.2",76.2,NA,NA,65.8,84.2,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.3",83.3,NA,NA,80.8,85.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.5",84.5,NA,NA,81.7,86.9,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.5",82.5,NA,NA,67.7,91.4,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,74,86.6,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.1",84.1,NA,NA,80.6,87.1,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86",86,NA,NA,82.8,88.7,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","72.8",72.8,NA,NA,49.6,88,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86",86,NA,NA,82.8,88.7,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.2",86.2,NA,NA,81.8,89.6,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.4",88.4,NA,NA,83.1,92.3,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.1",86.1,NA,NA,83.4,88.5,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.8",89.8,NA,NA,86.9,92.2,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85",85,NA,NA,73.5,92,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78",78,NA,NA,67.1,86.1,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","70.4",70.4,NA,NA,58.5,80.1,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86",86,NA,NA,81.9,89.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,77.5,88.5,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","93",93,NA,NA,86,96.6,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.7",87.7,NA,NA,73.5,94.8,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","67.2",67.2,NA,NA,46.2,83,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.6",85.6,NA,NA,82.1,88.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.6",86.6,NA,NA,83,89.5,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.7",82.7,NA,NA,79.6,85.4,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.9",82.9,NA,NA,79.2,86.1,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.6",84.6,NA,NA,76.3,90.4,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.9",86.9,NA,NA,73.1,94.2,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.1",86.1,NA,NA,84.3,87.8,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.2",88.2,NA,NA,86.4,89.9,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.6",76.6,NA,NA,66.2,84.6,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,77.4,92.1,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.5",73.5,NA,NA,62.9,82,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.4",81.4,NA,NA,77.4,84.9,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,76.7,84.9,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,83.7,91,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.2",89.2,NA,NA,83.1,93.2,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.4",88.4,NA,NA,82.4,92.5,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,79.5,87,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.5",85.5,NA,NA,81.1,89,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.7",78.7,NA,NA,65,88.1,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.2,88.1,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88",88,NA,NA,84.6,90.8,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.9",86.9,NA,NA,80.8,91.3,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.3",80.3,NA,NA,72.8,86.2,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.1",83.1,NA,NA,78.4,86.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86",86,NA,NA,81.3,89.8,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","64.6",64.6,NA,NA,44.9,80.3,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,79.3,84.3,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.9",82.9,NA,NA,80.1,85.5,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.4",84.4,NA,NA,68.7,93.1,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.4",80.4,NA,NA,71.8,86.9,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","69.6",69.6,NA,NA,49.2,84.3,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84",84,NA,NA,79,88,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,78.4,87.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.9",83.9,NA,NA,81.2,86.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.6",87.6,NA,NA,84.1,90.5,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.7",85.7,NA,NA,79.2,90.4,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,80.7,89.7,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","63.6",63.6,NA,NA,50.9,74.7,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76",76,NA,NA,64.8,84.5,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.3",79.3,NA,NA,75.4,82.7,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.2",84.2,NA,NA,78.8,88.4,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.6",79.6,NA,NA,73.5,84.5,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","71.8",71.8,NA,NA,60.9,80.6,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.2",79.2,NA,NA,72.7,84.4,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.1",88.1,NA,NA,82.1,92.2,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.4",81.4,NA,NA,77.8,84.5,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.9",85.9,NA,NA,81.1,89.7,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.4",86.4,NA,NA,78.9,91.6,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.7",82.7,NA,NA,75,88.3,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","57.4",57.4,NA,NA,43.7,70.1,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.9",82.9,NA,NA,79.6,85.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.3",83.3,NA,NA,79.7,86.4,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.5",80.5,NA,NA,66.5,89.5,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.2",79.2,NA,NA,75.7,82.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.4",80.4,NA,NA,76.1,84.2,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.8",78.8,NA,NA,64.5,88.3,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,71.1,87.6,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.7",78.7,NA,NA,69.4,85.8,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,81.4,88.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.6",85.6,NA,NA,81.2,89.1,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,75.5,94.4,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,77.5,84.3,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,79.8,87,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.1",82.1,NA,NA,72.3,89,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.1",77.1,NA,NA,73.8,80.1,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.1",77.1,NA,NA,73.8,80.1,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.2",85.2,NA,NA,81,88.6,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.2",86.2,NA,NA,81,90.1,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.7",86.7,NA,NA,75.2,93.3,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.9",84.9,NA,NA,82,87.4,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.7",81.7,NA,NA,77.4,85.3,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90",90,NA,NA,85.7,93.2,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.6",90.6,NA,NA,74.6,97,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.5",86.5,NA,NA,81.8,90.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,83.4,91.1,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.5",83.5,NA,NA,64.9,93.3,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.8",86.8,NA,NA,82.4,90.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.6",84.6,NA,NA,79.1,88.9,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","93.3",93.3,NA,NA,83.2,97.5,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.2",86.2,NA,NA,82.4,89.4,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.1",83.1,NA,NA,78.1,87.1,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","94.8",94.8,NA,NA,88.5,97.7,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.2",78.2,NA,NA,75.3,80.9,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.1",83.1,NA,NA,78.9,86.6,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.4",80.4,NA,NA,70.7,87.4,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.9",76.9,NA,NA,72.6,80.7,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","65.5",65.5,NA,NA,47.8,79.7,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"US","United States","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84",84,"*","50 States + DC: US Median",82.2,85.1,"Overall","Overall",NA,"59","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"US","United States","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.5",81.5,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",79.4,86.2,"Overall","Overall",NA,"59","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.4",77.4,NA,NA,75.3,79.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.4",78.4,NA,NA,76.1,80.5,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.4",78.4,NA,NA,72.1,83.6,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","66.3",66.3,NA,NA,53.4,77.1,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.9",85.9,NA,NA,82.9,88.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.6",87.6,NA,NA,84.1,90.4,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.1",85.1,NA,NA,76.6,90.9,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88",88,NA,NA,79,93.4,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","69.6",69.6,NA,NA,53.7,81.9,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.7",85.7,NA,NA,82.4,88.5,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,83,89.1,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.1",79.1,NA,NA,75.6,82.2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.5",83.5,NA,NA,79.9,86.6,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.5",80.5,NA,NA,71.5,87.2,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","66.8",66.8,NA,NA,53.6,77.8,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87",87,NA,NA,83.3,89.9,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.6",88.6,NA,NA,85,91.5,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.3",84.3,NA,NA,81,87.1,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.5",84.5,NA,NA,81,87.4,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.9",57.9,NA,NA,54.9,60.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.4",84.4,NA,NA,79.5,88.3,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.8",82.8,NA,NA,77,87.4,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","MRC"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","WHT"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","BLK"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","HIS"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","OTH"
2013,2013,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,55.7,61.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,51.9,60.4,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.4",57.4,NA,NA,53.2,61.5,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,55.6,63.7,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,55.9,63.7,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.9",57.9,NA,NA,54.9,60.9,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,55.6,61.5,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.9",56.9,NA,NA,47.4,66,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56",56,NA,NA,47.2,64.5,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.7",69.7,NA,NA,51,83.5,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.5",70.5,NA,NA,53.3,83.4,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,60.7,64.6,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.9",61.9,NA,NA,60,63.8,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,57.9,64.3,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61",61,NA,NA,57.8,64,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,61.7,66.3,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,60.5,65,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,61.8,66.1,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,NA,NA,60.4,64.7,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.8",61.8,NA,NA,57.6,65.8,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,58.2,66.1,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","34.3",34.3,NA,NA,21.3,50.3,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","39",39,NA,NA,29.1,49.8,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.2",52.2,NA,NA,34.4,69.5,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.1",50.1,NA,NA,34.5,65.7,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,55.8,61,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.1",57.1,NA,NA,54.4,59.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,51.5,59.9,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.9",54.9,NA,NA,50.7,59.1,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.9",60.9,NA,NA,57.6,64,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.2",59.2,NA,NA,55.9,62.5,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59",59,NA,NA,56.1,61.8,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.1",57.1,NA,NA,54.2,60,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,47.8,63.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.3",57.3,NA,NA,49.8,64.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73",73,NA,NA,57.4,84.4,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.2",70.2,NA,NA,57.3,80.5,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.3",61.3,NA,NA,59.6,62.9,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60",60,NA,NA,58.3,61.7,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.8",59.8,NA,NA,57.2,62.4,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.5",58.5,NA,NA,55.8,61.1,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,60.5,64.6,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.4",61.4,NA,NA,59.2,63.5,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.4",64.4,NA,NA,62.7,66.1,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,NA,NA,60.8,64.4,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,53.1,73.7,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.6",63.6,NA,NA,54,72.3,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.2",50.2,NA,NA,44.8,55.6,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.5",51.5,NA,NA,46.4,56.5,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.3",50.3,NA,NA,42.3,58.3,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.3",50.3,NA,NA,42.6,58.1,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.1",67.1,NA,NA,50.1,80.5,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.1",71.1,NA,NA,57.1,81.9,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,58.8,63.3,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.6",60.6,NA,NA,58.4,62.8,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.1",59.1,NA,NA,55.8,62.4,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.6",59.6,NA,NA,56.4,62.7,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.9",62.9,NA,NA,59.7,66,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,58.6,64.9,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.4",67.4,NA,NA,64.8,69.9,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.9",65.9,NA,NA,63.4,68.4,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73",73,NA,NA,64.3,80.2,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,64.2,79.4,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","44.8",44.8,NA,NA,39.9,49.8,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","45",45,NA,NA,40.1,50,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.6",57.6,NA,NA,48.3,66.4,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.8",55.8,NA,NA,47,64.1,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.5",58.5,NA,NA,42.4,73,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,46.8,74.9,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,63.1,66,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64",64,NA,NA,62.6,65.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,60.4,64.7,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,59.7,63.9,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,64.4,68.3,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66",66,NA,NA,64.1,67.9,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.2",66.2,NA,NA,64.7,67.8,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.4",65.4,NA,NA,63.9,66.9,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,63.4,80.4,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,60.9,78.3,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.5",52.5,NA,NA,47.2,57.7,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.7",53.7,NA,NA,48.6,58.6,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.8",64.8,NA,NA,53.4,74.7,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.1",68.1,NA,NA,58.1,76.6,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.7",56.7,NA,NA,43.2,69.2,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.9",55.9,NA,NA,44.1,67,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.9",70.9,NA,NA,69,72.8,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,68.8,72.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.5",69.5,NA,NA,66.6,72.3,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,66.6,72.2,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.2",72.2,NA,NA,69.6,74.7,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72",72,NA,NA,69.3,74.5,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,70.5,74.7,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.2",72.2,NA,NA,70.1,74.2,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.7",69.7,NA,NA,61.6,76.8,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,61.2,76.2,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.2",60.2,NA,NA,51.6,68.3,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,55,70.7,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.4",59.4,NA,NA,44.4,72.8,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.5",58.5,NA,NA,45.6,70.2,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,60.6,67.2,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.8",63.8,NA,NA,60.5,67.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.7",61.7,NA,NA,56.1,67,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,56.6,67.4,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66",66,NA,NA,61.9,69.8,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.3",65.3,NA,NA,61.3,69.1,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.2",71.2,NA,NA,66.6,75.4,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,65.7,74.6,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.6",58.6,NA,NA,53.5,63.5,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.8",58.8,NA,NA,53.8,63.7,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,38.4,71.8,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57",57,NA,NA,41.6,71.1,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.8",68.8,NA,NA,66.2,71.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.1",68.1,NA,NA,65.6,70.5,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,63.1,71.1,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.5",66.5,NA,NA,62.5,70.3,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.2",70.2,NA,NA,67,73.2,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.6",69.6,NA,NA,66.4,72.6,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.7",70.7,NA,NA,68,73.3,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.6",69.6,NA,NA,66.8,72.3,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,56.3,71.1,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.8",64.8,NA,NA,57.8,71.2,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,40,71.3,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.5",62.5,NA,NA,50.3,73.3,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,53.8,73.2,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.5",62.5,NA,NA,52.4,71.5,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.2",64.2,NA,NA,62.3,66,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.5",62.5,NA,NA,60.7,64.3,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.3",61.3,NA,NA,58.3,64.1,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,57.1,62.7,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.8",66.8,NA,NA,64.5,69,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.8",64.8,NA,NA,62.6,67.1,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,65.9,69.8,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,63.1,67,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,NA,NA,59.5,71.5,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67",67,NA,NA,61.4,72.3,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.7",52.7,NA,NA,46.7,58.6,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.1",53.1,NA,NA,47.6,58.4,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.3",50.3,NA,NA,37.5,63,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.6",52.6,NA,NA,40.6,64.3,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.1",58.1,NA,NA,43,71.9,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.5",57.5,NA,NA,42.8,71,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,NA,NA,61.7,66.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.8",63.8,NA,NA,61.6,66,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,NA,NA,58.7,65.8,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,58.8,65.7,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,62.6,68.2,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,62.4,67.9,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66",66,NA,NA,63.4,68.5,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65",65,NA,NA,62.4,67.6,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66",66,NA,NA,61.4,70.4,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,61.5,70.5,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","25.9",25.9,NA,NA,15.9,39.3,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","32.7",32.7,NA,NA,21.4,46.3,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","40.7",40.7,NA,NA,36.4,45.1,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","41.5",41.5,NA,NA,37.1,45.9,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","43.7",43.7,NA,NA,37.4,50.2,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","44.5",44.5,NA,NA,38.4,50.9,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","37.5",37.5,NA,NA,31.8,43.5,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","38.2",38.2,NA,NA,32.5,44.2,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.2",60.2,NA,NA,44.9,73.8,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.4",58.4,NA,NA,45.2,70.4,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","49.8",49.8,NA,NA,35.6,64,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.2",50.2,NA,NA,38.3,62,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","37",37,NA,NA,31.9,42.4,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","37.1",37.1,NA,NA,32,42.5,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","38.9",38.9,NA,NA,27.7,51.4,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","36.7",36.7,NA,NA,26,48.8,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,63.8,68.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,62.8,67.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,60.7,67.3,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.6",63.6,NA,NA,60.3,66.8,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.1",68.1,NA,NA,64.9,71.2,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.7",66.7,NA,NA,63.4,69.9,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,64.1,71.5,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,63,70.6,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65",65,NA,NA,55.9,73,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,57.6,74,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.5",66.5,NA,NA,62.7,70.2,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65",65,NA,NA,61.1,68.8,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.7",64.7,NA,NA,60.3,68.9,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.4",64.4,NA,NA,60,68.7,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,NA,NA,64,67.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,63.2,66.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.8",63.8,NA,NA,61,66.5,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,60.4,65.9,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.7",67.7,NA,NA,65.3,70,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,64.5,69.2,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.1",67.1,NA,NA,65.3,68.9,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,64.5,68.1,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.5",47.5,NA,NA,31.3,64.3,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.7",48.7,NA,NA,34.1,63.6,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.1",59.1,NA,NA,56.6,61.6,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.7",57.7,NA,NA,55.3,60.1,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57",57,NA,NA,53.1,60.8,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.5",55.5,NA,NA,51.7,59.3,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,57.8,64.4,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.7",59.7,NA,NA,56.6,62.7,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.9",60.9,NA,NA,58.3,63.5,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.1",59.1,NA,NA,56.5,61.6,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","46.4",46.4,NA,NA,32.6,60.9,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.6",48.6,NA,NA,36.4,61,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,57.9,63,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.3",60.3,NA,NA,57.8,62.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.1",60.1,NA,NA,56.1,64.1,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,55.6,63.4,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.8",60.8,NA,NA,57.5,64,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.9",60.9,NA,NA,57.7,64.1,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,60,65.3,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,59.6,64.9,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.4",56.4,NA,NA,48.1,64.4,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.9",55.9,NA,NA,48.2,63.3,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.2",50.2,NA,NA,38.8,61.6,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.2",51.2,NA,NA,40.2,62.2,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.7",58.7,NA,NA,42.3,73.3,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.2",52.2,NA,NA,38.1,66,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.6",59.6,NA,NA,58,61.2,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,57.9,61.1,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.1",57.1,NA,NA,54.5,59.5,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.2",57.2,NA,NA,54.8,59.7,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62",62,NA,NA,60,64.1,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,59.4,63.5,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.3",60.3,NA,NA,58.6,62,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60",60,NA,NA,58.4,61.7,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.2",58.2,NA,NA,50.9,65.1,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.8",58.8,NA,NA,51.5,65.7,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","42.8",42.8,NA,NA,29.9,56.8,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","46.4",46.4,NA,NA,34.1,59.3,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,43.2,74.2,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.5",60.5,NA,NA,46.5,73,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.5",52.5,NA,NA,35.5,68.9,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.2",52.2,NA,NA,34.6,69.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,NA,NA,60.9,63.7,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,60.1,62.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.6",61.6,NA,NA,59.5,63.7,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.8",60.8,NA,NA,58.8,62.9,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63",63,NA,NA,61.2,64.8,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,60.3,63.9,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.2",64.2,NA,NA,62.7,65.6,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.9",62.9,NA,NA,61.5,64.3,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.8",57.8,NA,NA,50.4,64.8,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,51.5,65.4,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","37.8",37.8,NA,NA,30.3,45.9,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","40.2",40.2,NA,NA,32.5,48.4,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,45.4,66.4,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.1",55.1,NA,NA,44.7,65.1,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,45.1,65.8,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55",55,NA,NA,44.4,65.3,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,62.9,66.8,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,61.9,65.8,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,59.2,65.6,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,58.6,64.8,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,64.8,69.4,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,63.7,68.4,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.2",65.2,NA,NA,63.2,67.2,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,62.1,66.1,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.1",62.1,NA,NA,51.9,71.3,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,52.3,70.5,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.7",60.7,NA,NA,40.5,77.7,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,44.5,76.5,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","39.9",39.9,NA,NA,24.1,58,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","42.9",42.9,NA,NA,32.1,54.5,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.4",61.4,NA,NA,59.4,63.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.7",60.7,NA,NA,58.8,62.7,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.2",58.2,NA,NA,55,61.4,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58",58,NA,NA,54.9,61,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,61.7,66.6,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,60.8,65.6,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.1",62.1,NA,NA,59.7,64.4,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.6",60.6,NA,NA,58.3,62.9,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.4",60.4,NA,NA,56.4,64.3,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61",61,NA,NA,57.1,64.8,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","41.3",41.3,NA,NA,26.2,58.2,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.8",43.8,NA,NA,31.2,57.2,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.1",62.1,NA,NA,47.7,74.6,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,45.5,70.5,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.6",72.6,NA,NA,71,74.2,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.5",72.5,NA,NA,70.9,74,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.3",72.3,NA,NA,69.9,74.6,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.2",72.2,NA,NA,69.8,74.6,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73",73,NA,NA,70.8,75,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.7",72.7,NA,NA,70.6,74.7,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.6",74.6,NA,NA,73,76.2,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.3",74.3,NA,NA,72.7,75.9,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,53.2,70.7,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.3",61.3,NA,NA,52.5,69.4,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.1",60.1,NA,NA,51.2,68.3,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,54.2,70.6,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.1",62.1,NA,NA,50.9,72.2,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,53.7,73,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.8",74.8,NA,NA,61.5,84.6,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.9",73.9,NA,NA,61.2,83.6,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.6",68.6,NA,NA,66.7,70.5,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,66.8,70.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.3",67.3,NA,NA,64.1,70.4,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.6",67.6,NA,NA,64.7,70.3,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.8",69.8,NA,NA,67.4,72.1,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,67.2,71.7,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.4",69.4,NA,NA,67.3,71.5,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,66.6,70.7,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,63.3,72.1,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,66.5,73.9,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,48.5,77.9,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64",64,NA,NA,51.2,75,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,53.5,73.9,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.4",59.4,NA,NA,50.4,67.9,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.1",73.1,NA,NA,58,84.2,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.2",68.2,NA,NA,55.7,78.5,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.4",73.4,NA,NA,71.8,75,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,70.9,74.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.2",71.2,NA,NA,68.5,73.8,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,67.5,72.9,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","75.5",75.5,NA,NA,73.5,77.4,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.8",74.8,NA,NA,72.7,76.8,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.2",74.2,NA,NA,72.5,75.8,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.4",73.4,NA,NA,71.7,75.1,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.3",54.3,NA,NA,39.4,68.4,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.2",52.2,NA,NA,38.5,65.5,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.8",68.8,NA,NA,67.1,70.5,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.4",68.4,NA,NA,66.7,70,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67",67,NA,NA,64.3,69.5,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67",67,NA,NA,64.4,69.4,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.6",70.6,NA,NA,68.3,72.7,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,67.6,72,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.6",69.6,NA,NA,67.7,71.3,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.1",69.1,NA,NA,67.2,70.8,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.8",69.8,NA,NA,63.8,75.2,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.7",69.7,NA,NA,64.1,74.9,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.3",66.3,NA,NA,50.7,79,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,48.8,80.1,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.8",50.8,NA,NA,35.5,65.8,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.3",57.3,NA,NA,45.1,68.7,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.5",56.5,NA,NA,42.1,69.9,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58",58,NA,NA,45.3,69.7,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.7",68.7,NA,NA,67.4,69.9,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.4",68.4,NA,NA,67.2,69.6,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,64.5,68.2,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,64.5,68.2,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.9",70.9,NA,NA,69.2,72.5,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,68.8,72,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.8",69.8,NA,NA,68.6,71.1,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,68.2,70.6,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.5",63.5,NA,NA,53.8,72.2,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,57.8,74.1,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.8",51.8,NA,NA,40.1,63.3,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,48.8,69.3,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","49.8",49.8,NA,NA,38.9,60.6,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.6",50.6,NA,NA,41.8,59.3,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.7",69.7,NA,NA,52.3,82.8,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,55,82.7,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.8",59.8,NA,NA,57.5,62,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.4",59.4,NA,NA,57.1,61.6,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.6",54.6,NA,NA,51.1,58,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.2",54.2,NA,NA,50.7,57.7,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,61.5,67.3,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,61,66.7,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.2",60.2,NA,NA,57.8,62.6,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,57,61.8,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.7",61.7,NA,NA,53.6,69.3,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,54,69.9,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,34.9,75.4,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.1",48.1,NA,NA,33.4,63.1,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.3",65.3,NA,NA,47.9,79.5,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.2",61.2,NA,NA,47.4,73.4,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.7",57.7,NA,NA,54.9,60.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.1",57.1,NA,NA,54.4,59.7,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.7",56.7,NA,NA,52.2,61.1,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.3",56.3,NA,NA,52,60.5,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.5",58.5,NA,NA,55.1,61.9,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.9",57.9,NA,NA,54.6,61.2,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.6",59.6,NA,NA,56.1,63,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.2",58.2,NA,NA,54.8,61.5,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.7",54.7,NA,NA,49.8,59.4,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.7",55.7,NA,NA,51.2,60.1,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.1",60.1,NA,NA,58,62.2,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.2",58.2,NA,NA,56,60.3,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.5",59.5,NA,NA,56.4,62.6,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.3",57.3,NA,NA,54.2,60.4,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.7",60.7,NA,NA,57.7,63.6,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.1",59.1,NA,NA,56.1,62,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.3",61.3,NA,NA,59,63.5,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.1",59.1,NA,NA,56.8,61.3,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.9",60.9,NA,NA,41.5,77.4,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,44.3,76.3,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","41.8",41.8,NA,NA,33.3,50.7,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.8",43.8,NA,NA,36.6,51.3,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.5",54.5,NA,NA,37.6,70.4,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.8",58.8,NA,NA,43.9,72.3,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.5",68.5,NA,NA,66.6,70.3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.3",67.3,NA,NA,65.4,69.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65",65,NA,NA,62.1,67.8,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,60.8,66.8,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.4",71.4,NA,NA,68.9,73.7,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,67.8,72.6,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.2",70.2,NA,NA,68,72.2,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,66.3,70.8,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.2",68.2,NA,NA,63.8,72.3,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.5",67.5,NA,NA,63.2,71.6,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","31.5",31.5,NA,NA,21.8,43,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","31.8",31.8,NA,NA,21.6,44,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.3",61.3,NA,NA,48.7,72.6,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.4",60.4,NA,NA,49.1,70.7,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,57.5,61.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.3",59.3,NA,NA,57.1,61.4,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.3",58.3,NA,NA,55,61.6,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58",58,NA,NA,54.7,61.2,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,58.3,63.9,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.6",60.6,NA,NA,57.8,63.4,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.6",60.6,NA,NA,58.4,62.8,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,57.6,62.1,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.5",51.5,NA,NA,37.8,65,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.1",53.1,NA,NA,40.2,65.6,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,61,63.7,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,60.4,63.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.2",61.2,NA,NA,59.2,63.3,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.7",60.7,NA,NA,58.6,62.8,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61.6,65.2,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.7",62.7,NA,NA,60.9,64.6,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,62.2,65,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.9",62.9,NA,NA,61.5,64.3,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.3",63.3,NA,NA,52.1,73.2,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62",62,NA,NA,51.6,71.3,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","32.2",32.2,NA,NA,24.4,41.1,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","34.1",34.1,NA,NA,26.5,42.7,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,46,69.9,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,49.7,68.5,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.1",59.1,NA,NA,40.5,75.3,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.3",59.3,NA,NA,46.6,70.9,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71",71,NA,NA,68.8,73,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,68.7,72.8,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.8",70.8,NA,NA,67.4,74,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.5",70.5,NA,NA,67.3,73.6,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.1",71.1,NA,NA,68.3,73.8,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.1",71.1,NA,NA,68.3,73.7,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,69.2,73.6,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.3",71.3,NA,NA,69.1,73.3,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.5",52.5,NA,NA,35,69.4,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.4",54.4,NA,NA,38.6,69.4,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,60.6,64.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,NA,NA,60.8,64.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,60.6,66,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.6",63.6,NA,NA,61,66.2,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.8",61.8,NA,NA,59.2,64.3,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.7",61.7,NA,NA,59.3,64.1,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,63.4,67.4,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.6",64.6,NA,NA,62.6,66.5,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61",61,NA,NA,55.4,66.4,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,NA,NA,57.2,67.6,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.3",54.3,NA,NA,47.9,60.6,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.2",57.2,NA,NA,51.2,62.9,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.4",52.4,NA,NA,42.5,62.2,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53",53,NA,NA,44,61.7,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.6",59.6,NA,NA,57.5,61.6,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.9",58.9,NA,NA,56.8,60.9,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.5",59.5,NA,NA,56.4,62.6,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.2",59.2,NA,NA,56,62.2,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.6",59.6,NA,NA,56.9,62.3,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.7",58.7,NA,NA,55.9,61.4,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,61.8,66.7,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.9",62.9,NA,NA,60.3,65.5,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.1",73.1,NA,NA,56.6,85,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,63.2,85.7,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53",53,NA,NA,49,56.9,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.5",52.5,NA,NA,48.6,56.5,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.2",53.2,NA,NA,45.3,60.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.6",54.6,NA,NA,47,62,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.5",57.5,NA,NA,53.9,61.1,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.3",56.3,NA,NA,52.9,59.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.7",53.7,NA,NA,48.1,59.2,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.6",53.6,NA,NA,48.3,58.8,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.2",61.2,NA,NA,56.5,65.7,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.4",58.4,NA,NA,54.1,62.5,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.4",61.4,NA,NA,57.7,65.1,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,56.4,63.7,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.8",61.8,NA,NA,45.6,75.8,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.7",58.7,NA,NA,43.3,72.6,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","37.1",37.1,NA,NA,26.1,49.7,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","42.6",42.6,NA,NA,32.1,53.7,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.9",50.9,NA,NA,34.6,67,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","46.7",46.7,NA,NA,36.3,57.5,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.8",56.8,NA,NA,31.1,79.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.1",55.1,NA,NA,42.3,67.2,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.7",65.7,NA,NA,63.6,67.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.3",65.3,NA,NA,63.1,67.4,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,60.8,67.3,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,60.6,67,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,64.3,69.9,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,63.5,69,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.2",68.2,NA,NA,65.8,70.5,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,65,69.7,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.6",65.6,NA,NA,59.3,71.4,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,59.7,71.3,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,52,67,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.3",60.3,NA,NA,52.6,67.5,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.6",54.6,NA,NA,42.5,66.3,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.2",56.2,NA,NA,45.6,66.3,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.9",62.9,NA,NA,61,64.7,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.4",62.4,NA,NA,60.5,64.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.1",63.1,NA,NA,60.2,66,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,NA,NA,59.7,65.4,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,60.3,65,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.2",62.2,NA,NA,59.8,64.5,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,60.7,64.6,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62",62,NA,NA,60,63.9,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.6",68.6,NA,NA,61.5,75,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.7",69.7,NA,NA,63,75.6,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.4",52.4,NA,NA,35.3,69,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.1",56.1,NA,NA,44,67.5,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","43.8",43.8,NA,NA,29.2,59.6,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","46.3",46.3,NA,NA,32.4,60.9,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.5",56.5,NA,NA,54.7,58.3,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.9",55.9,NA,NA,54.1,57.6,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.8",52.8,NA,NA,50,55.6,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.7",52.7,NA,NA,50,55.4,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.9",59.9,NA,NA,57.6,62.2,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.9",58.9,NA,NA,56.6,61.2,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.9",57.9,NA,NA,55.9,59.9,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.7",56.7,NA,NA,54.7,58.7,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,50.5,65.8,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.6",57.6,NA,NA,49.7,65.1,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","34.5",34.5,NA,NA,25,45.6,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","36.2",36.2,NA,NA,26.2,47.6,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.1",55.1,NA,NA,47.5,62.6,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.6",55.6,NA,NA,48.9,62.1,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.3",51.3,NA,NA,43.4,59.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.2",53.2,NA,NA,46.1,60.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61,65.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.2",62.2,NA,NA,59.8,64.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.3",60.3,NA,NA,56.5,63.9,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.3",59.3,NA,NA,55.7,62.8,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.3",66.3,NA,NA,63.3,69.1,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,62,68.2,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.8",64.8,NA,NA,62.4,67.1,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.5",63.5,NA,NA,60.9,65.9,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.4",52.4,NA,NA,37.9,66.6,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.6",53.6,NA,NA,39.7,67.1,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","43.5",43.5,NA,NA,27.2,61.3,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","45.9",45.9,NA,NA,30.8,61.7,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,52.2,73.6,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,49.7,69.6,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,62.8,66.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64",64,NA,NA,62.3,65.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63",63,NA,NA,60.4,65.6,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,60.1,65.4,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,NA,NA,63.6,68,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,62.9,67.4,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.7",65.7,NA,NA,63.9,67.4,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65",65,NA,NA,63.2,66.8,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.2",62.2,NA,NA,55.7,68.4,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.2",61.2,NA,NA,54.8,67.3,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.6",51.6,NA,NA,37.2,65.7,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49",49,NA,NA,36.1,62.1,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.3",52.3,NA,NA,36.3,67.8,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.1",56.1,NA,NA,41.5,69.7,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.6",51.6,NA,NA,49.3,53.9,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.8",50.8,NA,NA,48.5,53.2,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.1",51.1,NA,NA,47.3,54.9,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.4",50.4,NA,NA,46.6,54.3,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52",52,NA,NA,49.2,54.8,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.3",51.3,NA,NA,48.6,54.1,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.5",51.5,NA,NA,49.1,53.8,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.6",50.6,NA,NA,48.3,53,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,69.5,73.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.1",71.1,NA,NA,69.1,73.1,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.9",71.9,NA,NA,68.7,74.8,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,68.3,74.6,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.3",71.3,NA,NA,68.7,73.7,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.7",70.7,NA,NA,68.1,73.2,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.5",73.5,NA,NA,71.4,75.5,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,70.8,74.9,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.7",66.7,NA,NA,51.7,78.9,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,53.3,78.1,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.7",58.7,NA,NA,48.9,67.8,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.7",58.7,NA,NA,49,67.7,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.8",62.8,NA,NA,48.4,75.3,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.5",60.5,NA,NA,46.5,73,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.1",65.1,NA,NA,63.5,66.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.8",63.8,NA,NA,62.1,65.5,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,60.1,65,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.1",61.1,NA,NA,58.6,63.6,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.3",67.3,NA,NA,65.1,69.4,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,63.9,68.3,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67",67,NA,NA,65,68.8,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65",65,NA,NA,63,67,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.2",62.2,NA,NA,58.8,65.6,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62",62,NA,NA,58.5,65.4,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.1",51.1,NA,NA,36.3,65.8,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.6",54.6,NA,NA,41.2,67.4,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.9",50.9,NA,NA,37.9,63.7,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.1",50.1,NA,NA,37.9,62.4,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.9",48.9,NA,NA,32.3,65.8,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.3",52.3,NA,NA,37.8,66.5,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,61.6,67.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.3",64.3,NA,NA,61.5,67,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.9",59.9,NA,NA,55.4,64.2,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60",60,NA,NA,55.9,64,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69",69,NA,NA,65.5,72.4,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69",69,NA,NA,65.4,72.3,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.3",65.3,NA,NA,62.4,68.1,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,62.2,67.9,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.9",60.9,NA,NA,49.2,71.4,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.4",60.4,NA,NA,48.7,71,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.2",62.2,NA,NA,59.7,64.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.3",61.3,NA,NA,58.8,63.8,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.4",61.4,NA,NA,57.3,65.3,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.8",60.8,NA,NA,56.7,64.8,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63",63,NA,NA,59.8,66,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.7",61.7,NA,NA,58.6,64.7,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62",62,NA,NA,59.3,64.6,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.7",60.7,NA,NA,58,63.4,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,54.1,70.3,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.7",63.7,NA,NA,56.3,70.5,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.5",58.5,NA,NA,56.4,60.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.4",58.4,NA,NA,56.3,60.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.6",57.6,NA,NA,54.4,60.7,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.7",57.7,NA,NA,54.5,60.7,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.4",59.4,NA,NA,56.5,62.1,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.3",59.3,NA,NA,56.5,61.9,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,61.9,66.7,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.4",63.4,NA,NA,60.9,65.7,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.9",70.9,NA,NA,63.7,77.2,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.9",71.9,NA,NA,65.1,77.9,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","40.5",40.5,NA,NA,36.2,45,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.5",43.5,NA,NA,39.5,47.5,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","45.2",45.2,NA,NA,31.4,59.8,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","40.8",40.8,NA,NA,28.4,54.4,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.9",66.9,NA,NA,47.9,81.6,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.2",68.2,NA,NA,53.9,79.7,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64",64,"*","50 States + DC: US Median",62.3,65.1,"Overall","Overall",NA,"59","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.6",62.6,"*","50 States + DC: US Median",61.3,64.3,"Overall","Overall",NA,"59","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,"*","50 States + DC: US Median",60.3,63.4,"Gender","Male",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.1",61.1,"*","50 States + DC: US Median",59.9,63.2,"Gender","Male",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,"*","50 States + DC: US Median",63,67.3,"Gender","Female",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,"*","50 States + DC: US Median",62.1,66.3,"Gender","Female",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.3",68.3,NA,NA,66.8,69.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68",68,NA,NA,66.5,69.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.4",68.4,NA,NA,66.3,70.6,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.2",68.2,NA,NA,66.1,70.3,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.3",68.3,NA,NA,66.2,70.3,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,65.7,69.8,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.7",70.7,NA,NA,69.2,72.2,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,68.8,71.7,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.8",47.8,NA,NA,40.3,55.3,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","47.4",47.4,NA,NA,40.4,54.6,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.5",47.5,NA,NA,37.1,58.2,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51",51,NA,NA,40.6,61.3,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.9",66.9,NA,NA,65.2,68.7,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.6",66.6,NA,NA,64.8,68.3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.4",64.4,NA,NA,61.6,67.1,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64",64,NA,NA,61.2,66.8,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.2",69.2,NA,NA,67,71.4,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.8",68.8,NA,NA,66.6,71,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.8",67.8,NA,NA,65.8,69.7,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.2",67.2,NA,NA,65.2,69.1,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.7",64.7,NA,NA,59.8,69.3,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.6",65.6,NA,NA,60.8,70,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.7",60.7,NA,NA,47.2,72.8,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.4",63.4,NA,NA,51,74.3,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,55.6,77,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,52.2,74.2,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.3",65.3,NA,NA,49.1,78.6,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.2",64.2,NA,NA,48.7,77.2,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.1",68.1,NA,NA,66.2,69.9,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67",67,NA,NA,65.1,68.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68",68,NA,NA,65.2,70.7,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.2",67.2,NA,NA,64.3,69.9,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.1",68.1,NA,NA,65.6,70.5,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.8",66.8,NA,NA,64.3,69.3,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.2",68.2,NA,NA,66.3,70,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67",67,NA,NA,65.1,68.9,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,56.8,78.4,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,46.1,76.4,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.1",63.1,NA,NA,47.7,76.2,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,65.4,68.9,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,64.6,68.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,63.3,68.7,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.6",65.6,NA,NA,62.8,68.2,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.3",68.3,NA,NA,66,70.4,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.1",67.1,NA,NA,64.8,69.3,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.3",69.3,NA,NA,67.5,71,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.3",68.3,NA,NA,66.4,70,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.1",68.1,NA,NA,54.5,79.2,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.7",66.7,NA,NA,53.5,77.7,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","44",44,NA,NA,33.9,54.6,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","46.6",46.6,NA,NA,36.4,57.1,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.9",55.9,NA,NA,47.6,63.8,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.9",55.9,NA,NA,48.2,63.4,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.9",71.9,NA,NA,58.7,82.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.7",71.7,NA,NA,69.6,73.7,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.3",71.3,NA,NA,69.2,73.3,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.5",70.5,NA,NA,67.4,73.5,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70",70,NA,NA,66.9,73,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.8",72.8,NA,NA,70,75.5,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,69.5,75.2,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72",72,NA,NA,69.9,74.1,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.4",71.4,NA,NA,69.2,73.4,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","85.8",85.8,NA,NA,72.4,93.3,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","84.6",84.6,NA,NA,72.1,92.1,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.9",51.9,NA,NA,35.1,68.3,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.7",52.7,NA,NA,36.1,68.8,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,60.6,64.5,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61",61,NA,NA,59,62.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,59.7,65.6,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.8",60.8,NA,NA,57.9,63.7,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,59.9,65,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.3",61.3,NA,NA,58.6,63.9,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.1",63.1,NA,NA,61.1,65.1,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,59.5,63.5,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.9",54.9,NA,NA,41.1,68,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.7",55.7,NA,NA,42.5,68.2,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.4",54.4,NA,NA,52,56.8,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.9",53.9,NA,NA,51.5,56.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50",50,NA,NA,46.2,53.7,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49.6",49.6,NA,NA,46.1,53.2,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59",59,NA,NA,56.1,61.8,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.3",58.3,NA,NA,55.5,61.2,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.9",54.9,NA,NA,52.4,57.4,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.4",54.4,NA,NA,52,56.7,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.8",47.8,NA,NA,34.3,61.6,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","47",47,NA,NA,34.8,59.6,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.1",53.1,NA,NA,36.5,69.1,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.6",55.6,NA,NA,41.7,68.7,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","MRC"
2014,2014,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","332",332,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","293",293,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","35",35,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","580",580,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","769",769,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","169",169,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.6",11.6,NA,NA,10.4,12.9,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","11",11,NA,NA,10,12.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","80",80,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.9",12.9,NA,NA,12.5,13.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","15",15,NA,NA,14.6,15.5,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","722",722,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.6",12.6,NA,NA,12,13.1,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.6",14.6,NA,NA,14,15.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","429",429,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","8.8",8.8,NA,NA,8.5,9.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","10",10,NA,NA,9.6,10.3,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","646",646,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.4",10.4,NA,NA,10.2,10.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","10.7",10.7,NA,NA,10.5,10.8,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","4020",4020,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10",10,NA,NA,9.6,10.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","10.5",10.5,NA,NA,10.1,10.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","539",539,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.2",11.2,NA,NA,10.7,11.7,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.5",13.5,NA,NA,12.9,14,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","483",483,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.4",11.4,NA,NA,10.2,12.7,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","11.2",11.2,NA,NA,10,12.4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","69",69,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.2",12.2,NA,NA,11.2,13.1,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.6",14.6,NA,NA,13.6,15.8,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","133",133,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.9",12.9,NA,NA,12.7,13.1,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","16.7",16.7,NA,NA,16.5,17,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","3194",3194,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.1",12.1,NA,NA,11.8,12.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.3",12.3,NA,NA,12,12.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1209",1209,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.9",11.9,NA,NA,11.1,12.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14",14,NA,NA,13.1,14.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","193",193,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.3",12.3,NA,NA,11.8,12.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.7",14.7,NA,NA,14.1,15.3,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","450",450,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","13",13,NA,NA,12.2,13.8,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.9",13.9,NA,NA,13,14.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","219",219,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.8",11.8,NA,NA,11.6,12.1,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13",13,NA,NA,12.7,13.3,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1671",1671,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.5",11.5,NA,NA,11.1,11.8,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.9",12.9,NA,NA,12.5,13.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","841",841,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.3",11.3,NA,NA,10.8,11.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.5",12.5,NA,NA,11.9,13.1,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","359",359,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","13.8",13.8,NA,NA,13.3,14.2,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","16",16,NA,NA,15.5,16.6,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","700",700,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.9",12.9,NA,NA,12.5,13.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.1",14.1,NA,NA,13.6,14.6,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","646",646,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.9",11.9,NA,NA,11.6,12.3,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14",14,NA,NA,13.6,14.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","926",926,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.7",10.7,NA,NA,10.3,11,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","11.9",11.9,NA,NA,11.5,12.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","694",694,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.2",12.2,NA,NA,11.4,13,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","16.3",16.3,NA,NA,15.4,17.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","217",217,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.4",11.4,NA,NA,11.2,11.7,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.6",13.6,NA,NA,13.3,13.9,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1344",1344,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.9",11.9,NA,NA,11.5,12.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.5",13.5,NA,NA,13,13.9,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","721",721,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.7",11.7,NA,NA,11.3,12.1,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.7",13.7,NA,NA,13.3,14.1,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","822",822,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","13.1",13.1,NA,NA,12.5,13.7,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.5",14.5,NA,NA,13.9,15.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","432",432,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.5",11.5,NA,NA,10.7,12.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.4",14.4,NA,NA,13.3,15.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","143",143,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.3",12.3,NA,NA,12,12.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.9",13.9,NA,NA,13.5,14.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1339",1339,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.5",11.5,NA,NA,10.4,12.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.2",13.2,NA,NA,12,14.5,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","91",91,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11",11,NA,NA,10.3,11.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.4",12.4,NA,NA,11.6,13.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","228",228,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.5",11.5,NA,NA,10.8,12.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.2",14.2,NA,NA,13.3,15.2,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","188",188,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.4",10.4,NA,NA,10.1,10.7,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.1",12.1,NA,NA,11.7,12.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1066",1066,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","9.4",9.4,NA,NA,8.8,10,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","10.8",10.8,NA,NA,10.2,11.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","224",224,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.5",10.5,NA,NA,10.3,10.7,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12",12,NA,NA,11.8,12.2,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","2345",2345,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.9",10.9,NA,NA,10.7,11.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13",13,NA,NA,12.7,13.3,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1503",1503,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","13.1",13.1,NA,NA,12.6,13.6,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.7",14.7,NA,NA,14.1,15.2,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","555",555,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.4",11.4,NA,NA,10.9,11.8,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.7",13.7,NA,NA,13.1,14.2,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","528",528,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.6",11.6,NA,NA,11.4,11.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.4",14.4,NA,NA,14.1,14.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","1831",1831,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11",11,NA,NA,10.2,11.9,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.2",13.2,NA,NA,12.2,14.2,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","139",139,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.5",12.5,NA,NA,12.1,13,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.7",14.7,NA,NA,14.3,15.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","690",690,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.6",11.6,NA,NA,10.6,12.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.4",13.4,NA,NA,12.4,14.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","111",111,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","12.3",12.3,NA,NA,11.9,12.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.2",14.2,NA,NA,13.8,14.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","912",912,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.6",10.6,NA,NA,10.4,10.8,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","10.3",10.3,NA,NA,10.1,10.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","2649",2649,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.4",11.4,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",11.3,11.4,"Overall","Overall",NA,"59","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","9.9",9.9,NA,NA,8.8,11,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","12.8",12.8,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",12.7,12.9,"Overall","Overall",NA,"59","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","39885",39885,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","8.2",8.2,NA,NA,7.7,8.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","6.8",6.8,NA,NA,6.4,7.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","191",191,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","10.8",10.8,NA,NA,10.5,11.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","11.9",11.9,NA,NA,11.6,12.3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","958",958,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.3",11.3,NA,NA,10.2,12.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","14.6",14.6,NA,NA,13.3,16,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","91",91,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.8",11.8,NA,NA,11.4,12.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.2",13.2,NA,NA,12.8,13.6,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","898",898,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.8",11.8,NA,NA,11.4,12.2,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","13.8",13.8,NA,NA,13.4,14.3,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","790",790,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Age-adjusted Rate","11.9",11.9,NA,NA,11.3,12.6,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","15.5",15.5,NA,NA,14.7,16.4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","288",288,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence","per 100,000","Average Annual Crude Rate","11.2",11.2,NA,NA,10,12.5,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the oral cavity or pharynx, incidence",NA,"Average Annual Number","64",64,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.6,2.7,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","1.8",1.8,NA,NA,1.4,2.3,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","13",13,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.5,2.9,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","149",149,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.8,3.4,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.6",3.6,NA,NA,3.3,3.9,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","106",106,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","1.9",1.9,NA,NA,1.8,2.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.2",2.2,NA,NA,2,2.4,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","142",142,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.4,2.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","928",928,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2",2,NA,NA,1.8,2.1,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.8,2.1,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","99",99,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","1.9",1.9,NA,NA,1.7,2.1,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.2,2.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","85",85,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3.3",3.3,NA,NA,2.7,4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,2.7,4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","21",21,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.2,3.1,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.7,3.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","29",29,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.5,2.7,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.4,3.7,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","676",676,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.5,2.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","249",249,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.2,2.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.7,3.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","42",42,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2,2.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.8",2.8,NA,NA,2.5,3.1,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","85",85,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.1,2.8,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.2,2.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","40",40,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.5,2.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.5,2.8,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","173",173,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2",2,NA,NA,1.8,2.2,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2,2.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","65",65,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.7,3.2,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.1,3.6,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","147",147,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3.3",3.3,NA,NA,3,3.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.8,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","162",162,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.3,2.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","193",193,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.2,2.5,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.4,2.8,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","150",150,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.4,3.1,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.7",3.7,NA,NA,3.3,4.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","49",49,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.9,2.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.2,2.6,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","127",127,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.3,2.7,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","176",176,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3.7",3.7,NA,NA,3.4,4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","4.1",4.1,NA,NA,3.8,4.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","122",122,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.7,2.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.2,3.2,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","27",27,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.4,2.7,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","277",277,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,1.7,2.7,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2,3.1,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","17",17,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2,2.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.3,3,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","49",49,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.8,2.5,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","2060",2060,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.2,3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","34",34,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2",2,NA,NA,1.9,2.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","204",204,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,2,2.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.3,2.9,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","53",53,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.1,2.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.2,2.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","68",68,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,2.1,2.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","495",495,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","344",344,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.4,2.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.3,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","114",114,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.1,2.5,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.8",2.8,NA,NA,2.6,3.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","109",109,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,2,2.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","348",348,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.7,2.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.1,3,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","27",27,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.8,3.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.2,3.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","162",162,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.7,2.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2,3,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","21",21,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.9,3.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","224",224,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.5,2.7,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.3,2.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","622",622,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.4,2.5,"Overall","Overall",NA,"59","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.7,2.8,"Overall","Overall",NA,"59","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","8565",8565,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","1.6",1.6,NA,NA,1.4,1.9,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","1.2",1.2,NA,NA,1.1,1.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.7,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","204",204,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.1,3.2,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,2.8,4.1,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","21",21,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.7,3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","212",212,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.3,2.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","164",164,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.5,3.1,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","3.6",3.6,NA,NA,3.3,4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","67",67,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,1.8,2.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2,3.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the oral cavity and pharynx, mortality",NA,"Average Annual Number","15",15,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN10_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","100.3",100.3,NA,NA,94.9,106,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","86.8",86.8,NA,NA,82.6,91.1,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","326",326,NA,NA,NA,NA,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","139.1",139.1,NA,NA,137,141.2,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","155.7",155.7,NA,NA,153.4,158,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3624",3624,NA,NA,NA,NA,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","128.4",128.4,NA,NA,126,130.9,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","147.5",147.5,NA,NA,144.7,150.3,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2125",2125,NA,NA,NA,NA,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","84.1",84.1,NA,NA,82.8,85.5,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","93.6",93.6,NA,NA,92.1,95.1,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3017",3017,NA,NA,NA,NA,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","118.7",118.7,NA,NA,118,119.5,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","112.8",112.8,NA,NA,112.1,113.5,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","21132",21132,NA,NA,NA,NA,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","122.1",122.1,NA,NA,120.1,124.1,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","120.9",120.9,NA,NA,119,122.8,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3106",3106,NA,NA,NA,NA,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","130.3",130.3,NA,NA,128,132.6,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","149.3",149.3,NA,NA,146.8,151.9,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2607",2607,NA,NA,NA,NA,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","169.1",169.1,NA,NA,162,176.4,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","155.1",155.1,NA,NA,148.8,161.6,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","455",455,NA,NA,NA,NA,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","151.2",151.2,NA,NA,146.4,156.1,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","179.9",179.9,NA,NA,174.3,185.6,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","791",791,NA,NA,NA,NA,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","111.2",111.2,NA,NA,110.3,112,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","145.3",145.3,NA,NA,144.2,146.4,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","13576",13576,NA,NA,NA,NA,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","139.8",139.8,NA,NA,138.2,141.4,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","132.3",132.3,NA,NA,130.8,133.8,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","6342",6342,NA,NA,NA,NA,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","96.5",96.5,NA,NA,93.4,99.8,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","107.3",107.3,NA,NA,103.9,110.9,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","743",743,NA,NA,NA,NA,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","119.2",119.2,NA,NA,116.9,121.5,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","137.5",137.5,NA,NA,134.9,140.2,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2088",2088,NA,NA,NA,NA,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","131.8",131.8,NA,NA,128.3,135.5,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","139",139,NA,NA,135.4,142.8,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1103",1103,NA,NA,NA,NA,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","128.8",128.8,NA,NA,127.5,130.1,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","132.8",132.8,NA,NA,131.5,134.1,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","8372",8372,NA,NA,NA,NA,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","102",102,NA,NA,100.5,103.6,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","108.5",108.5,NA,NA,106.9,110.1,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3479",3479,NA,NA,NA,NA,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","133.5",133.5,NA,NA,130.8,136.2,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","140.3",140.3,NA,NA,137.6,143.1,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2000",2000,NA,NA,NA,NA,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","118.1",118.1,NA,NA,116.1,120.1,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","130.9",130.9,NA,NA,128.7,133,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2810",2810,NA,NA,NA,NA,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","154.4",154.4,NA,NA,152,156.7,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","160.9",160.9,NA,NA,158.6,163.3,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3598",3598,NA,NA,NA,NA,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","124.9",124.9,NA,NA,123.3,126.6,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","141.4",141.4,NA,NA,139.6,143.3,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","4526",4526,NA,NA,NA,NA,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","135",135,NA,NA,133.1,136.9,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","144.4",144.4,NA,NA,142.4,146.4,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","4081",4081,NA,NA,NA,NA,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","106.5",106.5,NA,NA,103.4,109.7,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","142.9",142.9,NA,NA,138.8,147.1,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","929",929,NA,NA,NA,NA,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","137",137,NA,NA,135.6,138.4,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","157.5",157.5,NA,NA,155.9,159.1,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","7641",7641,NA,NA,NA,NA,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","130.3",130.3,NA,NA,128.4,132.2,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","141.2",141.2,NA,NA,139.1,143.2,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3748",3748,NA,NA,NA,NA,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","106.3",106.3,NA,NA,104.7,107.9,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","121.7",121.7,NA,NA,119.9,123.4,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3581",3581,NA,NA,NA,NA,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","142.7",142.7,NA,NA,139.9,145.5,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","151.8",151.8,NA,NA,148.9,154.6,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2195",2195,NA,NA,NA,NA,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","127.3",127.3,NA,NA,123.3,131.4,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","162.9",162.9,NA,NA,157.9,167.9,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","816",816,NA,NA,NA,NA,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","130.2",130.2,NA,NA,128.8,131.7,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","140.9",140.9,NA,NA,139.3,142.4,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","6623",6623,NA,NA,NA,NA,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","130.9",130.9,NA,NA,125.8,136.3,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","144.6",144.6,NA,NA,139,150.3,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","506",506,NA,NA,NA,NA,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","119.2",119.2,NA,NA,116.1,122.3,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","126.8",126.8,NA,NA,123.5,130.1,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1160",1160,NA,NA,NA,NA,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","133.5",133.5,NA,NA,129.8,137.2,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","163.4",163.4,NA,NA,159,167.9,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1064",1064,NA,NA,NA,NA,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","148.7",148.7,NA,NA,147.1,150.3,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","160.6",160.6,NA,NA,158.9,162.3,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","6915",6915,NA,NA,NA,NA,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","100.8",100.8,NA,NA,98.1,103.5,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","112.4",112.4,NA,NA,109.5,115.3,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1151",1151,NA,NA,NA,NA,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","145.2",145.2,NA,NA,144.2,146.3,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","156.6",156.6,NA,NA,155.5,157.7,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","14797",14797,NA,NA,NA,NA,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","119.7",119.7,NA,NA,118.5,120.9,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","136.9",136.9,NA,NA,135.5,138.3,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","7723",7723,NA,NA,NA,NA,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","120.6",120.6,NA,NA,118.4,122.8,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","128.9",128.9,NA,NA,126.6,131.2,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2415",2415,NA,NA,NA,NA,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","110.6",110.6,NA,NA,108.6,112.6,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","130.4",130.4,NA,NA,128.1,132.7,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","2495",2495,NA,NA,NA,NA,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","125.4",125.4,NA,NA,124.2,126.5,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","151.7",151.7,NA,NA,150.3,153,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","9422",9422,NA,NA,NA,NA,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","117.4",117.4,NA,NA,113.4,121.5,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","134.6",134.6,NA,NA,130.1,139.2,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","685",685,NA,NA,NA,NA,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","129",129,NA,NA,126.9,131,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","148.4",148.4,NA,NA,146.2,150.6,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3378",3378,NA,NA,NA,NA,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","119.6",119.6,NA,NA,115.1,124.2,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","134.8",134.8,NA,NA,129.8,139.8,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","558",558,NA,NA,NA,NA,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","126.3",126.3,NA,NA,124.5,128,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","141.6",141.6,NA,NA,139.7,143.5,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","4418",4418,NA,NA,NA,NA,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","106.4",106.4,NA,NA,105.6,107.3,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","94.2",94.2,NA,NA,93.5,95,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","11997",11997,NA,NA,NA,NA,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","123.1",123.1,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",122.9,123.3,"Gender","Male",NA,"59","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","116",116,NA,NA,110.6,121.6,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","132.3",132.3,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",132.1,132.6,"Gender","Male",NA,"59","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","202783",202783,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Gender","Male",NA,"59","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","144.4",144.4,NA,NA,141.2,147.7,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","111.5",111.5,NA,NA,109.1,114,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1577",1577,NA,NA,NA,NA,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","118",118,NA,NA,116.5,119.6,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","124.6",124.6,NA,NA,123.1,126.2,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","4915",4915,NA,NA,NA,NA,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","109.8",109.8,NA,NA,105,114.7,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","139.5",139.5,NA,NA,133.7,145.5,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","430",430,NA,NA,NA,NA,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","125.7",125.7,NA,NA,124,127.4,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","134.2",134.2,NA,NA,132.5,136,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","4566",4566,NA,NA,NA,NA,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","122",122,NA,NA,120.3,123.8,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","138.7",138.7,NA,NA,136.8,140.6,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","3929",3929,NA,NA,NA,NA,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Age-adjusted Rate","106.6",106.6,NA,NA,104,109.4,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_1","AvgAnnAgeAdjRate","GENDER","GENM"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","138.7",138.7,NA,NA,135.3,142.2,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","1268",1268,NA,NA,NA,NA,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.2",21.2,NA,NA,20.4,22,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence","per 100,000","Average Annual Crude Rate","129.2",129.2,NA,NA,123.4,135.2,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_1","AvgAnnCrdRate","GENDER","GENM"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the prostate, incidence",NA,"Average Annual Number","376",376,NA,NA,NA,NA,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_1","AvgAnnNumbr","GENDER","GENM"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.5",20.5,NA,NA,17.4,23.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","10.3",10.3,NA,NA,8.9,11.9,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","39",39,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","25.2",25.2,NA,NA,24.2,26.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.9",21.9,NA,NA,21.1,22.8,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","510",510,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.8",21.8,NA,NA,20.7,23,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.2",20.2,NA,NA,19.2,21.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","291",291,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","18.7",18.7,NA,NA,18,19.4,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.7",17.7,NA,NA,17.1,18.4,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","571",571,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.6",20.6,NA,NA,20.2,20.9,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","16.4",16.4,NA,NA,16.1,16.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","3070",3070,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22",22,NA,NA,21.1,23,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","16",16,NA,NA,15.3,16.7,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","411",411,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.2",19.2,NA,NA,18.3,20.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19.2",19.2,NA,NA,18.3,20.1,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","335",335,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.1",18.1,NA,NA,17.4,18.8,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","35.7",35.7,NA,NA,32.2,39.4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","26.5",26.5,NA,NA,23.9,29.3,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","78",78,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.1",20.1,NA,NA,18.2,22.1,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19.5",19.5,NA,NA,17.7,21.4,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","86",86,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","18.1",18.1,NA,NA,17.8,18.5,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","22.4",22.4,NA,NA,22,22.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","2091",2091,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","23.9",23.9,NA,NA,23.1,24.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","15.9",15.9,NA,NA,15.4,16.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","762",762,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","13.9",13.9,NA,NA,12.7,15.2,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","14.6",14.6,NA,NA,13.3,15.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","101",101,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.8",19.8,NA,NA,18.8,20.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.5",20.5,NA,NA,19.5,21.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","312",312,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","23.6",23.6,NA,NA,22,25.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.1",20.1,NA,NA,18.7,21.5,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","159",159,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.5",21.5,NA,NA,21,22.1,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.1",18.1,NA,NA,17.7,18.6,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","1143",1143,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","18.9",18.9,NA,NA,17.9,20,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.5",17.5,NA,NA,16.5,18.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","249",249,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.5",20.5,NA,NA,19.6,21.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.1",17.1,NA,NA,16.3,17.9,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","367",367,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","23.1",23.1,NA,NA,22.1,24.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.7",18.7,NA,NA,17.9,19.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","417",417,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.9",19.9,NA,NA,19.2,20.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19",19,NA,NA,18.4,19.7,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","610",610,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.3",21.3,NA,NA,20.4,22.2,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.8",17.8,NA,NA,17.1,18.5,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","502",502,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.1",21.1,NA,NA,19.6,22.7,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","22.9",22.9,NA,NA,21.2,24.6,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","149",149,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.7",19.7,NA,NA,19.1,20.3,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.6",18.6,NA,NA,18.1,19.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","903",903,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.6",21.6,NA,NA,20.7,22.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19.5",19.5,NA,NA,18.7,20.2,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","517",517,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19",19,NA,NA,18.2,19.7,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.7",17.7,NA,NA,17,18.4,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","520",520,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","27.4",27.4,NA,NA,26,28.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","22.2",22.2,NA,NA,21.2,23.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","322",322,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22.5",22.5,NA,NA,20.7,24.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","23.4",23.4,NA,NA,21.6,25.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","117",117,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,21.5,22.9,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.3",18.3,NA,NA,17.7,18.8,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","859",859,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20",20,NA,NA,17.9,22.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20",20,NA,NA,18,22.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","70",70,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.6",21.6,NA,NA,20.2,23.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.4",20.4,NA,NA,19.1,21.7,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","187",187,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20",20,NA,NA,18.5,21.7,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.5",18.5,NA,NA,17.1,20.1,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","121",121,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.5",19.5,NA,NA,18.8,20.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.8",17.8,NA,NA,17.3,18.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.4",21.4,NA,NA,20.1,22.8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19.2",19.2,NA,NA,18,20.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","197",197,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.3",21.3,NA,NA,20,22.6,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","16.8",16.8,NA,NA,15.8,17.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","231",231,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.9",19.9,NA,NA,19.5,20.4,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.2",18.2,NA,NA,17.9,18.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","1724",1724,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.9",20.9,NA,NA,20.4,21.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20",20,NA,NA,19.4,20.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","1126",1126,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.6",21.6,NA,NA,20.6,22.7,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","19.2",19.2,NA,NA,18.3,20.1,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","360",360,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22",22,NA,NA,21.1,23,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.7",21.7,NA,NA,20.8,22.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","415",415,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.4",20.4,NA,NA,19.9,20.9,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.7",21.7,NA,NA,21.2,22.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","1349",1349,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.5",20.5,NA,NA,18.8,22.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.1",21.1,NA,NA,19.4,23,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","108",108,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","24.3",24.3,NA,NA,23.3,25.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.7",20.7,NA,NA,19.9,21.6,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","471",471,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.3",20.3,NA,NA,18.4,22.3,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.5",20.5,NA,NA,18.6,22.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","85",85,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.5",21.5,NA,NA,20.7,22.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.3",18.3,NA,NA,17.7,19,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","572",572,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.2",19.2,NA,NA,18.8,19.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","13",13,NA,NA,12.7,13.3,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","1654",1654,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","20.7",20.7,NA,NA,20.5,20.8,"Overall","Overall",NA,"59","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.2",18.2,NA,NA,18.1,18.3,"Overall","Overall",NA,"59","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","27909",27909,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22.3",22.3,NA,NA,20.9,23.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","13.8",13.8,NA,NA,12.9,14.7,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","195",195,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,21.4,23,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","17.4",17.4,NA,NA,16.9,18,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","694",694,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.3",21.3,NA,NA,19,23.7,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.3",21.3,NA,NA,19.1,23.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","66",66,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","21.3",21.3,NA,NA,20.6,22.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","18.1",18.1,NA,NA,17.4,18.7,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","615",615,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","22.4",22.4,NA,NA,21.6,23.2,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","21.2",21.2,NA,NA,20.5,22,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","601",601,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","19.6",19.6,NA,NA,18.3,20.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","20.6",20.6,NA,NA,19.3,21.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","188",188,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Age-adjusted Rate","18.9",18.9,NA,NA,16.5,21.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the prostate, mortality","per 100,000","Average Annual Crude Rate","15.8",15.8,NA,NA,13.8,18,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the prostate, mortality",NA,"Average Annual Number","46",46,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN11_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","425.8",425.8,NA,NA,417.9,433.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","365.5",365.5,NA,NA,359.3,371.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","2634",2634,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","454.6",454.6,NA,NA,452.1,457.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","521.8",521.8,NA,NA,518.9,524.7,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","25045",25045,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","445.3",445.3,NA,NA,442.1,448.5,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","516.1",516.1,NA,NA,512.4,519.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","15138",15138,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","386",386,NA,NA,384,388.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","25205",25205,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","429.8",429.8,NA,NA,427.5,432.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","27868",27868,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","417.1",417.1,NA,NA,416.2,418.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","419.8",419.8,NA,NA,418.9,420.7,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","158259",158259,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","412.8",412.8,NA,NA,410.2,415.3,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","416.9",416.9,NA,NA,414.4,419.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","21350",21350,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","483.2",483.2,NA,NA,480.2,486.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","567.9",567.9,NA,NA,564.4,571.4,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","20361",20361,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","480",480,NA,NA,472.1,488,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","469.2",469.2,NA,NA,461.7,476.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","2911",2911,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","498.1",498.1,NA,NA,492.1,504.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","588.2",588.2,NA,NA,581.2,595.3,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","5342",5342,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","428.5",428.5,NA,NA,427.4,429.7,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","559.3",559.3,NA,NA,557.8,560.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","106898",106898,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","455.8",455.8,NA,NA,453.8,457.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","484",484,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","448.6",448.6,NA,NA,446.7,450.5,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","44019",44019,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","416.9",416.9,NA,NA,412.3,421.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","486.4",486.4,NA,NA,481.2,491.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","6704",6704,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","469.1",469.1,NA,NA,465.9,472.3,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","554.7",554.7,NA,NA,551,558.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","16992",16992,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","439",439,NA,NA,434.5,443.6,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","461.8",461.8,NA,NA,457.1,466.6,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","7313",7313,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","468.3",468.3,NA,NA,466.7,470,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","503.7",503.7,NA,NA,502,505.5,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","64740",64740,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","449",449,NA,NA,446.8,451.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","492.4",492.4,NA,NA,490,494.8,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","32080",32080,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","460.4",460.4,NA,NA,456.9,463.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","502.8",502.8,NA,NA,499.1,506.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","14423",14423,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","511.2",511.2,NA,NA,508.3,514,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","577.6",577.6,NA,NA,574.4,580.8,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","482.3",482.3,NA,NA,479.5,485.1,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","515.8",515.8,NA,NA,512.9,518.8,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","23570",23570,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","473.6",473.6,NA,NA,471.3,475.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","545.2",545.2,NA,NA,542.7,547.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","36050",36050,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","449.2",449.2,NA,NA,446.8,451.6,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","487.4",487.4,NA,NA,484.9,490,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","28460",28460,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","473.9",473.9,NA,NA,469.2,478.6,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","618.9",618.9,NA,NA,612.9,624.9,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","8222",8222,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","463.1",463.1,NA,NA,461.3,464.9,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","537.6",537.6,NA,NA,535.5,539.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","53154",53154,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","458.5",458.5,NA,NA,456.1,461,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","504.4",504.4,NA,NA,501.8,507.1,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","26980",26980,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","452.2",452.2,NA,NA,449.9,454.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","520.7",520.7,NA,NA,518.1,523.3,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","31282",31282,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1769",1769,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","467",467,NA,NA,463.6,470.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","508.4",508.4,NA,NA,504.8,512.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","15138",15138,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","448.3",448.3,NA,NA,442.9,453.8,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","549.8",549.8,NA,NA,543.3,556.3,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","5489",5489,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","459.4",459.4,NA,NA,457.6,461.3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","507.6",507.6,NA,NA,505.6,509.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","48990",48990,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","447.8",447.8,NA,NA,441.1,454.7,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","510.1",510.1,NA,NA,502.6,517.7,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","3520",3520,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","439.5",439.5,NA,NA,435.4,443.7,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","485.4",485.4,NA,NA,480.9,489.9,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","8941",8941,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","487.1",487.1,NA,NA,482.1,492.1,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","580.7",580.7,NA,NA,574.9,586.5,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","7659",7659,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","484",484,NA,NA,482.1,486,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","549",549,NA,NA,546.9,551.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","48523",48523,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","379.1",379.1,NA,NA,375.5,382.7,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","423",423,NA,NA,419,426.9,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","8757",8757,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","482.5",482.5,NA,NA,481.1,483.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","543.3",543.3,NA,NA,541.9,544.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","105987",105987,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","454.9",454.9,NA,NA,453.3,456.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","531.3",531.3,NA,NA,529.4,533.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","61352",61352,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","445.8",445.8,NA,NA,443,448.8,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","493.1",493.1,NA,NA,489.9,496.2,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","18671",18671,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","440.4",440.4,NA,NA,437.6,443.2,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","514.9",514.9,NA,NA,511.7,518.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","19917",19917,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","487.2",487.2,NA,NA,485.6,488.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","600",600,NA,NA,598.1,602,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","76414",76414,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","478.9",478.9,NA,NA,473.4,484.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","565.7",565.7,NA,NA,559.3,572.2,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","5957",5957,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","452.7",452.7,NA,NA,450.1,455.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","520",520,NA,NA,517.1,523,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","24331",24331,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","444.2",444.2,NA,NA,438.1,450.4,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","509.2",509.2,NA,NA,502.3,516.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","4203",4203,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","463.4",463.4,NA,NA,461.2,465.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","525.9",525.9,NA,NA,523.3,528.4,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","33669",33669,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","410.2",410.2,NA,NA,409.1,411.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","384.8",384.8,NA,NA,383.8,385.9,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","98754",98754,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","448.5",448.5,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",448.2,448.9,"Overall","Overall",NA,"59","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","494.4",494.4,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",494,494.7,"Overall","Overall",NA,"59","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","1540559",1540559,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","406.6",406.6,NA,NA,402.9,410.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","333.3",333.3,NA,NA,330.3,336.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","9379",9379,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","429.3",429.3,NA,NA,427.3,431.3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","459.4",459.4,NA,NA,457.3,461.5,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","36890",36890,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","460.8",460.8,NA,NA,453.9,467.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","570.8",570.8,NA,NA,562.5,579.3,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","3573",3573,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","461.7",461.7,NA,NA,459.5,464,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","497.7",497.7,NA,NA,495.3,500,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","33943",33943,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","457.9",457.9,NA,NA,455.6,460.3,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","525.8",525.8,NA,NA,523.2,528.5,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","30010",30010,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","471",471,NA,NA,467,475,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","605.2",605.2,NA,NA,600.2,610.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","11216",11216,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Age-adjusted Rate","409.1",409.1,NA,NA,401.9,416.5,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence","per 100,000","Average Annual Crude Rate","447.2",447.2,NA,NA,439.5,455.1,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer (all sites combined), incidence",NA,"Average Annual Number","2551",2551,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","176.3",176.3,NA,NA,170.8,181.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","129.2",129.2,NA,NA,125.5,132.9,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","931",931,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","188.1",188.1,NA,NA,186.5,189.8,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","213.9",213.9,NA,NA,212,215.7,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","10264",10264,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","192.2",192.2,NA,NA,190.1,194.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","223.1",223.1,NA,NA,220.6,225.5,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","6543",6543,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","149.4",149.4,NA,NA,148.1,150.6,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","166.8",166.8,NA,NA,165.4,168.2,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","10814",10814,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","152.6",152.6,NA,NA,152,153.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","150.8",150.8,NA,NA,150.3,151.4,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","56856",56856,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","145.4",145.4,NA,NA,143.8,146.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","139.4",139.4,NA,NA,138,140.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","7140",7140,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","156.5",156.5,NA,NA,154.8,158.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","189.2",189.2,NA,NA,187.2,191.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","6782",6782,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","182.3",182.3,NA,NA,177.4,187.3,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","174.7",174.7,NA,NA,170,179.4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1084",1084,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","176.8",176.8,NA,NA,173.3,180.5,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","208.5",208.5,NA,NA,204.3,212.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1893",1893,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","160.3",160.3,NA,NA,159.6,161,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","218.7",218.7,NA,NA,217.8,219.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","41800",41800,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","171.6",171.6,NA,NA,170.4,172.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","160.2",160.2,NA,NA,159.1,161.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","15723",15723,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","137.8",137.8,NA,NA,135.2,140.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","165.5",165.5,NA,NA,162.5,168.6,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","2281",2281,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","169.7",169.7,NA,NA,167.8,171.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","209.2",209.2,NA,NA,206.9,211.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","6407",6407,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","156.7",156.7,NA,NA,154,159.5,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","162.2",162.2,NA,NA,159.4,165,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","2568",2568,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","176.2",176.2,NA,NA,175.2,177.2,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","188.8",188.8,NA,NA,187.7,189.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","24262",24262,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","185.2",185.2,NA,NA,183.8,186.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","202.8",202.8,NA,NA,201.3,204.4,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","13213",13213,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","168.4",168.4,NA,NA,166.4,170.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","187.8",187.8,NA,NA,185.6,190.1,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","5389",5389,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","202.6",202.6,NA,NA,200.8,204.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","226.4",226.4,NA,NA,224.4,228.4,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","9878",9878,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","193.5",193.5,NA,NA,191.7,195.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","202.5",202.5,NA,NA,200.6,204.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","9252",9252,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","166.8",166.8,NA,NA,165.5,168.2,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","195.8",195.8,NA,NA,194.3,197.3,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","12944",12944,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","168.2",168.2,NA,NA,166.8,169.7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","178.3",178.3,NA,NA,176.8,179.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","10412",10412,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","181.4",181.4,NA,NA,178.5,184.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","241.4",241.4,NA,NA,237.7,245.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","3207",3207,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","177.1",177.1,NA,NA,176,178.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","206.6",206.6,NA,NA,205.4,207.9,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","20432",20432,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","161",161,NA,NA,159.5,162.5,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","178.4",178.4,NA,NA,176.8,180,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","9541",9541,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","182.1",182.1,NA,NA,180.7,183.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","211.2",211.2,NA,NA,209.6,212.9,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","12689",12689,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","198.6",198.6,NA,NA,196.4,200.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","213",213,NA,NA,210.6,215.3,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","6340",6340,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","159",159,NA,NA,155.9,162.3,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","196.5",196.5,NA,NA,192.6,200.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1962",1962,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","173.4",173.4,NA,NA,172.3,174.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","188.3",188.3,NA,NA,187,189.5,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","18170",18170,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","154.7",154.7,NA,NA,150.8,158.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","184.7",184.7,NA,NA,180.2,189.3,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1274",1274,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","164.1",164.1,NA,NA,161.6,166.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","185.9",185.9,NA,NA,183.1,188.7,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","3424",3424,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","168.9",168.9,NA,NA,165.9,171.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","198.2",198.2,NA,NA,194.8,201.6,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","2614",2614,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","163.8",163.8,NA,NA,162.6,164.9,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","187.5",187.5,NA,NA,186.2,188.8,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","16572",16572,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","148",148,NA,NA,145.7,150.3,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","162.6",162.6,NA,NA,160.1,165.1,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","3366",3366,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","169.4",169.4,NA,NA,167.1,171.6,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","168.6",168.6,NA,NA,166.4,170.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","4604",4604,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","160.1",160.1,NA,NA,159.3,160.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","182.2",182.2,NA,NA,181.4,183.1,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","35546",35546,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","184.1",184.1,NA,NA,183,185.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","217.6",217.6,NA,NA,216.4,218.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","25124",25124,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","189.1",189.1,NA,NA,187.2,191,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","208.9",208.9,NA,NA,206.8,210.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","7909",7909,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","169.7",169.7,NA,NA,168,171.4,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","199.4",199.4,NA,NA,197.4,201.4,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","7712",7712,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","176.8",176.8,NA,NA,175.9,177.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","226.5",226.5,NA,NA,225.4,227.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","28850",28850,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","171.3",171.3,NA,NA,168.1,174.6,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","211.4",211.4,NA,NA,207.5,215.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","2226",2226,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","180",180,NA,NA,178.4,181.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","203",203,NA,NA,201.2,204.9,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","9499",9499,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","162.5",162.5,NA,NA,158.9,166.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","194.6",194.6,NA,NA,190.3,198.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1606",1606,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","190.8",190.8,NA,NA,189.4,192.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","213.5",213.5,NA,NA,211.9,215.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","13671",13671,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","161.8",161.8,NA,NA,161,162.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","145.1",145.1,NA,NA,144.5,145.8,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","37243",37243,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","168.5",168.5,NA,NA,168.3,168.7,"Overall","Overall",NA,"59","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","185.2",185.2,NA,NA,185,185.4,"Overall","Overall",NA,"59","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","577303",577303,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","128.1",128.1,NA,NA,125.9,130.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","99.2",99.2,NA,NA,97.6,100.9,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","2792",2792,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","169.1",169.1,NA,NA,167.8,170.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","175.9",175.9,NA,NA,174.6,177.2,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","14256",14256,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","171.2",171.2,NA,NA,167,175.5,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","212",212,NA,NA,206.9,217.2,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","1327",1327,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","165.7",165.7,NA,NA,164.3,167,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","175",175,NA,NA,173.6,176.4,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","11935",11935,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","169.7",169.7,NA,NA,168.2,171.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","197.8",197.8,NA,NA,196.1,199.4,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","11286",11286,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","196.1",196.1,NA,NA,193.6,198.7,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","255.3",255.3,NA,NA,252,258.5,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","4731",4731,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Age-adjusted Rate","158.1",158.1,NA,NA,153.6,162.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Invasive cancer (all sites combined), mortality","per 100,000","Average Annual Crude Rate","167.9",167.9,NA,NA,163.2,172.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Invasive cancer (all sites combined), mortality",NA,"Average Annual Number","958",958,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN4_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","123.5",123.5,NA,NA,117.9,129.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","117.1",117.1,NA,NA,112,122.3,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","404",404,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","119.3",119.3,NA,NA,117.5,121.1,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","141.9",141.9,NA,NA,139.8,144,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3506",3506,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","111.5",111.5,NA,NA,109.2,113.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","132.5",132.5,NA,NA,129.9,135.1,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1977",1977,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","111",111,NA,NA,109.4,112.5,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","127.1",127.1,NA,NA,125.4,128.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4146",4146,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","121.4",121.4,NA,NA,120.8,122.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","130",130,NA,NA,129.3,130.7,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","24656",24656,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","124.8",124.8,NA,NA,122.9,126.7,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","135.2",135.2,NA,NA,133.2,137.2,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3450",3450,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","137.8",137.8,NA,NA,135.6,140,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","168.7",168.7,NA,NA,166,171.3,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3101",3101,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","143",143,NA,NA,137.2,149.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","143.2",143.2,NA,NA,137.4,149.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","468",468,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","130.1",130.1,NA,NA,125.8,134.4,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","158.6",158.6,NA,NA,153.5,163.8,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","743",743,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","115.3",115.3,NA,NA,114.5,116.2,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","150.5",150.5,NA,NA,149.4,151.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","14705",14705,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","123.4",123.4,NA,NA,122.1,124.8,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","130.6",130.6,NA,NA,129.2,132,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","6554",6554,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","134.4",134.4,NA,NA,130.8,138.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","161.5",161.5,NA,NA,157.3,165.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1107",1107,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","122.6",122.6,NA,NA,120.3,124.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","148",148,NA,NA,145.3,150.7,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","2286",2286,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","119.4",119.4,NA,NA,116,122.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","129.7",129.7,NA,NA,126.2,133.3,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1025",1025,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","128.5",128.5,NA,NA,127.3,129.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","145.4",145.4,NA,NA,144.1,146.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","9523",9523,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","120",120,NA,NA,118.4,121.6,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","137.8",137.8,NA,NA,136,139.6,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4558",4558,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","122",122,NA,NA,119.5,124.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","138.2",138.2,NA,NA,135.5,141,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1995",1995,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","122",122,NA,NA,120.1,123.9,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","144.7",144.7,NA,NA,142.4,146.9,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3207",3207,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","123.4",123.4,NA,NA,121.5,125.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","138.1",138.1,NA,NA,136,140.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3223",3223,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","136",136,NA,NA,134.3,137.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","162.1",162.1,NA,NA,160.2,164.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","5531",5531,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","130.2",130.2,NA,NA,128.5,131.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","149.7",149.7,NA,NA,147.8,151.7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4509",4509,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","124.5",124.5,NA,NA,121.2,128,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","165.8",165.8,NA,NA,161.5,170.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1125",1125,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","123",123,NA,NA,121.7,124.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","147.5",147.5,NA,NA,146,149,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","7426",7426,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","130.2",130.2,NA,NA,128.3,132,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","148.5",148.5,NA,NA,146.4,150.5,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3998",3998,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","124.8",124.8,NA,NA,123.1,126.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","148.8",148.8,NA,NA,146.8,150.7,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4558",4558,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","116.1",116.1,NA,NA,113.8,118.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","130.9",130.9,NA,NA,128.3,133.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","2003",2003,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","122.7",122.7,NA,NA,118.7,126.8,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","153.9",153.9,NA,NA,149,158.8,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","765",765,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","128.4",128.4,NA,NA,127.1,129.8,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","148.8",148.8,NA,NA,147.3,150.3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","7364",7364,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","124.6",124.6,NA,NA,119.5,129.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","143.4",143.4,NA,NA,137.8,149.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","487",487,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","120.7",120.7,NA,NA,117.7,123.8,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","137.7",137.7,NA,NA,134.4,141.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1277",1277,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","138.1",138.1,NA,NA,134.4,141.8,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","170.8",170.8,NA,NA,166.4,175.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1141",1141,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","131.4",131.4,NA,NA,130,132.8,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","156.8",156.8,NA,NA,155.1,158.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","7105",7105,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","112.8",112.8,NA,NA,110.1,115.6,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","131",131,NA,NA,128,134.2,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1371",1371,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","128.4",128.4,NA,NA,127.5,129.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","150.6",150.6,NA,NA,149.5,151.7,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","15147",15147,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","122",122,NA,NA,120.8,123.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","147.7",147.7,NA,NA,146.3,149.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","8722",8722,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","117.7",117.7,NA,NA,115.6,119.8,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","135.3",135.3,NA,NA,133,137.7,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","2588",2588,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","128.1",128.1,NA,NA,126,130.2,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1430",1430,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","154.9",154.9,NA,NA,152.4,157.4,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3027",3027,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","129",129,NA,NA,127.9,130.1,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","163",163,NA,NA,161.6,164.3,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","10627",10627,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","130.4",130.4,NA,NA,126.4,134.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","158.8",158.8,NA,NA,154.1,163.6,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","863",863,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","125.6",125.6,NA,NA,123.8,127.5,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","149.8",149.8,NA,NA,147.6,152,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","3599",3599,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","130.6",130.6,NA,NA,125.9,135.5,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","151.6",151.6,NA,NA,146.3,157,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","624",624,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","121.7",121.7,NA,NA,120.1,123.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","144",144,NA,NA,142.1,145.8,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4725",4725,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","112.3",112.3,NA,NA,111.4,113.1,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","112.7",112.7,NA,NA,111.9,113.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","14574",14574,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","123.3",123.3,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",123.1,123.6,"Overall","Overall",NA,"59","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","141.8",141.8,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",141.5,142,"Overall","Overall",NA,"59","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","224504",224504,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","112.7",112.7,NA,NA,110,115.5,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","95.6",95.6,NA,NA,93.3,97.9,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1339",1339,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","126.9",126.9,NA,NA,125.4,128.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","143.8",143.8,NA,NA,142.2,145.5,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","5876",5876,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","128.3",128.3,NA,NA,123.2,133.5,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","164",164,NA,NA,157.7,170.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","521",521,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","135.6",135.6,NA,NA,133.9,137.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","153.7",153.7,NA,NA,151.8,155.5,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","5253",5253,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","127.2",127.2,NA,NA,125.5,128.9,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","150",150,NA,NA,148,152,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","4312",4312,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","114.4",114.4,NA,NA,111.6,117.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","149.6",149.6,NA,NA,146.1,153.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","1405",1405,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Age-adjusted Rate","109.6",109.6,NA,NA,104.4,115.1,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence","per 100,000","Average Annual Crude Rate","124.9",124.9,NA,NA,119.1,130.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the female breast, incidence",NA,"Average Annual Number","349",349,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","21.1",21.1,NA,NA,18.7,23.7,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","17.8",17.8,NA,NA,15.9,19.9,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","61",61,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,21.4,23,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27",27,NA,NA,26.1,28,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","668",668,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.3",22.3,NA,NA,21.3,23.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.6",27.6,NA,NA,26.4,28.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","412",412,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.6",19.6,NA,NA,19,20.3,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","23.2",23.2,NA,NA,22.5,24,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","758",758,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.9",20.9,NA,NA,20.6,21.2,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","22.9",22.9,NA,NA,22.6,23.3,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","4352",4352,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.5",19.5,NA,NA,18.7,20.2,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","21.2",21.2,NA,NA,20.4,22,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","540",540,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.8",19.8,NA,NA,19,20.7,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.3",26.3,NA,NA,25.3,27.4,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","29.3",29.3,NA,NA,26.8,32.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","30.7",30.7,NA,NA,28.1,33.5,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","100",100,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","21.8",21.8,NA,NA,20.1,23.6,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.3",27.3,NA,NA,25.2,29.5,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","128",128,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.6",20.6,NA,NA,20.2,20.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","28.8",28.8,NA,NA,28.3,29.3,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","2815",2815,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.9",22.9,NA,NA,22.3,23.5,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","24.1",24.1,NA,NA,23.5,24.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1210",1210,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","14.9",14.9,NA,NA,13.7,16.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","18.6",18.6,NA,NA,17.2,20.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","128",128,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.7",19.7,NA,NA,18.8,20.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.3",26.3,NA,NA,25.2,27.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","407",407,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.8",20.8,NA,NA,19.4,22.2,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","23.1",23.1,NA,NA,21.6,24.6,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","182",182,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.7",22.7,NA,NA,22.2,23.2,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27",27,NA,NA,26.5,27.6,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.3",22.3,NA,NA,21.6,23,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.7",26.7,NA,NA,25.9,27.5,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","884",884,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.6",20.6,NA,NA,19.6,21.6,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.1",25.1,NA,NA,23.9,26.2,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","362",362,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.4",22.4,NA,NA,21.6,23.2,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.5",27.5,NA,NA,26.5,28.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","609",609,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","24.5",24.5,NA,NA,23.7,25.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","28.1",28.1,NA,NA,27.1,29.1,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","656",656,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.7",19.7,NA,NA,19.1,20.3,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.3",25.3,NA,NA,24.6,26.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","864",864,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","23",23,NA,NA,22.3,23.7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27",27,NA,NA,26.2,27.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","814",814,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","18.8",18.8,NA,NA,17.6,20.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.7",26.7,NA,NA,25,28.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","181",181,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.5",22.5,NA,NA,21.9,23,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","28.4",28.4,NA,NA,27.7,29.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.6",19.6,NA,NA,19,20.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","24.1",24.1,NA,NA,23.2,24.9,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","648",648,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.8",22.8,NA,NA,22.1,23.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","28.5",28.5,NA,NA,27.6,29.3,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","872",872,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","24.1",24.1,NA,NA,23.1,25.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.8",27.8,NA,NA,26.7,29,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","426",426,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.9",20.9,NA,NA,19.3,22.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.5",27.5,NA,NA,25.5,29.7,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","137",137,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","21.7",21.7,NA,NA,21.2,22.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.8",25.8,NA,NA,25.1,26.4,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1275",1275,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19",19,NA,NA,17.2,21,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.3",25.3,NA,NA,23,27.8,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","86",86,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.8",19.8,NA,NA,18.6,21,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","24.5",24.5,NA,NA,23.1,26,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","227",227,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.6",19.6,NA,NA,18.3,21,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.3",25.3,NA,NA,23.6,27.1,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","23.4",23.4,NA,NA,22.8,24,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","29.7",29.7,NA,NA,29,30.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1347",1347,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.9",19.9,NA,NA,18.8,21.1,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","23.5",23.5,NA,NA,22.2,24.9,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","246",246,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","23.1",23.1,NA,NA,22,24.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25",25,NA,NA,23.8,26.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","338",338,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","21.2",21.2,NA,NA,20.9,21.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.6",26.6,NA,NA,26.1,27,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","2671",2671,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","23.3",23.3,NA,NA,22.8,23.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","30",30,NA,NA,29.4,30.6,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1772",1772,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","23.2",23.2,NA,NA,22.3,24.1,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.6",27.6,NA,NA,26.6,28.7,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","528",528,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.5",20.5,NA,NA,19.7,21.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26",26,NA,NA,25,27,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","508",508,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.8",22.8,NA,NA,22.3,23.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","31.6",31.6,NA,NA,31,32.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.4",19.4,NA,NA,17.9,21,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.9",25.9,NA,NA,24,27.9,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","141",141,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.5",22.5,NA,NA,21.7,23.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.4",27.4,NA,NA,26.4,28.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","657",657,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.1",20.1,NA,NA,18.3,21.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.3",26.3,NA,NA,24.1,28.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","108",108,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.5",22.5,NA,NA,21.8,23.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","27.3",27.3,NA,NA,26.5,28.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","897",897,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.7",20.7,NA,NA,20.3,21,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","20.8",20.8,NA,NA,20.4,21.1,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","2685",2685,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","21.5",21.5,NA,NA,21.4,21.6,"Overall","Overall",NA,"59","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.8",25.8,NA,NA,25.7,25.9,"Overall","Overall",NA,"59","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","40923",40923,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.7",20.7,NA,NA,19.6,21.9,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","17.6",17.6,NA,NA,16.6,18.6,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","246",246,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,21.6,22.8,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.7",25.7,NA,NA,25,26.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","1059",1059,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","19.1",19.1,NA,NA,17.2,21.1,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","25.5",25.5,NA,NA,23.1,28.1,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","81",81,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.2",20.2,NA,NA,19.5,20.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","23.5",23.5,NA,NA,22.8,24.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","804",804,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.9",20.9,NA,NA,20.2,21.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","26.7",26.7,NA,NA,25.8,27.5,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","767",767,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,21,23.4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","30.6",30.6,NA,NA,29.1,32.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","288",288,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Age-adjusted Rate","20.2",20.2,NA,NA,18.1,22.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female breast, mortality","per 100,000","Average Annual Crude Rate","23.9",23.9,NA,NA,21.4,26.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female breast, mortality",NA,"Average Annual Number","67",67,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN5_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.1",7.1,NA,NA,5.8,8.5,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.9",6.9,NA,NA,5.7,8.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","24",24,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.6",8.6,NA,NA,8.1,9.1,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.9",8.9,NA,NA,8.4,9.4,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","219",219,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","9.9",9.9,NA,NA,9.1,10.6,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9.8",9.8,NA,NA,9.1,10.6,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","147",147,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.7",6.7,NA,NA,6.3,7.2,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.7",6.7,NA,NA,6.3,7.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","218",218,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.5",7.5,NA,NA,7.3,7.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.6",7.6,NA,NA,7.4,7.7,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","1436",1436,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","5.9",5.9,NA,NA,5.5,6.3,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6",6,NA,NA,5.6,6.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","153",153,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.7",6.7,NA,NA,6.2,7.3,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7",7,NA,NA,6.5,7.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","130",130,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","9.3",9.3,NA,NA,7.8,10.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.9",8.9,NA,NA,7.5,10.4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","29",29,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.3",8.3,NA,NA,7.2,9.6,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.9",8.9,NA,NA,7.8,10.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","42",42,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.9",8.9,NA,NA,8.6,9.1,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9.5",9.5,NA,NA,9.3,9.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","933",933,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.7",7.7,NA,NA,7.4,8.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.8",7.8,NA,NA,7.5,8.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","391",391,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.4",7.4,NA,NA,6.5,8.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.6",7.6,NA,NA,6.7,8.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","52",52,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.7",6.7,NA,NA,6.1,7.3,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.6",6.6,NA,NA,6.1,7.2,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","102",102,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.1",6.1,NA,NA,5.4,7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.9",5.9,NA,NA,5.2,6.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","47",47,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.7",7.7,NA,NA,7.4,8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8",8,NA,NA,7.7,8.4,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","527",527,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.6",7.6,NA,NA,7.2,8.1,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.7",7.7,NA,NA,7.3,8.2,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","256",256,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.3",7.3,NA,NA,6.7,8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.1",7.1,NA,NA,6.5,7.7,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","102",102,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.7",8.7,NA,NA,8.1,9.3,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.9",8.9,NA,NA,8.4,9.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","197",197,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.8",8.8,NA,NA,8.2,9.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.7",8.7,NA,NA,8.2,9.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","203",203,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","5.2",5.2,NA,NA,4.9,5.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.6",5.6,NA,NA,5.3,6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","191",191,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.6",6.6,NA,NA,6.2,7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.9",6.9,NA,NA,6.5,7.4,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","209",209,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.1",6.1,NA,NA,5.2,7,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.6",6.6,NA,NA,5.7,7.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","45",45,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.8",6.8,NA,NA,6.5,7.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7",7,NA,NA,6.6,7.3,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","351",351,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","5.8",5.8,NA,NA,5.4,6.2,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.9",5.9,NA,NA,5.5,6.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","160",160,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.5",8.5,NA,NA,8,8.9,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.7",8.7,NA,NA,8.2,9.2,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","266",266,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","9.3",9.3,NA,NA,8.6,10,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9.4",9.4,NA,NA,8.7,10.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","144",144,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.3",6.3,NA,NA,5.3,7.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.7",6.7,NA,NA,5.7,7.8,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","33",33,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7",7,NA,NA,6.7,7.3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.3",7.3,NA,NA,6.9,7.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","360",360,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","5.4",5.4,NA,NA,4.3,6.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.2",5.2,NA,NA,4.2,6.4,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","18",18,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.2",7.2,NA,NA,6.4,8.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.9",6.9,NA,NA,6.2,7.7,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","64",64,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","4.6",4.6,NA,NA,3.9,5.4,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.1",5.1,NA,NA,4.3,5.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","34",34,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.9",7.9,NA,NA,7.5,8.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.6",8.6,NA,NA,8.2,9,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","390",390,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.2",7.2,NA,NA,6.4,8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.2",7.2,NA,NA,6.5,8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","75",75,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.9",7.9,NA,NA,7.6,8.1,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.5",8.5,NA,NA,8.2,8.7,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","852",852,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.5",7.5,NA,NA,7.2,7.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.7",7.7,NA,NA,7.4,8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","456",456,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","9.4",9.4,NA,NA,8.8,10.1,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9.3",9.3,NA,NA,8.7,9.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","177",177,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.6",6.6,NA,NA,6.1,7.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.7",6.7,NA,NA,6.2,7.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","131",131,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.6",7.6,NA,NA,7.3,7.9,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.1",8.1,NA,NA,7.8,8.4,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","530",530,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.3",6.3,NA,NA,5.4,7.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.5",6.5,NA,NA,5.6,7.6,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","36",36,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.1",8.1,NA,NA,7.6,8.6,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8.3",8.3,NA,NA,7.8,8.8,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","198",198,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.8",6.8,NA,NA,5.7,8.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.6",6.6,NA,NA,5.5,7.8,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","27",27,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8.7",8.7,NA,NA,8.2,9.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9",9,NA,NA,8.5,9.5,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","295",295,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","9.2",9.2,NA,NA,8.9,9.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","9",9,NA,NA,8.8,9.2,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","1162",1162,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","7.6",7.6,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",7.5,7.7,"Overall","Overall",NA,"59","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.8",7.8,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",7.8,7.9,"Overall","Overall",NA,"59","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","12404",12404,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","5.2",5.2,NA,NA,4.6,5.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","4.5",4.5,NA,NA,4,5,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","63",63,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.2",6.2,NA,NA,5.9,6.6,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.5",6.5,NA,NA,6.2,6.9,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","266",266,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","4.7",4.7,NA,NA,3.7,5.9,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","5.2",5.2,NA,NA,4.1,6.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","16",16,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6.9",6.9,NA,NA,6.5,7.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","7.1",7.1,NA,NA,6.7,7.5,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","242",242,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","6",6,NA,NA,5.6,6.5,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","6.2",6.2,NA,NA,5.8,6.7,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","179",179,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","10",10,NA,NA,9.1,10.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","10.5",10.5,NA,NA,9.6,11.5,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","99",99,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Age-adjusted Rate","8",8,NA,NA,6.6,9.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence","per 100,000","Average Annual Crude Rate","8",8,NA,NA,6.6,9.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive cancer of the cervix, incidence",NA,"Average Annual Number","22",22,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.9",1.9,NA,NA,1.3,2.7,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.3,2.7,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","7",7,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.8,3.4,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.1,3.8,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","84",84,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3.4",3.4,NA,NA,3,3.9,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.8",3.8,NA,NA,3.3,4.2,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","56",56,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.9,2.3,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2,2.5,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","74",74,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.4,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.3,2.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","454",454,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.5",1.5,NA,NA,1.3,1.8,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.7",1.7,NA,NA,1.4,1.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","42",42,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.6",1.6,NA,NA,1.4,1.9,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.7,2.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","35",35,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.1,3.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.2,4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","10",10,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2,3.3,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.3,3.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","14",14,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,3.1,3.5,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","322",322,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.4,2.8,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.5,2.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","137",137,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.6,2.6,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,1.9,2.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","16",16,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2",2,NA,NA,1.7,2.3,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.2",2.2,NA,NA,1.9,2.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","35",35,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.7",1.7,NA,NA,1.3,2.1,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.7",1.7,NA,NA,1.4,2.2,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","14",14,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.3,2.6,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","179",179,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.2,2.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.5,3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","90",90,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.9",1.9,NA,NA,1.6,2.3,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.1",2.1,NA,NA,1.7,2.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","30",30,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.7,3.3,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.1,3.8,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","75",75,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.7,3.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.8,3.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","73",73,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.3",1.3,NA,NA,1.2,1.5,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.6",1.6,NA,NA,1.4,1.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","55",55,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.9,2.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2.1,2.6,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","71",71,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.4",1.4,NA,NA,1.1,1.9,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.5,2.4,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","13",13,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.9,2.3,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.2,2.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","120",120,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.5",1.5,NA,NA,1.3,1.7,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.6",1.6,NA,NA,1.4,1.8,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","43",43,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.4,2.9,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3.2,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","90",90,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3.4",3.4,NA,NA,3,3.9,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3.7",3.7,NA,NA,3.3,4.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","57",57,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.8",1.8,NA,NA,1.4,2.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.2",2.2,NA,NA,1.7,2.9,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","11",11,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.9,2.3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.2,2.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","117",117,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.2",1.2,NA,NA,0.8,1.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.4",1.4,NA,NA,0.9,2.1,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","5",5,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2",2,NA,NA,1.6,2.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.1",2.1,NA,NA,1.7,2.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","20",20,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.6",1.6,NA,NA,1.2,2,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.5,2.4,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","13",13,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.5,3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","124",124,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.7,2.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.2",2.2,NA,NA,1.8,2.7,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","23",23,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.8,2.5,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2,2.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","31",31,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.2,2.5,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","274",274,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.3,2.7,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","168",168,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.6,3.3,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.7,3.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","58",58,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.8",1.8,NA,NA,1.5,2.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2",2,NA,NA,1.7,2.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","39",39,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,2,2.3,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.4,2.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","167",167,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.3",1.3,NA,NA,0.9,1.7,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.5",1.5,NA,NA,1.1,2.1,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","8",8,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.4,3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.7,3.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","72",72,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.7",1.7,NA,NA,1.2,2.3,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.3,2.6,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","8",8,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.4,2.9,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","99",99,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.8,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","350",350,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.3,2.3,"Overall","Overall",NA,"59","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.5,2.6,"Overall","Overall",NA,"59","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","4046",4046,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.4",1.4,NA,NA,1.1,1.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.2",1.2,NA,NA,1,1.5,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","17",17,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.8",1.8,NA,NA,1.6,2,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2",2,NA,NA,1.8,2.2,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","81",81,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.2",1.2,NA,NA,0.7,1.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.5",1.5,NA,NA,1,2.2,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","5",5,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.8",1.8,NA,NA,1.6,2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2",2,NA,NA,1.8,2.2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","68",68,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","1.4",1.4,NA,NA,1.3,1.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","1.7",1.7,NA,NA,1.5,1.9,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","48",48,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","3.4",3.4,NA,NA,2.9,4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","4",4,NA,NA,3.4,4.6,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","37",37,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,1.8,3.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female cervix, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2,3.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the female cervix, mortality",NA,"Average Annual Number","8",8,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN6_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44.3",44.3,NA,NA,41.8,47,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","37.1",37.1,NA,NA,35.2,39.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","268",268,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44.1",44.1,NA,NA,43.3,44.9,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","50.3",50.3,NA,NA,49.4,51.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2416",2416,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","43",43,NA,NA,42,44,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","49.7",49.7,NA,NA,48.5,50.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3466",3466,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1457",1457,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","34.7",34.7,NA,NA,34.1,35.4,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","38.5",38.5,NA,NA,37.8,39.2,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2497",2497,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","38.3",38.3,NA,NA,38,38.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","38.4",38.4,NA,NA,38.1,38.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","14458",14458,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","34.6",34.6,NA,NA,33.8,35.3,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","33.9",33.9,NA,NA,33.2,34.6,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1735",1735,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","40.2",40.2,NA,NA,39.3,41.1,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","47.8",47.8,NA,NA,46.8,48.9,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1715",1715,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44",44,NA,NA,41.6,46.5,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","42.2",42.2,NA,NA,40,44.6,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","262",262,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","38.2",38.2,NA,NA,36.6,39.9,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","44.9",44.9,NA,NA,43,46.9,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","408",408,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.9",37.9,NA,NA,37.5,38.2,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","50.2",50.2,NA,NA,49.8,50.7,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","9599",9599,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","41.7",41.7,NA,NA,41.1,42.3,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","40.6",40.6,NA,NA,40,41.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","3981",3981,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44.3",44.3,NA,NA,42.8,45.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","52.4",52.4,NA,NA,50.7,54.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","722",722,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","45.5",45.5,NA,NA,44.5,46.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","54.8",54.8,NA,NA,53.6,56,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1679",1679,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.1",37.1,NA,NA,35.7,38.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","38.5",38.5,NA,NA,37.2,39.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","610",610,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","45.3",45.3,NA,NA,44.8,45.9,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","48.7",48.7,NA,NA,48.2,49.3,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","6264",6264,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44",44,NA,NA,43.3,44.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","48",48,NA,NA,47.2,48.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","3126",3126,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","41.8",41.8,NA,NA,40.8,42.9,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","45.8",45.8,NA,NA,44.7,47,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1315",1315,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","50.8",50.8,NA,NA,49.9,51.7,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","57",57,NA,NA,56,58,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2487",2487,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","48.6",48.6,NA,NA,47.7,49.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","51.7",51.7,NA,NA,50.8,52.7,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2364",2364,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","38.9",38.9,NA,NA,38.2,39.5,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","45.1",45.1,NA,NA,44.3,45.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2980",2980,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.6",37.6,NA,NA,36.9,38.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","40.4",40.4,NA,NA,39.7,41.1,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2358",2358,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.9",39.9,NA,NA,38.6,41.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","51.9",51.9,NA,NA,50.2,53.7,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","690",690,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.5",39.5,NA,NA,39,40.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","45.8",45.8,NA,NA,45.2,46.4,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","4529",4529,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.6",39.6,NA,NA,38.9,40.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","43.5",43.5,NA,NA,42.7,44.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2327",2327,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","43.2",43.2,NA,NA,42.5,43.9,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","49.6",49.6,NA,NA,48.8,50.4,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2982",2982,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","49.8",49.8,NA,NA,48.7,50.9,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","54",54,NA,NA,52.8,55.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1607",1607,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.9",39.9,NA,NA,38.3,41.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","49.1",49.1,NA,NA,47.2,51.1,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","490",490,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","38.4",38.4,NA,NA,37.8,38.9,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","41.9",41.9,NA,NA,41.4,42.5,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","4047",4047,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","47.1",47.1,NA,NA,44.9,49.3,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","54.1",54.1,NA,NA,51.7,56.7,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","374",374,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","43.7",43.7,NA,NA,42.4,45,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","48.7",48.7,NA,NA,47.3,50.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","897",897,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.9",37.9,NA,NA,36.5,39.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","44.8",44.8,NA,NA,43.2,46.5,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","591",591,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","43.5",43.5,NA,NA,42.9,44.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","49.6",49.6,NA,NA,48.9,50.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","4384",4384,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","34.7",34.7,NA,NA,33.6,35.8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","38.7",38.7,NA,NA,37.5,39.9,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","801",801,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","41.5",41.5,NA,NA,41.1,41.9,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","46.9",46.9,NA,NA,46.5,47.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","9148",9148,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","41.8",41.8,NA,NA,41.3,42.3,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","49",49,NA,NA,48.4,49.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","5654",5654,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","43.5",43.5,NA,NA,42.6,44.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","47.9",47.9,NA,NA,46.9,48.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1813",1813,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.1",37.1,NA,NA,36.2,37.9,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","42.9",42.9,NA,NA,42,43.8,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1658",1658,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","44.3",44.3,NA,NA,43.8,44.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","55.5",55.5,NA,NA,54.9,56,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","7063",7063,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","38.6",38.6,NA,NA,37,40.2,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","46.4",46.4,NA,NA,44.6,48.3,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","489",489,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.4",39.4,NA,NA,38.6,40.1,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","44.8",44.8,NA,NA,43.9,45.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2096",2096,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","45.2",45.2,NA,NA,43.2,47.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","52.9",52.9,NA,NA,50.7,55.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","437",437,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","41.4",41.4,NA,NA,40.8,42.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","46.4",46.4,NA,NA,45.7,47.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2973",2973,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.2",39.2,NA,NA,38.9,39.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","36.4",36.4,NA,NA,36.1,36.8,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","9348",9348,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","60.5",60.5,NA,NA,58.9,62.1,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","40.6",40.6,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",40.5,40.7,"Overall","Overall",NA,"59","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","44.6",44.6,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",44.5,44.7,"Overall","Overall",NA,"59","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","139095",139095,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","31.9",31.9,NA,NA,30.9,33,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","25.5",25.5,NA,NA,24.7,26.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","717",717,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.9",37.9,NA,NA,37.3,38.5,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","40.1",40.1,NA,NA,39.4,40.7,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","3216",3216,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.4",37.4,NA,NA,35.4,39.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","46.4",46.4,NA,NA,44,48.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","290",290,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.6",37.6,NA,NA,36.9,38.2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","40",40,NA,NA,39.3,40.7,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2727",2727,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","39.1",39.1,NA,NA,38.4,39.8,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","45",45,NA,NA,44.2,45.8,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","2570",2570,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","47",47,NA,NA,45.7,48.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","1122",1122,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Age-adjusted Rate","37.6",37.6,NA,NA,35.4,39.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence","per 100,000","Average Annual Crude Rate","40.6",40.6,NA,NA,38.3,43,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the colon and recturm (colorectal), incidence",NA,"Average Annual Number","232",232,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.6",15.6,NA,NA,14.1,17.3,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","11.7",11.7,NA,NA,10.6,12.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","84",84,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.9",16.9,NA,NA,16.4,17.4,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.1",19.1,NA,NA,18.5,19.6,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","914",914,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","18.2",18.2,NA,NA,17.5,18.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","21",21,NA,NA,20.2,21.7,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","615",615,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.2",13.2,NA,NA,12.9,13.6,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","14.7",14.7,NA,NA,14.3,15.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","952",952,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.9",13.9,NA,NA,13.7,14,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","13.8",13.8,NA,NA,13.6,14,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","5197",5197,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13",13,NA,NA,12.5,13.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","12.5",12.5,NA,NA,12,12.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","638",638,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","12.2",12.2,NA,NA,11.7,12.7,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15",15,NA,NA,14.5,15.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","539",539,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.7",16.7,NA,NA,15.2,18.3,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16",16,NA,NA,14.6,17.5,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","99",99,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.1",14.1,NA,NA,13.1,15.1,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.5",16.5,NA,NA,15.3,17.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","150",150,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14",14,NA,NA,13.8,14.2,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.1",19.1,NA,NA,18.8,19.3,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","3644",3644,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.5",15.5,NA,NA,15.1,15.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","14.5",14.5,NA,NA,14.1,14.8,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1420",1420,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.7",13.7,NA,NA,12.9,14.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.5",16.5,NA,NA,15.5,17.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","227",227,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.4",16.4,NA,NA,15.8,17,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","20.6",20.6,NA,NA,19.9,21.3,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","630",630,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.5",13.5,NA,NA,12.7,14.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","14",14,NA,NA,13.2,14.8,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","222",222,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.2",16.2,NA,NA,15.9,16.5,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.5",17.5,NA,NA,17.2,17.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","2248",2248,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.2",16.2,NA,NA,15.8,16.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.9",17.9,NA,NA,17.4,18.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1164",1164,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.3",15.3,NA,NA,14.7,15.9,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.1",17.1,NA,NA,16.5,17.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","492",492,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","17.6",17.6,NA,NA,17.1,18.2,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.5",19.5,NA,NA,18.9,20.1,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","851",851,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","18.1",18.1,NA,NA,17.5,18.6,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.9",18.9,NA,NA,18.3,19.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","864",864,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.8",13.8,NA,NA,13.4,14.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.4",16.4,NA,NA,16,16.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1084",1084,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.9",14.9,NA,NA,14.4,15.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.9",15.9,NA,NA,15.4,16.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","927",927,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.4",14.4,NA,NA,13.6,15.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.1",19.1,NA,NA,18.1,20.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","254",254,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.2",15.2,NA,NA,14.9,15.5,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.8",17.8,NA,NA,17.4,18.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1755",1755,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.5",13.5,NA,NA,13.1,13.9,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.1",15.1,NA,NA,14.7,15.6,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","810",810,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.4",16.4,NA,NA,15.9,16.8,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.9",18.9,NA,NA,18.4,19.4,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1135",1135,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","19.5",19.5,NA,NA,18.8,20.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","20.8",20.8,NA,NA,20.1,21.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","619",619,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.9",13.9,NA,NA,13,14.9,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.4",17.4,NA,NA,16.3,18.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","174",174,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.3",14.3,NA,NA,13.9,14.6,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.4",15.4,NA,NA,15.1,15.8,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1487",1487,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.6",15.6,NA,NA,14.4,16.8,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.9",18.9,NA,NA,17.5,20.4,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","130",130,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.3",16.3,NA,NA,15.5,17.1,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.6",18.6,NA,NA,17.7,19.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","343",343,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.7",13.7,NA,NA,12.9,14.6,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.9",15.9,NA,NA,15,16.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","210",210,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.6",15.6,NA,NA,15.3,16,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.1",18.1,NA,NA,17.7,18.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1601",1601,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.3",14.3,NA,NA,13.6,15,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.7",15.7,NA,NA,14.9,16.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","325",325,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","17",17,NA,NA,16.3,17.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.7",16.7,NA,NA,16,17.4,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","455",455,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.6",14.6,NA,NA,14.4,14.9,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.8",16.8,NA,NA,16.5,17,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","3274",3274,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.6",16.6,NA,NA,16.3,16.9,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.7",19.7,NA,NA,19.3,20,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","2269",2269,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","17.3",17.3,NA,NA,16.7,17.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19",19,NA,NA,18.4,19.6,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","719",719,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.6",14.6,NA,NA,14.1,15.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.1",17.1,NA,NA,16.5,17.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","661",661,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","16.3",16.3,NA,NA,16,16.6,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","21.1",21.1,NA,NA,20.8,21.5,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","2689",2689,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.7",14.7,NA,NA,13.8,15.7,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","18.6",18.6,NA,NA,17.4,19.8,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","195",195,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.8",15.8,NA,NA,15.3,16.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.7",17.7,NA,NA,17.2,18.3,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","829",829,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.7",15.7,NA,NA,14.6,16.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19.1",19.1,NA,NA,17.8,20.5,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","158",158,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","17.1",17.1,NA,NA,16.7,17.6,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","19",19,NA,NA,18.5,19.5,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1215",1215,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.1",15.1,NA,NA,14.8,15.3,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","13.6",13.6,NA,NA,13.4,13.8,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","3487",3487,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","15.1",15.1,NA,NA,15,15.2,"Overall","Overall",NA,"59","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.6",16.6,NA,NA,16.6,16.7,"Overall","Overall",NA,"59","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","51801",51801,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","11.5",11.5,NA,NA,10.9,12.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","8.9",8.9,NA,NA,8.4,9.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","250",250,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.5",14.5,NA,NA,14.2,14.9,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15",15,NA,NA,14.7,15.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","1219",1219,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.3",14.3,NA,NA,13.2,15.6,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","17.7",17.7,NA,NA,16.2,19.2,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","111",111,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","13.5",13.5,NA,NA,13.2,13.9,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","14.4",14.4,NA,NA,14,14.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","981",981,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.2",14.2,NA,NA,13.8,14.6,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","16.6",16.6,NA,NA,16.2,17.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","950",950,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2390",2390,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","18.8",18.8,NA,NA,18,19.6,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","24.2",24.2,NA,NA,23.2,25.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","449",449,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Age-adjusted Rate","14.3",14.3,NA,NA,12.9,15.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality","per 100,000","Average Annual Crude Rate","15.4",15.4,NA,NA,14,16.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the colon and recturm (colorectal), mortality",NA,"Average Annual Number","88",88,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN7_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","62.7",62.7,NA,NA,59.5,66,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","47.8",47.8,NA,NA,45.6,50.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","345",345,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","71.3",71.3,NA,NA,70.3,72.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","83.3",83.3,NA,NA,82.2,84.5,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3999",3999,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","77.1",77.1,NA,NA,75.8,78.4,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","91.6",91.6,NA,NA,90.1,93.2,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2687",2687,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","51.6",51.6,NA,NA,50.9,52.4,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","58.5",58.5,NA,NA,57.7,59.3,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3793",3793,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","46.5",46.5,NA,NA,46.2,46.8,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","45.3",45.3,NA,NA,45,45.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","17075",17075,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","45.5",45.5,NA,NA,44.6,46.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","43.6",43.6,NA,NA,42.8,44.5,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2235",2235,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","63.1",63.1,NA,NA,62,64.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","74.3",74.3,NA,NA,73.1,75.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2664",2664,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","59",59,NA,NA,56.3,61.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","56.6",56.6,NA,NA,54,59.3,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","351",351,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","71.3",71.3,NA,NA,69.1,73.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","85.1",85.1,NA,NA,82.5,87.9,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","773",773,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","63",63,NA,NA,62.5,63.4,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","86.1",86.1,NA,NA,85.5,86.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","16448",16448,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","67.3",67.3,NA,NA,66.5,68.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","64.5",64.5,NA,NA,63.8,65.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","6329",6329,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","47.2",47.2,NA,NA,45.7,48.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","56.3",56.3,NA,NA,54.6,58.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","776",776,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","64.6",64.6,NA,NA,63.4,65.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","78",78,NA,NA,76.6,79.4,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","51.1",51.1,NA,NA,49.5,52.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","53.4",53.4,NA,NA,51.8,55,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","845",845,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","67.9",67.9,NA,NA,67.3,68.5,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","72.4",72.4,NA,NA,71.8,73.1,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","9306",9306,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","74.2",74.2,NA,NA,73.3,75.2,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","81.6",81.6,NA,NA,80.6,82.6,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5314",5314,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","62.2",62.2,NA,NA,61,63.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","68.6",68.6,NA,NA,67.2,70,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","1967",1967,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","96.4",96.4,NA,NA,95.2,97.7,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","110.2",110.2,NA,NA,108.8,111.6,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","4808",4808,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","71.4",71.4,NA,NA,70.3,72.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","76.3",76.3,NA,NA,75.2,77.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3486",3486,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","66.1",66.1,NA,NA,65.3,66.9,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","76",76,NA,NA,75,76.9,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5023",5023,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","59.2",59.2,NA,NA,58.3,60,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","62.9",62.9,NA,NA,62,63.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3675",3675,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","74.6",74.6,NA,NA,72.8,76.4,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","99.6",99.6,NA,NA,97.2,102,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","1323",1323,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","67.5",67.5,NA,NA,66.8,68.2,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","79",79,NA,NA,78.2,79.8,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","7814",7814,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","55.5",55.5,NA,NA,54.6,56.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","60.6",60.6,NA,NA,59.7,61.6,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3242",3242,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","75.8",75.8,NA,NA,74.9,76.8,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","88.4",88.4,NA,NA,87.4,89.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5313",5313,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","76.4",76.4,NA,NA,75,77.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","83.9",83.9,NA,NA,82.4,85.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2497",2497,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","58.2",58.2,NA,NA,56.3,60.2,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","72.1",72.1,NA,NA,69.7,74.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","719",719,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","70.7",70.7,NA,NA,69.9,71.4,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","78.3",78.3,NA,NA,77.6,79.1,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","7562",7562,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","56.9",56.9,NA,NA,54.5,59.3,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","65.8",65.8,NA,NA,63.1,68.5,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","454",454,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","58.7",58.7,NA,NA,57.2,60.2,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","65.3",65.3,NA,NA,63.7,67,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","1203",1203,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","67.8",67.8,NA,NA,66,69.7,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","80.1",80.1,NA,NA,78,82.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","1057",1057,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","59",59,NA,NA,58.3,59.6,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","66.8",66.8,NA,NA,66,67.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5900",5900,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","41.9",41.9,NA,NA,40.7,43.1,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","46.7",46.7,NA,NA,45.4,48,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","967",967,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","61.8",61.8,NA,NA,61.3,62.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","69.8",69.8,NA,NA,69.3,70.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","13611",13611,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","70.7",70.7,NA,NA,70.1,71.4,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","83.6",83.6,NA,NA,82.8,84.3,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","9648",9648,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","71.2",71.2,NA,NA,70.1,72.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","79.8",79.8,NA,NA,78.5,81.1,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3022",3022,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","59.3",59.3,NA,NA,58.3,60.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","69.4",69.4,NA,NA,68.3,70.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2686",2686,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","66.3",66.3,NA,NA,65.8,66.9,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","83.7",83.7,NA,NA,83,84.4,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","10660",10660,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","69.5",69.5,NA,NA,67.4,71.7,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","82.9",82.9,NA,NA,80.5,85.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","873",873,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","68.7",68.7,NA,NA,67.7,69.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","80.1",80.1,NA,NA,78.9,81.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","3746",3746,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","57.8",57.8,NA,NA,55.7,60.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","67.7",67.7,NA,NA,65.2,70.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","559",559,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","76.8",76.8,NA,NA,75.9,77.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","88.3",88.3,NA,NA,87.3,89.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5653",5653,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","56.1",56.1,NA,NA,55.7,56.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","50.7",50.7,NA,NA,50.3,51.1,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","13006",13006,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","62.5",62.5,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",62.3,62.6,"Overall","Overall",NA,"59","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","68.9",68.9,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",68.7,69,"Overall","Overall",NA,"59","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","214614",214614,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","28.8",28.8,NA,NA,27.8,29.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","22.5",22.5,NA,NA,21.7,23.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","633",633,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","62.9",62.9,NA,NA,62.1,63.6,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","66.2",66.2,NA,NA,65.4,67,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","5315",5315,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","66.7",66.7,NA,NA,64.1,69.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","83.6",83.6,NA,NA,80.5,86.9,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","524",524,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","60",60,NA,NA,59.2,60.9,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","63.2",63.2,NA,NA,62.3,64,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","4308",4308,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","61.1",61.1,NA,NA,60.3,62,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","70.5",70.5,NA,NA,69.6,71.5,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","4026",4026,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","81.2",81.2,NA,NA,79.6,82.8,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","108.1",108.1,NA,NA,106,110.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","2003",2003,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Age-adjusted Rate","47.3",47.3,NA,NA,44.9,49.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence","per 100,000","Average Annual Crude Rate","51.2",51.2,NA,NA,48.6,53.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Cancer of the lung and bronchus, incidence",NA,"Average Annual Number","292",292,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","50.8",50.8,NA,NA,47.8,53.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","36.2",36.2,NA,NA,34.3,38.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","261",261,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","57.3",57.3,NA,NA,56.4,58.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","66.3",66.3,NA,NA,65.3,67.4,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3183",3183,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","61.9",61.9,NA,NA,60.7,63.1,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","72.9",72.9,NA,NA,71.5,74.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2138",2138,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","37.5",37.5,NA,NA,36.8,38.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","42.3",42.3,NA,NA,41.5,43,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2740",2740,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","537",537,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","34.8",34.8,NA,NA,34.5,35.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","33.8",33.8,NA,NA,33.6,34.1,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","12757",12757,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","33.1",33.1,NA,NA,32.4,33.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","31.3",31.3,NA,NA,30.6,32,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1603",1603,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.6",40.6,NA,NA,39.8,41.5,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","48.4",48.4,NA,NA,47.4,49.4,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1736",1736,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.6",40.6,NA,NA,38.3,43.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","38.6",38.6,NA,NA,36.5,40.9,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","240",240,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","52.2",52.2,NA,NA,50.3,54.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","62.2",62.2,NA,NA,59.9,64.5,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","565",565,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","45.3",45.3,NA,NA,44.9,45.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","62.4",62.4,NA,NA,61.9,62.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","11925",11925,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","49",49,NA,NA,48.3,49.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","46.1",46.1,NA,NA,45.5,46.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","4526",4526,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","32.6",32.6,NA,NA,31.4,33.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","39",39,NA,NA,37.5,40.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.1",47.1,NA,NA,46.2,48.2,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","57.3",57.3,NA,NA,56.1,58.5,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1756",1756,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","38",38,NA,NA,36.7,39.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","39.4",39.4,NA,NA,38,40.8,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","624",624,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","48.5",48.5,NA,NA,47.9,49,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","51.6",51.6,NA,NA,51,52.1,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","6629",6629,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","56.3",56.3,NA,NA,55.5,57.1,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","61.5",61.5,NA,NA,60.7,62.4,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","4009",4009,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.4",47.4,NA,NA,46.3,48.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","52.5",52.5,NA,NA,51.3,53.7,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1506",1506,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","70",70,NA,NA,68.9,71,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","79.2",79.2,NA,NA,78.1,80.4,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3458",3458,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","56.4",56.4,NA,NA,55.4,57.3,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","59.5",59.5,NA,NA,58.5,60.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2718",2718,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","45.3",45.3,NA,NA,44.6,46,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","52.4",52.4,NA,NA,51.6,53.2,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","44.5",44.5,NA,NA,43.8,45.3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","46.9",46.9,NA,NA,46.1,47.7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2739",2739,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","53.7",53.7,NA,NA,52.2,55.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","71.8",71.8,NA,NA,69.8,73.9,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","954",954,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","50.9",50.9,NA,NA,50.3,51.5,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","59.5",59.5,NA,NA,58.8,60.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","5878",5878,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.4",40.4,NA,NA,39.7,41.1,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","44.2",44.2,NA,NA,43.4,45,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2363",2363,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","56",56,NA,NA,55.2,56.8,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","65.2",65.2,NA,NA,64.3,66.1,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3916",3916,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","60",60,NA,NA,58.8,61.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","65.2",65.2,NA,NA,63.9,66.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1940",1940,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.8",40.8,NA,NA,39.2,42.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","50.6",50.6,NA,NA,48.6,52.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","505",505,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","51.8",51.8,NA,NA,51.2,52.4,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","56.8",56.8,NA,NA,56.1,57.5,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","5482",5482,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.2",40.2,NA,NA,38.3,42.3,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","47.2",47.2,NA,NA,45,49.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","326",326,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","43.7",43.7,NA,NA,42.4,45,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","48.8",48.8,NA,NA,47.4,50.3,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","899",899,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.5",47.5,NA,NA,46,49.1,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","55.8",55.8,NA,NA,54,57.7,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","736",736,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","40.9",40.9,NA,NA,40.3,41.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","46.4",46.4,NA,NA,45.8,47,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","4100",4100,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","32.1",32.1,NA,NA,31.1,33.2,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","35.3",35.3,NA,NA,34.2,36.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","732",732,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.8",47.8,NA,NA,46.6,49,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","48",48,NA,NA,46.8,49.1,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1310",1310,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","41.2",41.2,NA,NA,40.8,41.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","46.6",46.6,NA,NA,46.2,47,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","9091",9091,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","54.3",54.3,NA,NA,53.7,54.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","64.1",64.1,NA,NA,63.5,64.8,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","7406",7406,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","57.9",57.9,NA,NA,56.8,58.9,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","64.5",64.5,NA,NA,63.4,65.7,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2443",2443,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","45.7",45.7,NA,NA,44.8,46.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","53.3",53.3,NA,NA,52.3,54.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2062",2062,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.5",47.5,NA,NA,47,48,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","60.5",60.5,NA,NA,59.8,61.1,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","7698",7698,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","49",49,NA,NA,47.3,50.8,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","59.2",59.2,NA,NA,57.1,61.3,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","623",623,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","52",52,NA,NA,51.1,52.9,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","59.8",59.8,NA,NA,58.8,60.8,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2796",2796,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","43.6",43.6,NA,NA,41.7,45.5,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","51.5",51.5,NA,NA,49.3,53.7,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","425",425,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","60",60,NA,NA,59.1,60.8,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","68.1",68.1,NA,NA,67.2,69,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","4360",4360,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","42",42,NA,NA,41.6,42.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","37.3",37.3,NA,NA,37,37.7,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","9581",9581,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","46",46,NA,NA,45.9,46.1,"Overall","Overall",NA,"59","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","50.5",50.5,NA,NA,50.4,50.6,"Overall","Overall",NA,"59","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","157376",157376,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","20.3",20.3,NA,NA,19.5,21.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","15.7",15.7,NA,NA,15.1,16.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","443",443,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47",47,NA,NA,46.3,47.6,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","49",49,NA,NA,48.3,49.7,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3974",3974,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","47.6",47.6,NA,NA,45.4,49.8,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","59.1",59.1,NA,NA,56.5,61.9,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","370",370,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","44",44,NA,NA,43.3,44.7,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","46.1",46.1,NA,NA,45.4,46.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","3142",3142,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","44.9",44.9,NA,NA,44.2,45.7,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","52",52,NA,NA,51.2,52.8,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","2967",2967,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","61.6",61.6,NA,NA,60.2,63,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","81.3",81.3,NA,NA,79.5,83.2,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","1507",1507,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Age-adjusted Rate","38.5",38.5,NA,NA,36.3,40.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the lung and bronchus, mortality","per 100,000","Average Annual Crude Rate","40.7",40.7,NA,NA,38.4,43.1,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Cancer of the lung and bronchus, mortality",NA,"Average Annual Number","232",232,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN8_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","13",13,NA,NA,11.7,14.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","11.9",11.9,NA,NA,10.8,13.1,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","86",86,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.1",21.1,NA,NA,20.5,21.7,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","23.4",23.4,NA,NA,22.8,24,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1122",1122,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","17.8",17.8,NA,NA,17.2,18.5,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","19.8",19.8,NA,NA,19.1,20.6,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","582",582,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","18.3",18.3,NA,NA,17.9,18.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","20",20,NA,NA,19.6,20.5,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1300",1300,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.1",21.1,NA,NA,20.8,21.3,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","21.2",21.2,NA,NA,21,21.4,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","7980",7980,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","22",22,NA,NA,21.5,22.6,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","22.3",22.3,NA,NA,21.7,22.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1142",1142,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.5",21.5,NA,NA,20.8,22.1,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24.9",24.9,NA,NA,24.2,25.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","893",893,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","8.3",8.3,NA,NA,7.3,9.4,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","8.5",8.5,NA,NA,7.5,9.6,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","53",53,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","30.1",30.1,NA,NA,28.6,31.6,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","34.7",34.7,NA,NA,33,36.4,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","315",315,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","20.6",20.6,NA,NA,20.4,20.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","26.3",26.3,NA,NA,26,26.6,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","5028",5028,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","24.2",24.2,NA,NA,23.7,24.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","23.6",23.6,NA,NA,23.2,24,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2315",2315,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","20.2",20.2,NA,NA,19.2,21.2,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","23.2",23.2,NA,NA,22.1,24.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","320",320,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","24.6",24.6,NA,NA,23.9,25.4,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","27.4",27.4,NA,NA,26.6,28.2,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","839",839,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","26.3",26.3,NA,NA,25.2,27.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","27.2",27.2,NA,NA,26.1,28.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","431",431,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","18",18,NA,NA,17.7,18.3,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","19",19,NA,NA,18.7,19.3,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2442",2442,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","17.8",17.8,NA,NA,17.4,18.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","19",19,NA,NA,18.5,19.5,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1237",1237,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","23.7",23.7,NA,NA,22.9,24.5,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","25.2",25.2,NA,NA,24.4,26,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","722",722,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","24.4",24.4,NA,NA,23.8,25,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","26.7",26.7,NA,NA,26,27.4,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1165",1165,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","16",16,NA,NA,15.5,16.6,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","16.6",16.6,NA,NA,16.1,17.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","759",759,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.2",21.2,NA,NA,20.8,21.7,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24",24,NA,NA,23.5,24.5,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1587",1587,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21",21,NA,NA,20.5,21.5,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","22.4",22.4,NA,NA,21.9,23,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1310",1310,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","23.2",23.2,NA,NA,22.1,24.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","29.2",29.2,NA,NA,27.9,30.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","388",388,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","18.8",18.8,NA,NA,18.4,19.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","20.9",20.9,NA,NA,20.5,21.3,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2070",2070,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","27.7",27.7,NA,NA,27.1,28.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","29.8",29.8,NA,NA,29.2,30.5,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1596",1596,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","18.1",18.1,NA,NA,17.6,18.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","20.1",20.1,NA,NA,19.6,20.6,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1206",1206,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","17.5",17.5,NA,NA,16.8,18.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","18.5",18.5,NA,NA,17.8,19.2,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","550",550,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","24.6",24.6,NA,NA,23.3,26,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","28.8",28.8,NA,NA,27.3,30.3,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","287",287,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","23.1",23.1,NA,NA,22.7,23.5,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24.8",24.8,NA,NA,24.3,25.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2390",2390,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","22.2",22.2,NA,NA,20.7,23.8,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24.5",24.5,NA,NA,22.8,26.2,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","169",169,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","19.4",19.4,NA,NA,18.5,20.3,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","20.6",20.6,NA,NA,19.7,21.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","379",379,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","26.6",26.6,NA,NA,25.4,27.8,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","30.9",30.9,NA,NA,29.6,32.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","408",408,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.7",21.7,NA,NA,21.2,22.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24.3",24.3,NA,NA,23.8,24.7,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2143",2143,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","16.6",16.6,NA,NA,15.8,17.4,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","18.2",18.2,NA,NA,17.4,19.1,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","377",377,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number",NA,NA,"~~~","Data are not available because cancer registry did not meet the data quality criteria for all the years for publication in United States Cancer statistics (USCS)",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","17.9",17.9,NA,NA,17.7,18.2,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","19.9",19.9,NA,NA,19.6,20.1,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","3873",3873,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","19.7",19.7,NA,NA,19.3,20.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","22",22,NA,NA,21.6,22.4,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","2541",2541,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","16.8",16.8,NA,NA,16.3,17.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","107",107,NA,NA,NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","18.1",18.1,NA,NA,17.5,18.7,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","685",685,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","27",27,NA,NA,26.3,27.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","30.6",30.6,NA,NA,29.8,31.4,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1182",1182,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.7",21.7,NA,NA,21.4,22.1,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","25.7",25.7,NA,NA,25.3,26.1,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","3276",3276,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.6",21.6,NA,NA,20.4,22.8,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","25",25,NA,NA,23.7,26.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","263",263,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","22.5",22.5,NA,NA,21.9,23.1,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","25.1",25.1,NA,NA,24.4,25.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1173",1173,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","20.5",20.5,NA,NA,19.1,21.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","22.4",22.4,NA,NA,21,23.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","185",185,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21",21,NA,NA,20.5,21.5,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","23.1",23.1,NA,NA,22.5,23.6,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1477",1477,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","13",13,NA,NA,12.8,13.2,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","12.2",12.2,NA,NA,12,12.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","3125",3125,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","20.3",20.3,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",20.2,20.3,"Overall","Overall",NA,"59","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","21.9",21.9,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",21.8,22,"Overall","Overall",NA,"59","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","68242",68242,"^^^^","Data are from cancer registries that meet the data quality criteria for all invasive cancer sites combined,  for all years covering approximately 99% of the U.S. population. See registry-specific data quality information at http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.htm",NA,NA,"Overall","Overall",NA,"59","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","34.3",34.3,NA,NA,33.2,35.4,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","28.3",28.3,NA,NA,27.5,29.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","797",797,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","18.8",18.8,NA,NA,18.4,19.2,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","19.9",19.9,NA,NA,19.4,20.3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1594",1594,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","30.6",30.6,NA,NA,28.8,32.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","37.1",37.1,NA,NA,35,39.3,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","232",232,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","25.8",25.8,NA,NA,25.2,26.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","27.5",27.5,NA,NA,26.9,28.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1875",1875,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.5",21.5,NA,NA,21,22.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","24",24,NA,NA,23.4,24.5,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","1367",1367,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","21.1",21.1,NA,NA,20.2,22,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","25.4",25.4,NA,NA,24.3,26.4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","470",470,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Age-adjusted Rate","22.7",22.7,NA,NA,20.9,24.5,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_1","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive melanoma, incidence","per 100,000","Average Annual Crude Rate","23.7",23.7,NA,NA,22,25.6,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_1","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Statewide central cancer registries","Cancer","Invasive melanoma, incidence",NA,"Average Annual Number","135",135,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_1","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.1",2.1,NA,NA,1.6,2.8,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","1.6",1.6,NA,NA,1.2,2.1,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AK","Alaska","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","12",12,NA,NA,NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,3,3.4,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AL","Alabama","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","153",153,NA,NA,NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.6,3.1,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,2.9,3.5,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AR","Arkansas","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","95",95,NA,NA,NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.8,3.2,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,3.1,3.5,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"AZ","Arizona","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","215",215,NA,NA,NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CA","California","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","942",942,NA,NA,NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.2",3.2,NA,NA,3,3.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,2.9,3.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"CO","Colorado","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","161",161,NA,NA,NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.2,2.7,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"CT","Connecticut","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.7,3.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","1.1",1.1,NA,NA,0.8,1.6,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","1.1",1.1,NA,NA,0.8,1.6,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DC","District of Columbia","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","7",7,NA,NA,NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.4,3.4,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,2.8,3.9,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"DE","Delaware","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","30",30,NA,NA,NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.9,3.1,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.9",3.9,NA,NA,3.8,4.1,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"FL","Florida","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","751",751,NA,NA,NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.3,2.6,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2.2,2.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"GA","Georgia","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","226",226,NA,NA,NA,NA,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","1.6",1.6,NA,NA,1.3,1.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","1.9",1.9,NA,NA,1.6,2.3,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"HI","Hawaii","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","27",27,NA,NA,NA,NA,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.7,3.2,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.2,3.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IA","Iowa","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","107",107,NA,NA,NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.6",3.6,NA,NA,3.2,4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.7",3.7,NA,NA,3.3,4.1,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ID","Idaho","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","59",59,NA,NA,NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.4,2.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IL","Illinois","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","346",346,NA,NA,NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,3,3.3,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.2,3.6,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"IN","Indiana","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","222",222,NA,NA,NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.8,3.3,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.1,3.7,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KS","Kansas","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","97",97,NA,NA,NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.2",3.2,NA,NA,3,3.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.8,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"KY","Kentucky","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","153",153,NA,NA,NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,2.1,2.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.3",2.3,NA,NA,2.1,2.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"LA","Louisiana","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","106",106,NA,NA,NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.8,3.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3.2,3.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MA","Massachusetts","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","224",224,NA,NA,NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.5,2.8,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.8",2.8,NA,NA,2.6,3,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MD","Maryland","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","162",162,NA,NA,NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.7,3.4,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","4",4,NA,NA,3.5,4.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ME","Maine","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","53",53,NA,NA,NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.3,2.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.8",2.8,NA,NA,2.7,3,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MI","Michigan","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","280",280,NA,NA,NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.4,2.8,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.8",2.8,NA,NA,2.6,3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MN","Minnesota","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","152",152,NA,NA,NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.7,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MO","Missouri","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","211",211,NA,NA,NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,2,2.5,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.4",2.4,NA,NA,2.1,2.7,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MS","Mississippi","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","71",71,NA,NA,NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.6,3.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.7",3.7,NA,NA,3.2,4.3,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"MT","Montana","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","37",37,NA,NA,NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.7,3,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.9,3.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NC","North Carolina","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","297",297,NA,NA,NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.3",2.3,NA,NA,1.9,2.8,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.2,3.3,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"ND","North Dakota","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","19",19,NA,NA,NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.7,3.4,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.4",3.4,NA,NA,3,3.8,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NE","Nebraska","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","62",62,NA,NA,NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.4,3.2,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,2.8,3.6,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NH","New Hampshire","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","42",42,NA,NA,NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.3,2.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.7",2.7,NA,NA,2.6,2.9,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NJ","New Jersey","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","241",241,NA,NA,NA,NA,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.4,3,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.6,3.3,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NM","New Mexico","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","61",61,NA,NA,NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.6,3.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.9",2.9,NA,NA,2.6,3.2,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NV","Nevada","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","79",79,NA,NA,NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,2.2,2.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.5",2.5,NA,NA,2.4,2.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"NY","New York","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","493",493,NA,NA,NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.8,3.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.6,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OH","Ohio","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","399",399,NA,NA,NA,NA,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.8,3.3,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,3.1,3.6,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OK","Oklahoma","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","126",126,NA,NA,NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.3",3.3,NA,NA,3.1,3.6,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.9",3.9,NA,NA,3.6,4.2,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"OR","Oregon","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","150",150,NA,NA,NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.8,3,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.6",3.6,NA,NA,3.5,3.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"PA","Pennsylvania","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","462",462,NA,NA,NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.5",2.5,NA,NA,2.2,3,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,2.7,3.7,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"RI","Rhode Island","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","34",34,NA,NA,NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.5,2.9,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.2,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SC","South Carolina","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","141",141,NA,NA,NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.2",2.2,NA,NA,1.8,2.7,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.6",2.6,NA,NA,2.1,3.1,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"SD","South Dakota","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","21",21,NA,NA,NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.5",3.5,NA,NA,3.3,3.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TN","Tennessee","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","221",221,NA,NA,NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.4",2.4,NA,NA,2.3,2.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","2.1",2.1,NA,NA,2.1,2.2,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"TX","Texas","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","548",548,NA,NA,NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.7,2.7,"Overall","Overall",NA,"59","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.9,3,"Overall","Overall",NA,"59","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"US","United States","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","9225",9225,NA,NA,NA,NA,"Overall","Overall",NA,"59","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.7",3.7,NA,NA,3.4,4.1,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.7,3.3,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"UT","Utah","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","84",84,NA,NA,NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.8",2.8,NA,NA,2.7,3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3",3,NA,NA,2.8,3.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VA","Virginia","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","239",239,NA,NA,NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.6",2.6,NA,NA,2.1,3.2,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.3",3.3,NA,NA,2.7,4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"VT","Vermont","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","21",21,NA,NA,NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.9",2.9,NA,NA,2.7,3.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WA","Washington","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","210",210,NA,NA,NA,NA,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","2.7",2.7,NA,NA,2.5,2.9,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.1",3.1,NA,NA,2.9,3.3,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WI","Wisconsin","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","175",175,NA,NA,NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3.4",3.4,NA,NA,3,3.7,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","4.2",4.2,NA,NA,3.8,4.6,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WV","West Virginia","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","77",77,NA,NA,NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Age-adjusted Rate","3",3,NA,NA,2.4,3.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_2","AvgAnnAgeAdjRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Melanoma, mortality","per 100,000","Average Annual Crude Rate","3.2",3.2,NA,NA,2.5,3.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_2","AvgAnnCrdRate","OVERALL","OVR"
2009,2013,"WY","Wyoming","Death certificate","Cancer","Melanoma, mortality",NA,"Average Annual Number","18",18,NA,NA,NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN9_2","AvgAnnNumbr","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.6",83.6,NA,NA,82,85.2,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.8",83.8,NA,NA,81.9,85.5,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.7",89.7,NA,NA,88.5,90.7,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.0",81,NA,NA,79.1,82.7,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.7",83.7,NA,NA,82,85.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.7",73.7,NA,NA,71.4,75.8,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.9",77.9,NA,NA,75.4,80.2,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.6",70.6,NA,NA,68.2,72.8,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.9",74.9,NA,NA,73.2,76.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.8",73.8,NA,NA,69.5,77.7,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.3",84.3,NA,NA,81.9,86.5,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.2,88.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.8",76.8,NA,NA,74.2,79.3,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.8",81.8,NA,NA,79.4,84,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.8",80.8,NA,NA,78,83.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.4",69.4,NA,NA,65.6,72.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.7",77.7,NA,NA,74.9,80.3,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.4",71.4,NA,NA,69,73.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.9",79.9,NA,NA,77.8,81.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.2",79.2,NA,NA,77.4,80.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.6",75.6,NA,NA,73.5,77.7,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.4",78.4,NA,NA,76.1,80.5,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.4",78.4,"*","50 States + DC: US Median",76.4,80.2,"Overall","Overall",NA,"59","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.4",79.4,NA,NA,77.3,81.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.3",74.3,NA,NA,70.4,77.9,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.8",74.8,NA,NA,71.6,77.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.4",69.4,NA,NA,66.4,72.2,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.7",82.7,NA,NA,80.7,84.5,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.4",73.4,NA,NA,71.4,75.3,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.1",84.1,NA,NA,82,86,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.1",85.1,NA,NA,83.1,86.8,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.4",79.4,NA,NA,77.5,81.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.7",72.7,NA,NA,70.4,74.8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.9",80.9,NA,NA,77.8,83.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.3",80.3,NA,NA,78.4,82.1,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.2",79.2,NA,NA,76.3,81.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.2",78.2,NA,NA,76.4,80,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.3",70.3,NA,NA,68,72.6,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.3",75.3,NA,NA,72.5,77.9,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.2",80.2,NA,NA,78.6,81.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.4",85.4,NA,NA,83,87.5,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.7",75.7,NA,NA,73.6,77.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.7",79.7,NA,NA,76.3,82.8,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.0",77,NA,NA,74.5,79.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.7",72.7,NA,NA,69.8,75.4,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.2",73.2,NA,NA,71.1,75.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.8",81.8,NA,NA,79.6,83.9,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,78.8,83.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.4",76.4,NA,NA,74.6,78.1,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,75.6,80.4,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.9",83.9,NA,NA,81,86.4,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.5",66.5,NA,NA,63.2,69.7,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.5",72.5,NA,NA,66,78.1,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.8",81.8,NA,NA,79.5,83.9,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2012,2012,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,"*","50 States + DC: US Median",76.3,80.2,"Overall","Overall",NA,"59","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.3",79.3,NA,NA,77.1,81.2,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.5",74.5,NA,NA,70.7,78,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,71.3,77.6,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,66.2,72,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.8",82.8,NA,NA,80.9,84.6,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.5",73.5,NA,NA,71.4,75.4,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.3",84.3,NA,NA,82.2,86.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.1",84.1,NA,NA,81.6,86.3,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.4",85.4,NA,NA,82.2,88.1,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.5",76.5,NA,NA,73.8,79,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.5,84.1,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,77.8,83.3,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,65.7,73,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.7",77.7,NA,NA,74.9,80.2,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.3",71.3,NA,NA,69,73.6,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.0",80,NA,NA,77.8,81.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.2",79.2,NA,NA,77.4,80.8,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.4",75.4,NA,NA,73.2,77.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,76,80.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,81.9,85.1,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,81.9,85.4,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.5",89.5,NA,NA,88.4,90.6,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,79,82.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.8",83.8,NA,NA,82,85.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,71.5,75.9,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,75.4,80.2,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.2",70.2,NA,NA,67.8,72.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.9",74.9,NA,NA,73.3,76.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.3",74.3,NA,NA,70.5,77.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.0",85,NA,NA,83,86.8,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,77.6,81.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,70.1,74.6,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,77.8,83.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,78.3,82,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.1",79.1,NA,NA,76.1,81.8,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,76.3,80,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.2",70.2,NA,NA,67.9,72.5,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.1",75.1,NA,NA,72.3,77.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,78.5,81.7,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,82.9,87.4,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.9",74.9,NA,NA,72.8,77,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.4",79.4,NA,NA,76,82.5,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.0",77,NA,NA,74.5,79.3,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,70.1,75.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.1",73.1,NA,NA,71.1,75.1,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.6,84,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.1",81.1,NA,NA,78.9,83.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,74.5,78,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,74.8,79.8,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,80.7,86.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.7",66.7,NA,NA,63.5,69.8,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.3",73.3,NA,NA,67.2,78.6,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.0",82,NA,NA,79.7,84.1,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,75.8,80.6,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.6",72.6,NA,NA,68,76.7,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,73.5,80,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","68.2",68.2,NA,NA,64.8,71.4,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.2",83.2,NA,NA,81,85.2,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.7",74.7,NA,NA,72.6,76.7,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.5",84.5,NA,NA,82.3,86.5,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.0",83,NA,NA,80.2,85.5,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.0",82,NA,NA,77,86.1,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.0",76,NA,NA,73,78.7,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.3",79.3,NA,NA,76.3,82,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,72.8,81.1,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.7",69.7,NA,NA,65.9,73.3,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.0",77,NA,NA,73.9,79.8,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.4",72.4,NA,NA,69.9,74.8,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.0",80,NA,NA,77.8,82,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.5",79.5,NA,NA,77.8,81.1,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.8",74.8,NA,NA,72.4,76.9,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,74.4,79.8,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.8",83.8,NA,NA,82.1,85.4,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,80.4,84.4,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.5",89.5,NA,NA,88.2,90.6,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.5",80.5,NA,NA,78.4,82.4,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.2",84.2,NA,NA,82.5,85.9,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.5",73.5,NA,NA,70.7,76.1,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.7",76.7,NA,NA,73.9,79.3,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.8",70.8,NA,NA,68.3,73.2,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.0",75,NA,NA,73.2,76.6,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.6",75.6,NA,NA,71.6,79.2,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.0",85,NA,NA,82.9,86.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.5",78.5,NA,NA,76.3,80.5,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.4",71.4,NA,NA,68.4,74.2,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.0",80,NA,NA,76.7,82.9,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.4",80.4,NA,NA,78.3,82.3,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.8",79.8,NA,NA,76.8,82.4,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.4",77.4,NA,NA,75.4,79.3,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","70.6",70.6,NA,NA,68,73,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.2",76.2,NA,NA,73.4,78.8,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.0",80,NA,NA,78.3,81.6,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.7",86.7,NA,NA,84.4,88.8,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.8",73.8,NA,NA,71.1,76.2,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.0",80,NA,NA,76.4,83.2,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,74.3,79.3,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.2",74.2,NA,NA,70.8,77.2,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.5",73.5,NA,NA,71.3,75.5,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.1",82.1,NA,NA,79.8,84.2,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.8",80.8,NA,NA,78.3,83.1,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,75.4,78.8,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,75.7,80.6,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.9",83.9,NA,NA,80.9,86.5,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.4",67.4,NA,NA,64,70.6,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,75.5,80.5,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.1",73.1,NA,NA,68.6,77.2,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,72.7,79.6,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,64.4,71.1,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,80.9,85.2,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,72.5,76.6,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.6",84.6,NA,NA,82.3,86.6,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,79.8,85.3,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,75.9,85.6,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.4",75.4,NA,NA,72.2,78.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.9",78.9,NA,NA,75.8,81.7,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.4",76.4,NA,NA,71.9,80.4,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.8",69.8,NA,NA,65.8,73.5,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.0",77,NA,NA,74,79.8,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.3",72.3,NA,NA,69.8,74.7,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.0",80,NA,NA,77.8,82,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,77.7,81.1,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.5",74.5,NA,NA,72.1,76.7,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,73.8,79.4,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,82,85.3,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,80.2,84.3,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.4",89.4,NA,NA,88.1,90.5,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,78.1,82.1,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,82.4,85.8,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.6",73.6,NA,NA,70.7,76.3,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,73.9,79.3,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,67.8,72.9,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.0",75,NA,NA,73.3,76.7,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.9",75.9,NA,NA,71.9,79.5,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.9",84.9,NA,NA,82.8,86.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,76.4,80.5,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.0",71,NA,NA,67.9,73.9,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.0",80,NA,NA,76.7,82.9,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,77.9,82.1,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.7",79.7,NA,NA,76.7,82.4,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,75.4,79.3,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,67.6,72.9,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,72.9,78.3,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.0",80,NA,NA,78.3,81.6,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,84.2,88.6,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,69.9,75.2,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.8",79.8,NA,NA,76.1,83,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,74.3,79.4,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.0",74,NA,NA,70.7,77.1,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.3",73.3,NA,NA,71.1,75.3,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.1",82.1,NA,NA,79.8,84.2,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,78.4,83.1,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.9",76.9,NA,NA,75.2,78.6,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.6",77.6,NA,NA,75,80.1,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,80.6,86.3,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.5",67.5,NA,NA,64.2,70.7,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.6",83.6,NA,NA,79.6,86.9,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.0",81,NA,NA,73.8,86.5,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","90.0",90,NA,NA,83.9,93.9,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.2",79.2,NA,NA,64.4,88.9,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.6",83.6,NA,NA,73.9,90.2,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.1",89.1,NA,NA,82.4,93.5,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.6",87.6,NA,NA,83.4,90.8,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.1",76.1,NA,NA,66.8,83.5,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.6",88.6,NA,NA,84.4,91.8,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.0",84,NA,NA,75.6,90,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.3",72.3,NA,NA,62.9,80,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.7",82.7,NA,NA,72.5,89.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.6",86.6,NA,NA,79.6,91.4,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.5",81.5,NA,NA,77.3,85.1,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.8",89.8,NA,NA,87,92.1,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","90.5",90.5,NA,NA,84.5,94.3,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.5",84.5,NA,NA,78.7,88.9,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.0",83,NA,NA,68.4,91.7,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.5",74.5,NA,NA,70.4,78.3,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","89.3",89.3,NA,NA,84,93,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.4",78.4,NA,NA,67.4,86.4,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.9",75.9,NA,NA,51.1,90.5,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.0",85,NA,NA,79.9,89,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.4",75.4,NA,NA,61.9,85.2,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.3",82.3,NA,NA,77,86.5,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","87.2",87.2,NA,NA,81.3,91.5,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.6",72.6,NA,NA,60.7,82,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","90.4",90.4,NA,NA,86.6,93.2,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.6",81.6,NA,NA,77.8,84.8,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.4",81.4,NA,NA,74.7,86.7,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.0",77,NA,NA,68.2,83.9,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.7",81.7,NA,NA,75.2,86.8,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","93.8",93.8,NA,NA,88.4,96.8,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.0",84,NA,NA,80.2,87.2,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,73.7,86.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.5",89.5,NA,NA,83.5,93.5,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,65.4,89.6,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,74,89.6,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","90.4",90.4,NA,NA,84.7,94.1,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,83.6,90.9,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.4",75.4,NA,NA,66.1,82.8,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.1",89.1,NA,NA,85.1,92,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.8",83.8,NA,NA,75.6,89.6,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.2",74.2,NA,NA,65.8,81.2,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.8",82.8,NA,NA,73.2,89.5,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.0",87,NA,NA,80.6,91.4,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,77.9,85.3,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","90.1",90.1,NA,NA,87.3,92.4,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.8",89.8,NA,NA,83.5,93.9,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,80.2,89.3,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,72.2,91.2,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.5",74.5,NA,NA,70.4,78.2,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.3",88.3,NA,NA,83.1,92.1,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.7",78.7,NA,NA,68.4,86.3,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.0",77,NA,NA,61.5,87.6,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.0",85,NA,NA,79.9,88.9,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,67.7,85.9,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,77.4,86.4,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,80.1,90.8,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.0",72,NA,NA,60.6,81.1,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","90.3",90.3,NA,NA,86.5,93.1,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,77.3,84.5,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,76.3,87.2,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,70,84.5,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,76.2,87.1,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","94.0",94,NA,NA,88.9,96.9,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.0",71,NA,NA,60.4,79.6,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,73.3,82.5,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.2",66.2,NA,NA,59.2,72.6,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.7",81.7,NA,NA,69.5,89.7,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.1",82.1,NA,NA,73.6,88.3,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.9",75.9,NA,NA,62.8,85.4,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.7",78.7,NA,NA,64.6,88.2,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.8",77.8,NA,NA,63.3,87.6,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.6",82.6,NA,NA,65.8,92.1,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","91.1",91.1,NA,NA,84.6,95,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.0",74,NA,NA,61.8,83.4,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.1",76.1,NA,NA,64,85.1,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","83.1",83.1,NA,NA,77.1,87.8,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.7",74.7,NA,NA,70.5,78.5,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.2",88.2,NA,NA,77.2,94.3,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.3",73.3,NA,NA,59.7,83.6,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.9",69.9,NA,NA,53.7,82.2,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","49.6",49.6,NA,NA,35,64.2,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.8",66.8,NA,NA,48.3,81.2,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.9",73.9,NA,NA,59.1,84.8,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.8",67.8,NA,NA,60.6,74.2,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.4",72.4,NA,NA,61.7,81.1,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.6",69.6,NA,NA,58.8,78.6,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","59.3",59.3,NA,NA,41,75.2,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.6",81.6,NA,NA,79.4,83.7,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,62,79.3,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.7",78.7,NA,NA,73.8,82.8,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,61.1,73.6,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,73.3,90.8,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.7",81.7,NA,NA,73.3,87.9,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.9",75.9,NA,NA,63.8,84.9,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.3",78.3,NA,NA,65.1,87.5,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.0",79,NA,NA,66.9,87.5,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,68.3,92.5,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","91.0",91,NA,NA,84.7,94.8,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.0",67,NA,NA,56.5,76.1,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.8",71.8,NA,NA,58.4,82.2,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.0",76,NA,NA,66.1,83.8,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.2",83.2,NA,NA,77.4,87.8,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.7",74.7,NA,NA,70.5,78.5,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,77,93.4,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.6",76.6,NA,NA,64.2,85.6,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.3",73.3,NA,NA,58.6,84.2,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","47.8",47.8,NA,NA,35.3,60.7,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.8",71.8,NA,NA,57.4,82.9,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.3",73.3,NA,NA,58.2,84.5,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,63,75.2,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,64.4,81.3,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","59.8",59.8,NA,NA,43.2,74.5,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.6,83.9,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.9",80.9,NA,NA,73.3,86.8,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.4",67.4,NA,NA,50.2,80.9,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.2",86.2,NA,NA,78.1,91.6,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.4",66.4,NA,NA,48,80.9,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,77.7,86.4,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.4",71.4,NA,NA,55.7,83.3,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","91.2",91.2,NA,NA,84,95.3,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.1",79.1,NA,NA,64.4,88.9,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.3",77.3,NA,NA,57.1,89.7,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.0",66,NA,NA,55.3,75.2,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.2",67.2,NA,NA,48.8,81.5,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","58.0",58,NA,NA,35.8,77.3,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.0",74,NA,NA,61.1,83.7,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,68.8,83.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.8",72.8,NA,NA,61.6,81.7,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.6",72.6,NA,NA,54.3,85.6,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.1",78.1,NA,NA,70,84.5,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","72.8",72.8,NA,NA,55.7,85,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.7",76.7,NA,NA,62,86.9,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.8",71.8,NA,NA,56.6,83.3,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","75.3",75.3,NA,NA,65.2,83.2,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","69.0",69,NA,NA,60.4,76.5,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,74.2,87,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,51.2,78.8,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.2",86.2,NA,NA,78.4,91.4,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","57.1",57.1,NA,NA,43.5,69.7,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","82.0",82,NA,NA,77.1,86.1,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","67.5",67.5,NA,NA,52.7,79.4,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","89.1",89.1,NA,NA,80.9,94.1,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,65.2,87.7,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.7",76.7,NA,NA,60.6,87.5,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.6",69.6,NA,NA,60.4,77.5,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,52.4,77.7,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,56.1,81.5,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,60.1,82.1,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.9",77.9,NA,NA,70.4,84,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.0",74,NA,NA,63.2,82.4,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.0",76,NA,NA,64.6,84.7,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,70.6,84.7,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","72.0",72,NA,NA,56.2,83.8,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,66.9,86.2,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,61.2,84.3,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,64.6,82.6,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,62.8,77.7,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","67.3",67.3,NA,NA,53.3,78.9,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.2",81.2,NA,NA,74.6,86.3,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.3",73.3,NA,NA,55.5,85.8,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.9",76.9,NA,NA,58.1,88.9,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.6",77.6,NA,NA,63.4,87.4,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","54.5",54.5,NA,NA,34.4,73.1,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","58.9",58.9,NA,NA,40.3,75.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","61.2",61.2,NA,NA,49.9,71.5,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","62.1",62.1,NA,NA,50.5,72.5,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","50.9",50.9,NA,NA,32.9,68.7,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","63.7",63.7,NA,NA,49.2,76.1,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","MRC"
2012,2012,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,54.4,76.2,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.9",88.9,NA,NA,86.7,90.7,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,75.5,86.5,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,52.5,82.1,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,64.7,88,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,67.2,88,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","57.0",57,NA,NA,40.4,72.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","58.9",58.9,NA,NA,44.1,72.3,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","61.7",61.7,NA,NA,50.8,71.4,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,50.3,71.6,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","47.2",47.2,NA,NA,30.8,64.3,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","64.9",64.9,NA,NA,50.8,76.8,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2012,2012,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.3",84.3,"*","50 States + DC: US Median",82.6,85.5,"Overall","Overall",NA,"59","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.0",84,NA,NA,81.8,86,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.5",83.5,NA,NA,80.4,86.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.8",78.8,NA,NA,75.4,81.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.0",79,NA,NA,75.9,81.8,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.6",85.6,NA,NA,83.8,87.2,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.5",85.5,NA,NA,83.9,87,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.0",88,NA,NA,86.1,89.6,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.1",88.1,NA,NA,84.2,91,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,77.5,82.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.4",84.4,NA,NA,81.9,86.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.2",82.2,NA,NA,79.7,84.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.6",74.6,NA,NA,70.6,78.2,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.7",85.7,NA,NA,83.2,87.9,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,78.2,82.5,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.0",87,NA,NA,85.1,88.8,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.8",84.8,NA,NA,83.1,86.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.6",81.6,NA,NA,79.6,83.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.0",85,NA,NA,82.7,87.1,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.9",87.9,NA,NA,86.3,89.3,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.2",88.2,NA,NA,86.3,89.9,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.6",89.6,NA,NA,88.4,90.7,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.2",86.2,NA,NA,84.5,87.8,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.8",87.8,NA,NA,86.2,89.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,78.5,83.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.3",82.3,NA,NA,79.8,84.6,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.2",82.2,NA,NA,80.2,84.2,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.9",83.9,NA,NA,82.5,85.2,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.4",77.4,NA,NA,74.2,80.4,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.9",86.9,NA,NA,84.5,88.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.9",84.9,NA,NA,83.3,86.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.0",83,NA,NA,81.1,84.7,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.6",82.6,NA,NA,79.7,85.2,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.3",86.3,NA,NA,84.8,87.7,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.3",84.3,NA,NA,81.4,86.9,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.5",84.5,NA,NA,82.8,86,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.0",81,NA,NA,78.9,83,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.3",80.3,NA,NA,77.5,82.8,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.2",83.2,NA,NA,81.5,84.8,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.7",88.7,NA,NA,86.4,90.7,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.1",82.1,NA,NA,80.1,83.9,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.7",86.7,NA,NA,84,88.9,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.7,87.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,78.5,82.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.1",79.1,NA,NA,77.3,80.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,84.6,88.7,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,85.5,89.1,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.0",83,NA,NA,81.3,84.5,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,78.4,83.3,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.2",85.2,NA,NA,82.1,87.8,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.9",79.9,NA,NA,76.6,82.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.5",68.5,NA,NA,64.1,72.5,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.8",75.8,NA,NA,73.6,78,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2012,2012,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.4",84.4,"*","50 States + DC: US Median",83.1,85.5,"Overall","Overall",NA,"59","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,81.6,85.7,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,80.5,86.3,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.3",79.3,NA,NA,76.1,82.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.3",78.3,NA,NA,75.2,81.1,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.7",85.7,NA,NA,83.9,87.2,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.5",85.5,NA,NA,83.9,86.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,86.4,89.8,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.4",89.4,NA,NA,87.3,91.2,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.3",88.3,NA,NA,84.6,91.2,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,77.3,82.8,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,81.9,86.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.2",82.2,NA,NA,79.8,84.4,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,70.6,77.9,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,83.2,88,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,78.1,82.4,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,85.3,89,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.8",84.8,NA,NA,83.2,86.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,79.6,83.4,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,82.2,86.6,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,86.6,89.7,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.4",88.4,NA,NA,86.5,90,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.8",89.8,NA,NA,88.6,90.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.6",86.6,NA,NA,84.9,88.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,86.3,89.4,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,77.8,82.3,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,80,84.6,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.6",82.6,NA,NA,80.5,84.5,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,82.8,85.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.5",77.5,NA,NA,74.3,80.4,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.2",87.2,NA,NA,84.8,89.3,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.0",85,NA,NA,83.4,86.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.1",83.1,NA,NA,81.2,84.8,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,80.8,85.7,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,85,87.8,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.6",84.6,NA,NA,81.7,87.1,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.7",84.7,NA,NA,83.1,86.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,78.4,82.5,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.0",81,NA,NA,78.4,83.3,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,81.5,84.9,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.4",89.4,NA,NA,87.3,91.3,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.9",81.9,NA,NA,79.9,83.7,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.6",86.6,NA,NA,83.9,89,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.6",85.6,NA,NA,83.4,87.5,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,78.4,82.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.1",79.1,NA,NA,77.5,80.7,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,85.2,89.1,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,85.9,89.3,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.1",83.1,NA,NA,81.5,84.6,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.2",81.2,NA,NA,78.6,83.5,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,82.1,88,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,76.5,82.9,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.5",68.5,NA,NA,64.2,72.5,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,74,78.4,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.9",81.9,NA,NA,78.9,84.5,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.9",84.9,NA,NA,81.4,87.8,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.8",82.8,NA,NA,79.3,85.8,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.6",77.6,NA,NA,74,80.9,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.0",85,NA,NA,82.7,87.1,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,85.1,88.4,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.9",88.9,NA,NA,86.8,90.7,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.6",88.6,NA,NA,86.1,90.7,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.2",90.2,NA,NA,84.2,94.2,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.2",80.2,NA,NA,76.6,83.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.6",82.6,NA,NA,78.9,85.7,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.7",85.7,NA,NA,81.6,89,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.4",76.4,NA,NA,72.4,80,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.5",85.5,NA,NA,82.8,87.9,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.3",81.3,NA,NA,78.8,83.5,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.8",87.8,NA,NA,85.9,89.5,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.9",85.9,NA,NA,84.2,87.5,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,79.2,83.3,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.3",85.3,NA,NA,82.3,87.9,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.6",88.6,NA,NA,87.1,90,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.8",87.8,NA,NA,85.6,89.7,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.5",91.5,NA,NA,90.2,92.6,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.6",85.6,NA,NA,83.7,87.4,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.6",88.6,NA,NA,87,90,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.4",78.4,NA,NA,74.8,81.6,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.1",82.1,NA,NA,79.4,84.6,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.4",82.4,NA,NA,80.2,84.4,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.8",83.8,NA,NA,82.3,85.2,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.4",78.4,NA,NA,74.4,81.9,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.3",87.3,NA,NA,84.9,89.3,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,83.4,87.2,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.1",83.1,NA,NA,80.4,85.5,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.6",86.6,NA,NA,83.8,88.9,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.2",86.2,NA,NA,84.3,87.9,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.4,87.9,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.0",84,NA,NA,82.1,85.7,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.0",81,NA,NA,78.5,83.3,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.9",80.9,NA,NA,77.8,83.5,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.3",83.3,NA,NA,81.5,84.9,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.3",90.3,NA,NA,87.9,92.3,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.6",80.6,NA,NA,78,83,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,84.2,89.5,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.4",85.4,NA,NA,83.1,87.5,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,78.2,84.3,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.5",79.5,NA,NA,77.6,81.2,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.4",88.4,NA,NA,86.3,90.2,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,85.3,89.3,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.1",84.1,NA,NA,82.4,85.6,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.3",81.3,NA,NA,78.6,83.7,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.3",86.3,NA,NA,83.1,88.9,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.9",79.9,NA,NA,76.3,83.1,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.3",79.3,NA,NA,57,91.8,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,78.6,84.1,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.1",85.1,NA,NA,81.7,88,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.1",83.1,NA,NA,79.6,86.2,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.5",77.5,NA,NA,73.8,80.8,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.5",85.5,NA,NA,83,87.6,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.0",87,NA,NA,85.3,88.5,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.2",89.2,NA,NA,87,91.1,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.5",89.5,NA,NA,86.9,91.6,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.8",89.8,NA,NA,84.7,93.3,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,76.3,83.6,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,79.1,85.9,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,81.5,89.2,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,72.4,79.8,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,83.5,88.7,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,79.1,83.7,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,86.3,89.9,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.1",86.1,NA,NA,84.5,87.6,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,79.4,83.4,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.9",84.9,NA,NA,81.9,87.5,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.9",88.9,NA,NA,87.3,90.3,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.4",88.4,NA,NA,86.2,90.3,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.4",91.4,NA,NA,90.1,92.5,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,83.9,87.7,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.7",88.7,NA,NA,87.1,90.2,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,75.1,81.6,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,79.6,84.8,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.8",82.8,NA,NA,80.5,84.8,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.3",84.3,NA,NA,82.8,85.6,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,74.4,82.1,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.6",87.6,NA,NA,85,89.7,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.0",86,NA,NA,83.9,88,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,80.7,86.3,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.2",87.2,NA,NA,84.4,89.5,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,84.6,88.1,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,82.9,88.2,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.3",84.3,NA,NA,82.5,86,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,78.2,83,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,78.8,84.2,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,81.5,85,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.2",91.2,NA,NA,89,92.9,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,78.1,83.1,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,84.2,89.8,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.5",85.5,NA,NA,83.2,87.6,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,78.3,84.4,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,77.7,81.2,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.6",88.6,NA,NA,86.5,90.4,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,85.7,89.8,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,82.4,85.8,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.4",81.4,NA,NA,78.7,83.8,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,83.1,89.2,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.1",80.1,NA,NA,76.4,83.3,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,67.1,91.4,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.6",89.6,NA,NA,86.2,92.2,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,NA,NA,74.4,88.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,77.8,92.9,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.9",87.9,NA,NA,76.5,94.1,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.7",88.7,NA,NA,82,93.1,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","93.3",93.3,NA,NA,88.9,96,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.0",91,NA,NA,86.6,94.1,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.1",85.1,NA,NA,77.3,90.6,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.3",89.3,NA,NA,85.2,92.4,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.3",91.3,NA,NA,82.3,95.9,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.5",82.5,NA,NA,73.9,88.7,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.1",87.1,NA,NA,78.6,92.5,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.5",86.5,NA,NA,79.2,91.6,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.3",85.3,NA,NA,80.9,88.8,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.6",91.6,NA,NA,87.8,94.3,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.8",85.8,NA,NA,79.5,90.4,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.3",89.3,NA,NA,84.4,92.8,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","93.5",93.5,NA,NA,87.7,96.7,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.0",84,NA,NA,80.5,86.9,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.9",85.9,NA,NA,78.2,91.2,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.3",88.3,NA,NA,79.9,93.5,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","69.0",69,NA,NA,55.1,80.2,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.1",90.1,NA,NA,87,92.6,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.0",84,NA,NA,76,89.7,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.0",89,NA,NA,85.5,91.7,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.6",88.6,NA,NA,83.7,92.2,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.5",83.5,NA,NA,74.8,89.6,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.6",89.6,NA,NA,85.7,92.5,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.6",90.6,NA,NA,78.2,96.3,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,84.2,90,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.4",89.4,NA,NA,84,93.1,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.3",86.3,NA,NA,79.8,90.9,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.8",89.8,NA,NA,84.5,93.4,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.1",91.1,NA,NA,74.1,97.3,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","92.4",92.4,NA,NA,82.5,96.9,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.1",89.1,NA,NA,85.8,91.7,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.0",80,NA,NA,71.3,86.6,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.9",87.9,NA,NA,81.3,92.3,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.5",88.5,NA,NA,78.2,94.2,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.0",88,NA,NA,81.4,92.5,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","93.2",93.2,NA,NA,88.9,95.9,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.3",91.3,NA,NA,87.2,94.2,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,76,89.9,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.1",89.1,NA,NA,84.8,92.3,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.0",91,NA,NA,83.3,95.4,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,74.9,87.9,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.5",86.5,NA,NA,78.5,91.9,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.3",85.3,NA,NA,77.4,90.7,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.0",85,NA,NA,80.9,88.3,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","92.3",92.3,NA,NA,89.3,94.4,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,80.5,90.5,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.7",89.7,NA,NA,85,93.1,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.8",91.8,NA,NA,84.2,96,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.6",81.6,NA,NA,78,84.8,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.2",86.2,NA,NA,79.2,91.1,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.4",88.4,NA,NA,79.6,93.7,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","69.1",69.1,NA,NA,55.3,80.1,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.0",90,NA,NA,86.9,92.5,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.8",83.8,NA,NA,77,88.8,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.7",89.7,NA,NA,86.4,92.3,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.4",88.4,NA,NA,83.7,91.8,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,75.4,89.4,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.0",90,NA,NA,86.3,92.8,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.3",90.3,NA,NA,77.3,96.2,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.2",87.2,NA,NA,84,89.8,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.8",88.8,NA,NA,83.7,92.4,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.1",86.1,NA,NA,79.7,90.7,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.1",90.1,NA,NA,85.4,93.4,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.6",90.6,NA,NA,75.8,96.7,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","92.5",92.5,NA,NA,84.7,96.4,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.9",72.9,NA,NA,55.2,85.5,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.8",72.8,NA,NA,64.8,79.6,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.0",91,NA,NA,75.9,97,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.8",88.8,NA,NA,85.9,91.2,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.8",80.8,NA,NA,76.1,84.8,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.5",86.5,NA,NA,80.7,90.8,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.2",84.2,NA,NA,71.8,91.8,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","71.8",71.8,NA,NA,50.5,86.4,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.7",79.7,NA,NA,72.3,85.5,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.5",81.5,NA,NA,69.9,89.3,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,79.5,91.8,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","68.8",68.8,NA,NA,52.5,81.5,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.9",83.9,NA,NA,74.2,90.4,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.9",74.9,NA,NA,63.5,83.7,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.1",88.1,NA,NA,70.9,95.8,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.4",82.4,NA,NA,74.2,88.3,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.2",84.2,NA,NA,61,94.8,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.3",91.3,NA,NA,81.7,96.1,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.8",86.8,NA,NA,82.4,90.3,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","91.2",91.2,NA,NA,82.4,95.8,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.8",83.8,NA,NA,71.3,91.5,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.9",90.9,NA,NA,77.7,96.6,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","87.4",87.4,NA,NA,82.2,91.3,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,73.7,85.8,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.3",85.3,NA,NA,81,88.8,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,80.4,86,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.0",83,NA,NA,73.9,89.4,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.8",85.8,NA,NA,80.5,89.8,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.3",89.3,NA,NA,80,94.6,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.4",84.4,NA,NA,77.2,89.6,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.1",85.1,NA,NA,75.2,91.4,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.4",82.4,NA,NA,73.7,88.6,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.3",88.3,NA,NA,81.7,92.8,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.0",83,NA,NA,70.3,91,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.1",79.1,NA,NA,75.4,82.3,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.1",81.1,NA,NA,74.6,86.3,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.3",86.3,NA,NA,75.7,92.7,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.3",82.3,NA,NA,76.5,87,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.5",78.5,NA,NA,65.3,87.6,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.1",70.1,NA,NA,53.4,82.8,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.9",75.9,NA,NA,73.6,78,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,52.9,82.7,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.0",74,NA,NA,66.8,80,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","90.3",90.3,NA,NA,77.2,96.2,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.6",88.6,NA,NA,85.9,90.8,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.3",80.3,NA,NA,75.7,84.2,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.0",87,NA,NA,81.4,91.1,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.3",86.3,NA,NA,75.7,92.8,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.9",70.9,NA,NA,50.9,85.2,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.4",79.4,NA,NA,71.9,85.3,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.4",80.4,NA,NA,67.5,89.1,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.4",86.4,NA,NA,79.3,91.3,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","64.9",64.9,NA,NA,48.8,78.2,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.1",84.1,NA,NA,74.5,90.5,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,59,81.6,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.6",87.6,NA,NA,76.9,93.8,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.0",81,NA,NA,71.8,87.7,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.7",83.7,NA,NA,67.6,92.7,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,78.3,88.3,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.5",87.5,NA,NA,83.2,90.8,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.9",91.9,NA,NA,83.2,96.3,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,73.6,91.1,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.9",88.9,NA,NA,76.3,95.2,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","86.7",86.7,NA,NA,80.6,91.1,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.8",80.8,NA,NA,74.4,86,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,82.1,89.1,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,80.6,86,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,78.5,91,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.3",83.3,NA,NA,76.6,88.3,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.7",88.7,NA,NA,80,93.9,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.9",80.9,NA,NA,72.4,87.3,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,72.6,89.7,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.4",79.4,NA,NA,69.6,86.7,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.4",88.4,NA,NA,82.4,92.6,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.4",81.4,NA,NA,69.2,89.5,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.2",78.2,NA,NA,74.5,81.5,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,73.5,85.5,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.8",87.8,NA,NA,77.1,93.9,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.0",83,NA,NA,77.7,87.2,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.0",79,NA,NA,68.4,86.8,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,53.7,81.7,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.3",76.3,NA,NA,74,78.4,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.0",84,NA,NA,77.9,88.7,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.3",75.3,NA,NA,63.5,84.3,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.1",80.1,NA,NA,73.9,85.1,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.5",85.5,NA,NA,73.8,92.5,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.4",81.4,NA,NA,70.4,89,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.8",76.8,NA,NA,56.4,89.4,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.5",72.5,NA,NA,57.9,83.5,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.9",73.9,NA,NA,57.9,85.4,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.9",78.9,NA,NA,74.4,82.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.6",74.6,NA,NA,59.8,85.3,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.1",70.1,NA,NA,54.5,82.1,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.1",75.1,NA,NA,64.1,83.6,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.9",77.9,NA,NA,70.1,84.2,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.8",77.8,NA,NA,63.4,87.6,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","73.5",73.5,NA,NA,58.6,84.4,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.4",76.4,NA,NA,64.7,85.2,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","72.3",72.3,NA,NA,59.5,82.2,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.1",74.1,NA,NA,61.2,83.9,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.6",79.6,NA,NA,62.3,90.2,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.3",74.3,NA,NA,67,80.5,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.0",82,NA,NA,75.9,86.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","60.0",60,NA,NA,45.6,72.8,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.1",77.1,NA,NA,67.1,84.8,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.8",79.8,NA,NA,65.5,89.1,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.8",81.8,NA,NA,69.7,89.7,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.0",77,NA,NA,68.8,83.6,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.8",70.8,NA,NA,52.2,84.3,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","58.6",58.6,NA,NA,37,77.2,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.1",77.1,NA,NA,59.4,88.6,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","63.2",63.2,NA,NA,42.7,79.9,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,74.9,89.4,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","76.2",76.2,NA,NA,63.8,85.4,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","69.7",69.7,NA,NA,58.7,78.9,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.3",82.3,NA,NA,73.1,88.9,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.8",79.8,NA,NA,72.7,85.4,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","65.6",65.6,NA,NA,60.2,70.5,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.2",84.2,NA,NA,78.4,88.7,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,66.6,85,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.6",79.6,NA,NA,73.6,84.6,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.7",87.7,NA,NA,77.5,93.6,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.4",82.4,NA,NA,71.1,89.9,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.2",75.2,NA,NA,54.3,88.6,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,58.7,81.5,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,58.8,85.6,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.9",77.9,NA,NA,74,81.4,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,64.8,86.1,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.5",74.5,NA,NA,61.6,84.2,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,64.9,82.4,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,78.9,88.8,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.5",78.5,NA,NA,66.4,87.1,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,70,89.3,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.1",79.1,NA,NA,70.5,85.7,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","73.2",73.2,NA,NA,60.9,82.7,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.5",74.5,NA,NA,63.2,83.2,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.9",83.9,NA,NA,71.2,91.6,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,67.5,80.2,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.5",81.5,NA,NA,75.2,86.5,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","61.9",61.9,NA,NA,47.8,74.3,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.7",78.7,NA,NA,69.9,85.4,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.1",76.1,NA,NA,62.7,85.8,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.8",81.8,NA,NA,70.5,89.4,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","75.9",75.9,NA,NA,67.8,82.4,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,53,81,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","67.6",67.6,NA,NA,53.8,78.8,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.4",78.4,NA,NA,63.4,88.4,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","60.4",60.4,NA,NA,39.1,78.4,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.7",82.7,NA,NA,74.4,88.7,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.3",74.3,NA,NA,60.2,84.7,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.2",74.2,NA,NA,64.9,81.7,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.8",81.8,NA,NA,72.8,88.3,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,75.1,86.3,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","65.6",65.6,NA,NA,60.4,70.4,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","95.5",95.5,NA,NA,86.5,98.6,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.4",84.4,NA,NA,74.2,91,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.6",81.6,NA,NA,66.3,90.9,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.9",82.9,NA,NA,77.7,87.1,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.7",78.7,NA,NA,60.9,89.7,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","92.8",92.8,NA,NA,83,97.1,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.1",85.1,NA,NA,71.3,92.9,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.0",88,NA,NA,78.1,93.8,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.4",77.4,NA,NA,59.9,88.6,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","58.7",58.7,NA,NA,39.4,75.7,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.2",81.2,NA,NA,63.3,91.6,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.7",75.7,NA,NA,59.1,87.1,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.7",79.7,NA,NA,67.8,88,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.2",74.2,NA,NA,62.8,83.1,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","90.1",90.1,NA,NA,80.4,95.3,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","74.2",74.2,NA,NA,56.1,86.6,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","93.0",93,NA,NA,82.1,97.5,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.2",70.2,NA,NA,57.2,80.5,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","77.0",77,NA,NA,65.6,85.5,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","MRC"
2012,2012,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","96.3",96.3,NA,NA,88.7,98.9,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.0",85,NA,NA,75.7,91.1,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.6",79.6,NA,NA,64.8,89.3,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.8",75.8,NA,NA,70.1,80.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.0",83,NA,NA,77.8,87.2,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.6",79.6,NA,NA,62.9,90,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","91.1",91.1,NA,NA,81.7,95.9,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.3",88.3,NA,NA,79.2,93.8,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.6",89.6,NA,NA,81.7,94.4,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.1",77.1,NA,NA,63,86.9,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","55.7",55.7,NA,NA,40.8,69.6,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.6",79.6,NA,NA,62.7,90.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","72.1",72.1,NA,NA,57.7,83.1,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.5",79.5,NA,NA,69.9,86.6,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.4",71.4,NA,NA,60.9,80,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","88.0",88,NA,NA,77.8,93.9,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","74.1",74.1,NA,NA,57.2,86,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,66.5,92.7,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.6",87.6,NA,NA,83.8,90.7,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","71.9",71.9,NA,NA,61.4,80.5,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,64.6,84.8,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2012,2012,"US","United States","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,"*","50 States + DC: US Median",84.3,86.3,"Overall","Overall",NA,"59","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,82.5,88,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.1",86.1,NA,NA,82.1,89.4,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.9",78.9,NA,NA,74,83.1,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.0",83,NA,NA,78.7,86.6,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.0",85,NA,NA,82.3,87.2,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.8",86.8,NA,NA,84.5,88.8,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.0",88,NA,NA,85.1,90.3,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","91.2",91.2,NA,NA,88,93.6,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.2",87.2,NA,NA,82.2,91,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.5",80.5,NA,NA,76.2,84.1,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.0",86,NA,NA,82.5,88.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.8",80.8,NA,NA,77.1,84,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.8",81.8,NA,NA,78.6,84.7,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.1",89.1,NA,NA,86,91.6,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,83,87.6,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,80.9,86.1,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.6",87.6,NA,NA,84.3,90.2,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.3",88.3,NA,NA,85.7,90.5,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.9",88.9,NA,NA,85.9,91.4,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.3",87.3,NA,NA,85.3,89.1,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.9",86.9,NA,NA,84.3,89.1,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.2",88.2,NA,NA,85.6,90.3,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.6",85.6,NA,NA,82.4,88.3,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,80,86.8,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.0",85,NA,NA,82,87.6,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.0",86,NA,NA,84.1,87.8,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.0",77,NA,NA,72.6,80.9,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,82,89.7,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.3",85.3,NA,NA,82.7,87.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.3",84.3,NA,NA,81.6,86.6,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.1",82.1,NA,NA,77.9,85.6,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.0",87,NA,NA,85,88.8,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.1",85.1,NA,NA,80.7,88.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.6",86.6,NA,NA,84.3,88.6,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.2",83.2,NA,NA,80.3,85.8,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.3",82.3,NA,NA,78.2,85.8,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.2",83.2,NA,NA,80.5,85.5,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.9",88.9,NA,NA,85,91.8,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.6",84.6,NA,NA,81.9,86.9,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.4",88.4,NA,NA,84.8,91.3,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.4",88.4,NA,NA,85.5,90.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.1",82.1,NA,NA,79.3,84.6,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.0",79,NA,NA,76.6,81.2,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.3",85.3,NA,NA,81.5,88.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.9",88.9,NA,NA,86.2,91.2,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,81.1,85.7,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.6",82.6,NA,NA,78.6,85.9,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,80.7,89.2,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.3",84.3,NA,NA,79.5,88.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","70.4",70.4,NA,NA,64.9,75.4,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.5",73.5,NA,NA,70.3,76.4,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,79.5,86.9,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.7",87.7,NA,NA,83,91.2,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.5",84.5,NA,NA,79.1,88.7,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,76.5,86.2,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,81.5,88.7,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.6",88.6,NA,NA,86.1,90.8,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.0",89,NA,NA,85,92,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","92.3",92.3,NA,NA,88.3,95.1,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.1",90.1,NA,NA,81.8,94.9,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.1",80.1,NA,NA,73.7,85.2,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.6",84.6,NA,NA,79.4,88.7,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.5",87.5,NA,NA,81,92,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.6",78.6,NA,NA,72.9,83.4,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.4",89.4,NA,NA,85,92.6,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.3",83.3,NA,NA,79.6,86.4,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.4",90.4,NA,NA,87.2,92.8,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.2",87.2,NA,NA,84.6,89.3,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.4",83.4,NA,NA,80.4,86,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.0",88,NA,NA,83.8,91.3,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.5",89.5,NA,NA,87.1,91.5,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.7",89.7,NA,NA,86,92.5,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.1",90.1,NA,NA,87.9,92,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.4",86.4,NA,NA,83.3,89,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.5",89.5,NA,NA,87,91.6,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.7",82.7,NA,NA,77.5,86.9,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.8",83.8,NA,NA,79.6,87.3,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.5",85.5,NA,NA,82.2,88.2,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,84.1,88.2,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.9",79.9,NA,NA,73.9,84.8,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.2",87.2,NA,NA,82.8,90.6,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.7",87.7,NA,NA,84.1,90.7,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.5",85.5,NA,NA,81.1,89.1,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,83,91.3,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.5",87.5,NA,NA,84.9,89.7,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.0",86,NA,NA,81.4,89.6,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.1,88.2,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,79.9,86.7,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.5",82.5,NA,NA,77.6,86.4,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.4",83.4,NA,NA,80.6,85.8,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","91.3",91.3,NA,NA,86.9,94.3,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,80,86.8,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.2",89.2,NA,NA,85,92.3,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.0",88,NA,NA,84.7,90.7,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.1",82.1,NA,NA,77.2,86.1,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.5",79.5,NA,NA,77,81.8,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.5",87.5,NA,NA,83.8,90.5,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.7",89.7,NA,NA,86.4,92.3,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.1",85.1,NA,NA,82.5,87.4,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.2",82.2,NA,NA,78,85.7,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.0",87,NA,NA,82,90.8,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.2",83.2,NA,NA,77.7,87.5,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.9",90.9,NA,NA,86.6,94,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.0",85,NA,NA,74,91.8,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.1",85.1,NA,NA,70.7,93.1,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","92.4",92.4,NA,NA,85.5,96.2,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","95.9",95.9,NA,NA,90.1,98.4,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.2",88.2,NA,NA,80.9,93,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,77.8,93.7,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.5",90.5,NA,NA,84.4,94.3,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","93.1",93.1,NA,NA,76.6,98.2,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,68.9,88.8,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.8",88.8,NA,NA,77.9,94.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.5",88.5,NA,NA,79.8,93.7,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.6",86.6,NA,NA,80.6,91,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","91.0",91,NA,NA,84.8,94.8,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.4",82.4,NA,NA,73.2,88.9,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.1",89.1,NA,NA,82.4,93.5,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","96.2",96.2,NA,NA,91.2,98.4,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.6",88.6,NA,NA,84.2,91.8,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.0",86,NA,NA,74.5,92.8,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.6",90.6,NA,NA,80.3,95.8,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.3",90.3,NA,NA,85.9,93.5,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.9",82.9,NA,NA,71.1,90.5,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.0",88,NA,NA,83.2,91.6,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","91.3",91.3,NA,NA,84.8,95.1,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.5",80.5,NA,NA,68.1,88.9,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.6",88.6,NA,NA,82.8,92.7,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.7",88.7,NA,NA,84.7,91.7,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.3",90.3,NA,NA,82.9,94.7,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.7",87.7,NA,NA,79.6,92.9,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","90.2",90.2,NA,NA,82.7,94.7,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","93.6",93.6,NA,NA,76.9,98.5,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","72.7",72.7,NA,NA,62.6,80.9,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.2",89.2,NA,NA,85.3,92.1,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.6",80.6,NA,NA,74.6,85.5,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.8",86.8,NA,NA,79.6,91.7,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.9",77.9,NA,NA,68.5,85.1,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.7",82.7,NA,NA,69.6,90.8,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,76.3,92.5,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.0",73,NA,NA,51.6,87.2,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.9",82.9,NA,NA,71.3,90.4,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","76.7",76.7,NA,NA,63.5,86.1,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.7",88.7,NA,NA,67.7,96.7,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.3",83.3,NA,NA,74,89.7,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","92.2",92.2,NA,NA,76.9,97.7,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,80.1,90.1,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,65,90.4,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.0",88,NA,NA,82.1,92.2,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.9",79.9,NA,NA,71.7,86.1,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.4",83.4,NA,NA,77.6,88,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.3",84.3,NA,NA,80.4,87.6,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.0",80,NA,NA,68.4,88,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.8",87.8,NA,NA,82,92,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.8",86.8,NA,NA,78.6,92.1,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.1",87.1,NA,NA,75.3,93.7,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.1",87.1,NA,NA,77.3,93.1,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.4",89.4,NA,NA,80.6,94.5,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.1",83.1,NA,NA,67,92.3,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.7",81.7,NA,NA,77.2,85.4,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.6",80.6,NA,NA,72.6,86.7,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.1",86.1,NA,NA,73.7,93.1,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.1",81.1,NA,NA,73.8,86.7,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.5",73.5,NA,NA,70.3,76.4,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.0",87,NA,NA,78.5,92.5,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.9",73.9,NA,NA,57.6,85.5,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.4",73.4,NA,NA,64.8,80.5,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.0",80,NA,NA,66.7,88.9,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","73.5",73.5,NA,NA,66.2,79.8,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","63.4",63.4,NA,NA,45,78.6,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","74.2",74.2,NA,NA,59.3,84.9,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","74.4",74.4,NA,NA,64.9,82.1,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","69.7",69.7,NA,NA,52.7,82.6,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.3",75.3,NA,NA,59.7,86.2,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","71.2",71.2,NA,NA,55.5,83,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","68.4",68.4,NA,NA,51,81.9,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","71.7",71.7,NA,NA,62.4,79.5,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.7",81.7,NA,NA,73.5,87.8,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","63.4",63.4,NA,NA,48,76.4,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.6",75.6,NA,NA,62,85.4,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.9",81.9,NA,NA,67,90.9,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.8",80.8,NA,NA,69.2,88.7,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","52.7",52.7,NA,NA,30.4,73.9,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.9",83.9,NA,NA,73,91,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.3",77.3,NA,NA,63.3,87,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","66.6",66.6,NA,NA,52.8,78,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.5",84.5,NA,NA,73.2,91.6,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.9",79.9,NA,NA,70.4,86.9,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","68.4",68.4,NA,NA,61.8,74.3,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","87.5",87.5,NA,NA,73.2,94.7,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.6",83.6,NA,NA,77.2,88.4,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.2",84.2,NA,NA,65,93.9,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","80.7",80.7,NA,NA,64.6,90.6,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.5",75.5,NA,NA,60.1,86.4,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.2",82.2,NA,NA,69.5,90.3,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","MRC"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.1",65.1,"*","50 States + DC: US Median",63,67.2,"Overall","Overall",NA,"59","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.0",66,NA,NA,64,67.9,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.0",56,NA,NA,52.8,59.2,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.5",58.5,NA,NA,55.8,61.2,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.8",56.8,NA,NA,54.3,59.3,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,65.3,69,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.3",65.3,NA,NA,63.6,66.9,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.2",72.2,NA,NA,70.2,74.1,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,69,74,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,63.3,70.8,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,63.6,68.4,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.7",67.7,NA,NA,65.3,70,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,62.3,67.5,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,57.6,63.4,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.0",61,NA,NA,58.4,63.5,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,58.6,62.4,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.2",66.2,NA,NA,64.3,68,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.7",64.7,NA,NA,63.1,66.3,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.0",63,NA,NA,61,64.9,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.2",60.2,NA,NA,58,62.4,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.5",73.5,NA,NA,71.9,74.9,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.8",70.8,NA,NA,68.9,72.6,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.4",76.4,NA,NA,75.1,77.8,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.2",69.2,NA,NA,67.5,70.9,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.6",70.6,NA,NA,69,72.2,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,56.3,60.4,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,61.7,66.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.4",56.4,NA,NA,54.5,58.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,59.6,62.5,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.6",58.6,NA,NA,55.3,61.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","75.0",75,NA,NA,73.1,76.9,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,60.6,64.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.6",57.6,NA,NA,55.8,59.5,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.6",69.6,NA,NA,67,72.1,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.6",68.6,NA,NA,66.9,70.2,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.1",58.1,NA,NA,55.6,60.6,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61.7,65,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.5",58.5,NA,NA,56.5,60.4,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.5",65.5,NA,NA,63.1,67.9,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.8",66.8,NA,NA,65.3,68.2,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.9",72.9,NA,NA,70.6,75.1,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.1",65.1,NA,NA,63.3,66.8,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,59.7,65.2,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,62.7,67.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.3",58.3,NA,NA,56,60.5,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,66.2,69.6,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,69.4,73.4,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,65.9,69.9,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.5",67.5,NA,NA,66,68.9,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.2",63.2,NA,NA,61.1,65.3,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.4",71.4,NA,NA,68.6,74,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,53.1,58.3,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","40.0",40,NA,NA,34.9,45.2,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.4",52.4,NA,NA,50.1,54.6,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.9",64.9,"*","50 States + DC: US Median",62.7,66.7,"Overall","Overall",NA,"59","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,63.3,67,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.4",57.4,NA,NA,54.3,60.5,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.2",58.2,NA,NA,55.5,60.8,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.1",56.1,NA,NA,53.6,58.6,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,65.9,69.4,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.8",65.8,NA,NA,64.2,67.3,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,70.5,74.2,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.9",70.9,NA,NA,68.4,73.3,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.7",66.7,NA,NA,63.1,70.2,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.6",64.6,NA,NA,62.2,66.9,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,65.4,69.9,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.8",64.8,NA,NA,62.3,67.3,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,57,62.7,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.4",61.4,NA,NA,58.9,63.8,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.6",60.6,NA,NA,58.7,62.5,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,64.2,67.9,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.9",64.9,NA,NA,63.4,66.4,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.7",62.7,NA,NA,60.7,64.5,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.7",59.7,NA,NA,57.6,61.8,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,71.1,74.1,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.0",71,NA,NA,69.3,72.7,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","76.1",76.1,NA,NA,74.8,77.4,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.0",69,NA,NA,67.3,70.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.0",71,NA,NA,69.4,72.5,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.0",58,NA,NA,56,59.9,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.2",64.2,NA,NA,61.9,66.5,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.5",55.5,NA,NA,53.6,57.4,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.0",61,NA,NA,59.6,62.4,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,55.4,61.8,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.2",75.2,NA,NA,73.4,77,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,61.1,64.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.2",57.2,NA,NA,55.3,59,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,66.7,71.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.3",68.3,NA,NA,66.7,69.9,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.0",58,NA,NA,55.6,60.4,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.4",63.4,NA,NA,61.8,65,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.3",58.3,NA,NA,56.4,60.2,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.5",65.5,NA,NA,63.1,67.9,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.6",66.6,NA,NA,65.1,68,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,70.6,75,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.3",64.3,NA,NA,62.5,66,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,59.4,64.7,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.0",65,NA,NA,62.8,67.2,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.6",58.6,NA,NA,56.5,60.7,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.2",68.2,NA,NA,66.5,69.8,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.2",71.2,NA,NA,69.3,73.1,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.5",68.5,NA,NA,66.6,70.4,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,66.3,69.2,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.2",62.2,NA,NA,60.1,64.3,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,69,74.1,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.8",55.8,NA,NA,53.3,58.2,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","41.1",41.1,NA,NA,36,46.3,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.8",51.8,NA,NA,49.6,54,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.0",64,"*","50 States + DC: US Median",62.3,65.4,"Gender","Male",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.1",64.1,NA,NA,60.8,67.3,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.0",51,NA,NA,46.4,55.6,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.1",57.1,NA,NA,52.9,61.3,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.4",56.4,NA,NA,52.4,60.4,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,62.5,68.3,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.6",65.6,NA,NA,63.1,68,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.4",71.4,NA,NA,68.2,74.3,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.2",71.2,NA,NA,66.8,75.2,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,57.3,69.2,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,60.7,68.4,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,63.9,71.2,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,61.2,68.5,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.9",62.9,NA,NA,58.3,67.2,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.0",59,NA,NA,54.9,63,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,56.6,62.7,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.9",62.9,NA,NA,60,65.7,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.2",63.2,NA,NA,60.5,65.7,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,57.3,63.7,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.9",58.9,NA,NA,55.3,62.5,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.1",72.1,NA,NA,69.7,74.4,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.6",68.6,NA,NA,65.5,71.6,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.6",76.6,NA,NA,74.4,78.6,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.5",66.5,NA,NA,63.7,69.3,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.5",68.5,NA,NA,65.9,70.9,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.5",55.5,NA,NA,52.2,58.8,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.0",64,NA,NA,60.1,67.7,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,53.2,59.1,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,56.1,60.6,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.3",57.3,NA,NA,52.3,62.2,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.8",73.8,NA,NA,70.7,76.7,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,NA,NA,59.6,65,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.0",55,NA,NA,52.1,57.9,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.1",70.1,NA,NA,66.3,73.6,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.6",66.6,NA,NA,63.9,69.2,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,51.8,59.5,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,58.5,63.7,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.4",56.4,NA,NA,53.4,59.4,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,62.1,69.8,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,62.2,66.8,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.7",71.7,NA,NA,68,75.2,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,61.5,67.1,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.6",60.6,NA,NA,56.4,64.7,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,58.7,66,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.1",57.1,NA,NA,53.6,60.5,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.5",66.5,NA,NA,63.8,69.2,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.6",69.6,NA,NA,66.4,72.7,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,61.1,67.7,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.7",65.7,NA,NA,63.3,67.9,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.0",63,NA,NA,59.8,66.2,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.0",69,NA,NA,64.6,73.1,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,51.8,59.6,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","36.1",36.1,NA,NA,29.3,43.6,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.3",51.3,NA,NA,47.7,54.9,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.3",63.3,"*","50 States + DC: US Median",62.1,66.1,"Gender","Male",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.3",63.3,NA,NA,60.3,66.3,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.0",53,NA,NA,48.5,57.4,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.5",57.5,NA,NA,53.5,61.3,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.7",55.7,NA,NA,51.7,59.7,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,63.6,68.9,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,64,68.7,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.1",72.1,NA,NA,69.2,74.7,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.5",70.5,NA,NA,66.3,74.4,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.9",62.9,NA,NA,57.2,68.3,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.1",63.1,NA,NA,59.5,66.6,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,63.7,70.9,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.9",64.9,NA,NA,61.3,68.3,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,57.6,66.3,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.8",59.8,NA,NA,55.9,63.6,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,57,63,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,60.4,66,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.7",63.7,NA,NA,61.3,66,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.7",60.7,NA,NA,57.5,63.8,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.4",58.4,NA,NA,54.9,61.9,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.0",71,NA,NA,68.6,73.3,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,66.6,71.9,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","76.2",76.2,NA,NA,74.1,78.2,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,63.7,69.1,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,66.7,71.5,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.1",55.1,NA,NA,51.8,58.2,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,60.1,67.5,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.9",54.9,NA,NA,52.1,57.6,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.5",58.5,NA,NA,56.2,60.6,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.4",57.4,NA,NA,52.9,61.9,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,71.5,77.1,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.7",62.7,NA,NA,60.1,65.3,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.5",54.5,NA,NA,51.6,57.3,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.0",70,NA,NA,66.3,73.3,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,63.6,68.7,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.7",55.7,NA,NA,52.1,59.3,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.7",61.7,NA,NA,59.1,64.3,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.5",56.5,NA,NA,53.5,59.4,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,62.5,70.2,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.6",64.6,NA,NA,62.3,66.8,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.0",72,NA,NA,68.3,75.4,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,61.1,66.7,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,56.1,63.9,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.5",62.5,NA,NA,58.9,66,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.6",57.6,NA,NA,54.4,60.8,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,64.9,69.9,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,66.2,72.1,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.4",65.4,NA,NA,62.4,68.3,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,63.9,68.2,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.2",62.2,NA,NA,59,65.4,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.1",69.1,NA,NA,64.9,73,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.5",55.5,NA,NA,51.6,59.3,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","37.2",37.2,NA,NA,30.1,44.8,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.0",51,NA,NA,47.5,54.5,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,"*","50 States + DC: US Median",64.2,68.9,"Gender","Female",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,65.3,69.8,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.6",61.6,NA,NA,57.2,65.7,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,56.3,63.1,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.1",57.1,NA,NA,54,60.2,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.7",68.7,NA,NA,66.3,71.1,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.0",65,NA,NA,62.8,67,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.0",73,NA,NA,70.5,75.4,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.9",71.9,NA,NA,68.9,74.7,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,65.5,74.8,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.4",67.4,NA,NA,64.4,70.2,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.7",67.7,NA,NA,64.7,70.6,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.0",65,NA,NA,61.2,68.5,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.3",58.3,NA,NA,54.4,62,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.7",62.7,NA,NA,59.5,65.8,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.3",61.3,NA,NA,58.8,63.7,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.4",69.4,NA,NA,67,71.7,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.2",66.2,NA,NA,64.2,68.1,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.2",65.2,NA,NA,62.8,67.5,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.4",61.4,NA,NA,58.8,63.8,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.7",74.7,NA,NA,72.7,76.5,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.8",72.8,NA,NA,70.6,74.8,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.3",76.3,NA,NA,74.6,78,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.7",71.7,NA,NA,69.6,73.7,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,70.6,74.7,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.9",60.9,NA,NA,58.4,63.3,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,61.2,67.3,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.7",56.7,NA,NA,54.1,59.2,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,61.7,65.4,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.9",59.9,NA,NA,55.5,64.1,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.2",76.2,NA,NA,73.8,78.5,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.4",62.4,NA,NA,60.2,64.6,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.0",60,NA,NA,57.5,62.4,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.2",69.2,NA,NA,65.4,72.7,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,68.3,72.4,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,57.2,63.8,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.5",65.5,NA,NA,63.4,67.5,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,58,62.9,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.0",65,NA,NA,61.9,67.9,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.9",68.9,NA,NA,67,70.7,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.9",73.9,NA,NA,71,76.6,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.8",65.8,NA,NA,63.6,68,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.2",64.2,NA,NA,60.5,67.7,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,64.5,69.7,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.3",59.3,NA,NA,56.2,62.3,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.2",69.2,NA,NA,67,71.4,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.2",73.2,NA,NA,70.6,75.7,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.0",71,NA,NA,68.6,73.4,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.3",69.3,NA,NA,67.4,71.1,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,60.7,66.1,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.5",73.5,NA,NA,69.9,76.8,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.7",55.7,NA,NA,52.4,59.1,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","43.4",43.4,NA,NA,36.4,50.6,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.2",53.2,NA,NA,50.5,56,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2012,2012,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,"*","50 States + DC: US Median",64,68.9,"Gender","Female",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,64.7,69.2,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.2",62.2,NA,NA,58,66.2,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.1",59.1,NA,NA,55.6,62.4,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.2",56.2,NA,NA,53.1,59.2,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,66.6,71.2,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.2",65.2,NA,NA,63.1,67.2,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.9",72.9,NA,NA,70.4,75.2,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.3",71.3,NA,NA,68.3,74.1,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.1",70.1,NA,NA,65.6,74.2,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,63.1,69,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.9",67.9,NA,NA,65.1,70.6,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.0",65,NA,NA,61.4,68.4,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.8",57.8,NA,NA,54.1,61.4,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.9",62.9,NA,NA,59.8,65.9,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.1",61.1,NA,NA,58.7,63.4,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,66.5,71.1,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,64.2,68,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.6",64.6,NA,NA,62.3,66.8,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.0",61,NA,NA,58.6,63.4,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.0",74,NA,NA,72.1,75.9,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.7",72.7,NA,NA,70.6,74.8,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","76.0",76,NA,NA,74.3,77.7,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.4",71.4,NA,NA,69.3,73.3,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.7",72.7,NA,NA,70.7,74.6,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.5",60.5,NA,NA,58.1,62.9,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.5",64.5,NA,NA,61.6,67.4,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.0",56,NA,NA,53.5,58.5,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.4",63.4,NA,NA,61.6,65.1,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.4",60.4,NA,NA,56.2,64.6,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","76.0",76,NA,NA,73.6,78.2,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,60.7,65,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.6",59.6,NA,NA,57.2,62,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,65.2,72.4,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.1",70.1,NA,NA,68.1,72.1,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,56.9,63.3,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,63.1,67,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,57.5,62.2,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.5",64.5,NA,NA,61.6,67.4,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.4",68.4,NA,NA,66.5,70.2,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,70.9,76.3,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.6",64.6,NA,NA,62.3,66.8,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.0",64,NA,NA,60.4,67.5,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.3",67.3,NA,NA,64.7,69.8,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.6",59.6,NA,NA,56.8,62.4,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,66.8,71,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.0",73,NA,NA,70.5,75.4,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.4",71.4,NA,NA,69,73.7,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,67.5,71.1,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.4",62.4,NA,NA,59.6,65.2,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.8",73.8,NA,NA,70.4,76.9,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.3",56.3,NA,NA,53.1,59.4,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","44.0",44,NA,NA,37.3,50.9,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.5",52.5,NA,NA,49.7,55.2,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,63.8,68.3,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.2",56.2,NA,NA,52.7,59.7,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.9",61.9,NA,NA,59,64.8,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.7",57.7,NA,NA,54.9,60.4,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.4",72.4,NA,NA,70.5,74.1,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.4",67.4,NA,NA,65.6,69,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.4",74.4,NA,NA,72.4,76.3,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.6",71.6,NA,NA,68.9,74.1,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.8",72.8,NA,NA,68.5,76.7,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.9",68.9,NA,NA,66.4,71.3,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.7",68.7,NA,NA,66,71.3,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.3",67.3,NA,NA,63.5,70.9,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.1",61.1,NA,NA,58,64.1,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.8",62.8,NA,NA,60.1,65.4,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.5",61.5,NA,NA,59.4,63.5,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.7",66.7,NA,NA,64.8,68.6,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.0",66,NA,NA,64.4,67.5,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61.4,65.4,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,61,66.1,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.9",73.9,NA,NA,72.3,75.4,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,69.5,73.4,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","77.7",77.7,NA,NA,76.3,79.1,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.6",70.6,NA,NA,68.8,72.3,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.0",72,NA,NA,70.3,73.5,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.1",62.1,NA,NA,59.7,64.5,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.3",64.3,NA,NA,61.6,66.8,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.7",57.7,NA,NA,55.6,59.7,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,61.1,64,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.2",61.2,NA,NA,57.8,64.5,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.8",74.8,NA,NA,72.8,76.7,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.9",63.9,NA,NA,62,65.8,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.5",61.5,NA,NA,59.1,63.8,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.8",68.8,NA,NA,66.2,71.4,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.2",70.2,NA,NA,68.4,72,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.2",59.2,NA,NA,56.6,61.7,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61.6,65.1,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.8",59.8,NA,NA,57.6,61.9,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.4",67.4,NA,NA,65,69.8,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.5",67.5,NA,NA,66,69.1,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","75.5",75.5,NA,NA,73.2,77.6,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.8",66.8,NA,NA,64.8,68.8,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.8",63.8,NA,NA,60.9,66.6,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.2",66.2,NA,NA,63.9,68.5,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.5",64.5,NA,NA,61.9,67.1,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.1",70.1,NA,NA,68.4,71.8,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.1",72.1,NA,NA,70,74.1,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.4",69.4,NA,NA,67.2,71.5,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.1",70.1,NA,NA,68.6,71.5,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.4",63.4,NA,NA,61.3,65.6,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.8",72.8,NA,NA,70,75.4,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.4",56.4,NA,NA,53.7,59.1,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,51.1,76.1,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.8",64.8,NA,NA,62.6,67,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.2",57.2,NA,NA,53.9,60.5,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.4",60.4,NA,NA,57.6,63.1,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.7",56.7,NA,NA,53.9,59.5,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.0",72,NA,NA,70.2,73.7,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.5",67.5,NA,NA,65.8,69.1,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.2",74.2,NA,NA,72.2,76,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,67.8,73,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.3",71.3,NA,NA,67.2,75.1,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,63.7,68.9,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.0",68,NA,NA,65.4,70.6,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.8",66.8,NA,NA,63,70.5,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.0",60,NA,NA,57,62.9,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.1",63.1,NA,NA,60.5,65.5,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,59.5,63.5,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.5",66.5,NA,NA,64.6,68.3,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.8",65.8,NA,NA,64.2,67.3,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.0",63,NA,NA,61,64.9,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,59.5,64.6,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.1",73.1,NA,NA,71.5,74.6,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.2",71.2,NA,NA,69.3,73.1,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,75.8,78.6,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.0",70,NA,NA,68.2,71.7,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.0",72,NA,NA,70.5,73.6,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.9",60.9,NA,NA,58.5,63.3,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,61.5,66.5,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.4",56.4,NA,NA,54.4,58.4,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,60.9,63.7,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.8",60.8,NA,NA,57.4,64,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.9",74.9,NA,NA,73,76.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,62.2,65.9,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.2",60.2,NA,NA,57.8,62.5,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.8",68.8,NA,NA,66.2,71.3,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.3",69.3,NA,NA,67.5,71.1,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.9",58.9,NA,NA,56.4,61.4,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,61.5,64.9,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.0",59,NA,NA,56.8,61.1,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.2",67.2,NA,NA,64.8,69.6,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.0",67,NA,NA,65.5,68.5,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.0",75,NA,NA,72.7,77.1,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,63.6,67.7,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,60.4,65.9,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.0",66,NA,NA,63.7,68.3,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,61.7,66.5,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,68.3,71.6,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.8",71.8,NA,NA,69.8,73.7,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.7",69.7,NA,NA,67.5,71.7,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.8",69.8,NA,NA,68.3,71.2,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,60.1,64.4,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.6",72.6,NA,NA,69.9,75.1,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.3",56.3,NA,NA,53.7,58.9,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,54.3,76.4,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.0",67,NA,NA,62.7,71.1,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.0",62,NA,NA,43.3,77.7,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.9",56.9,NA,NA,49.1,64.4,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.0",76,NA,NA,68.8,82,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,53.5,75.7,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,54.1,72.1,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.7",69.7,NA,NA,61.5,76.8,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.2",68.2,NA,NA,63,72.9,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,58.1,73.3,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.0",67,NA,NA,61.9,71.8,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.9",59.9,NA,NA,51.3,68,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.0",59,NA,NA,51.2,66.3,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.3",68.3,NA,NA,58.7,76.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.7",61.7,NA,NA,52.6,70,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.5",54.5,NA,NA,50.1,58.8,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,67.3,75.4,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.5",69.5,NA,NA,62.3,75.8,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.5",63.5,NA,NA,56.8,69.8,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.9",51.9,NA,NA,39.2,64.4,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.8",50.8,NA,NA,47,54.7,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,56.1,72.8,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.6",56.6,NA,NA,46.4,66.3,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.6",70.6,NA,NA,54.6,82.7,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.5",63.5,NA,NA,58.2,68.4,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.6",76.6,NA,NA,67.3,83.9,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,62.7,71.4,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,58.1,70.7,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.6",59.6,NA,NA,50.6,68,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.2",67.2,NA,NA,61.1,72.8,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.3",72.3,NA,NA,56.3,84.1,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.2",60.2,NA,NA,56.2,64.1,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.0",58,NA,NA,50.5,65.2,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,60.3,74.1,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.1",67.1,NA,NA,61.3,72.5,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,55.4,77.8,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,51,79,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.4",68.4,NA,NA,55.9,78.7,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,63.4,71.1,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.5",65.5,NA,NA,48.5,79.3,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.5",57.5,NA,NA,50.2,64.5,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.7",75.7,NA,NA,68.6,81.7,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.5",67.5,NA,NA,56.7,76.7,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,57.4,73.2,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.6",70.6,NA,NA,62.9,77.3,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.3",68.3,NA,NA,63.5,72.8,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,58.8,73,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.0",68,NA,NA,63.1,72.6,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.9",60.9,NA,NA,53.2,68,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.8",59.8,NA,NA,52.9,66.3,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.1",72.1,NA,NA,64.6,78.6,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.4",64.4,NA,NA,56.3,71.8,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.6",56.6,NA,NA,52.6,60.4,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.4",73.4,NA,NA,69.9,76.7,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.1",70.1,NA,NA,62.4,76.7,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.7",64.7,NA,NA,58.4,70.5,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.8",58.8,NA,NA,47.7,69,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.1",52.1,NA,NA,48.5,55.7,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,59.9,74,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.4",57.4,NA,NA,47.9,66.4,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,55.8,80.4,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.4",64.4,NA,NA,59.7,68.9,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","77.4",77.4,NA,NA,69.3,83.8,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.0",69,NA,NA,65,72.7,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.9",64.9,NA,NA,58.5,70.7,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.1",61.1,NA,NA,53.9,67.8,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.0",68,NA,NA,62.5,73.1,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.6",75.6,NA,NA,64.5,84.2,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.6",59.6,NA,NA,55.6,63.5,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.5",61.5,NA,NA,55,67.5,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,59.5,73.4,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,62.4,72.7,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.0",67,NA,NA,56.5,76.1,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.3",74.3,NA,NA,60.7,84.4,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,61.2,80,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.1",55.1,NA,NA,39.4,69.8,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.9",48.9,NA,NA,40.4,57.4,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","49.7",49.7,NA,NA,45.3,54.2,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.3",52.3,NA,NA,46.6,58.1,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.8",61.8,NA,NA,51.6,71,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.6",56.6,NA,NA,48.4,64.4,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","49.5",49.5,NA,NA,32.9,66.3,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.2",61.2,NA,NA,49.6,71.6,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","45.8",45.8,NA,NA,30.8,61.6,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.0",47,NA,NA,35.1,59.3,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","38.7",38.7,NA,NA,25,54.5,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.8",58.8,NA,NA,42.9,73.1,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.4",48.4,NA,NA,37.1,59.8,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.4",73.4,NA,NA,53.4,86.9,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.0",58,NA,NA,40.3,73.8,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.9",66.9,NA,NA,50.4,80,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.9",67.9,NA,NA,59.3,75.5,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.0",59,NA,NA,42.5,73.8,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","40.5",40.5,NA,NA,24.9,58.3,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,43.8,78.1,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","35.0",35,NA,NA,26.8,44.3,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","42.4",42.4,NA,NA,33.1,52.3,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.4",60.4,NA,NA,54.5,66,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.0",54,NA,NA,50.5,57.5,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.9",73.9,NA,NA,65.3,80.9,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","34.9",34.9,NA,NA,25.1,46.3,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,52.9,77.6,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.0",51,NA,NA,38.8,63.1,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","45.3",45.3,NA,NA,30.1,61.4,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.8",58.8,NA,NA,46.6,70.1,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.0",51,NA,NA,40.1,61.8,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.2",64.2,NA,NA,45.7,79.2,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","41.4",41.4,NA,NA,36.2,46.7,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.9",51.9,NA,NA,43.4,60.2,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","45.6",45.6,NA,NA,32,59.8,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","37.4",37.4,NA,NA,29.7,45.8,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","44.4",44.4,NA,NA,31.8,57.8,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","35.4",35.4,NA,NA,21.8,51.9,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.5",52.5,NA,NA,50.3,54.7,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,48.3,70.9,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.1",50.1,NA,NA,42.1,58.1,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.2",53.2,NA,NA,48.8,57.6,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.6",53.6,NA,NA,48.1,59,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.2",64.2,NA,NA,55,72.4,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.7",56.7,NA,NA,49.5,63.6,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.1",48.1,NA,NA,34.1,62.5,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.8",61.8,NA,NA,50.8,71.8,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49.4",49.4,NA,NA,35.3,63.5,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.5",51.5,NA,NA,40.8,62,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.8",43.8,NA,NA,31.2,57.3,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.7",61.7,NA,NA,46.6,74.9,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.3",53.3,NA,NA,43.7,62.7,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,56.9,76.9,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.2",58.2,NA,NA,44.5,70.9,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.4",67.4,NA,NA,54.2,78.2,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.9",68.9,NA,NA,61.7,75.4,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.4",59.4,NA,NA,45.6,71.9,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.2",48.2,NA,NA,35,61.6,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.7",63.7,NA,NA,46.5,78.1,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","37.4",37.4,NA,NA,29.2,46.5,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.0",43,NA,NA,34,52.5,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.7",62.7,NA,NA,57.2,67.9,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.6",54.6,NA,NA,51.2,57.9,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.5",73.5,NA,NA,65,80.6,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.7",43.7,NA,NA,35.4,52.4,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.1",64.1,NA,NA,51.2,75.2,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.5",54.5,NA,NA,42.5,65.9,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","44.9",44.9,NA,NA,29.4,61.4,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.9",57.9,NA,NA,46.9,68.3,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.5",59.5,NA,NA,49.1,69,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,55.1,79.5,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","44.7",44.7,NA,NA,39.9,49.6,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.9",57.9,NA,NA,50.4,65.2,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","46.5",46.5,NA,NA,35,58.4,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","48.7",48.7,NA,NA,41.7,55.8,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","44.9",44.9,NA,NA,33.8,56.6,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","39.3",39.3,NA,NA,25.4,55.1,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.9",51.9,NA,NA,49.7,54.1,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,46.8,72.8,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.0",57,NA,NA,49.1,64.5,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","38.8",38.8,NA,NA,27.9,51,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","39.3",39.3,NA,NA,26.6,53.8,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.1",71.1,NA,NA,63.5,77.6,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.0",59,NA,NA,47,70.1,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.9",62.9,NA,NA,48.3,75.5,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","79.2",79.2,NA,NA,60.9,90.3,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.6",53.6,NA,NA,36.4,69.9,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.8",68.8,NA,NA,53.7,80.7,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,60.2,68.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.5",56.5,NA,NA,43,69.1,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","38.8",38.8,NA,NA,21.5,59.5,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","35.6",35.6,NA,NA,23.5,49.9,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.7",63.7,NA,NA,47.9,77.1,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.0",60,NA,NA,48.9,70.2,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.0",66,NA,NA,55.9,74.8,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.7",60.7,NA,NA,48.5,71.7,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.6",58.6,NA,NA,45.8,70.4,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","45.1",45.1,NA,NA,36.6,53.9,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.6",58.6,NA,NA,44.9,71,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.6",51.6,NA,NA,35.8,67.2,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.1",73.1,NA,NA,58.1,84.2,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.5",48.5,NA,NA,39.3,57.9,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","41.7",41.7,NA,NA,34.5,49.2,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.6",71.6,NA,NA,63.1,78.8,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","30.6",30.6,NA,NA,17.9,47.1,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","49.8",49.8,NA,NA,36.1,63.5,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","52.1",52.1,NA,NA,44.9,59.2,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.4",47.4,NA,NA,30.5,65,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,NA,NA,46.7,75.6,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.1",66.1,NA,NA,51.8,78,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","41.5",41.5,NA,NA,32,51.7,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","56.1",56.1,NA,NA,38.5,72.2,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.2",53.2,NA,NA,41.3,64.7,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.9",54.9,NA,NA,41.3,67.7,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.8",61.8,NA,NA,53.8,69.1,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.0",61,NA,NA,37.2,80.5,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.7",51.7,NA,NA,34,69.1,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","33.9",33.9,NA,NA,28.2,40,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.8",63.8,NA,NA,51.9,74.2,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.1",58.1,NA,NA,50.6,65.2,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","41.6",41.6,NA,NA,31.2,52.8,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.3",43.3,NA,NA,31.6,55.8,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,64.7,77.5,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.3",61.3,NA,NA,47.5,73.6,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.1",67.1,NA,NA,56.7,76.1,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","80.5",80.5,NA,NA,62.5,91,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.8",55.8,NA,NA,41.2,69.5,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,54.9,80.8,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.9",63.9,NA,NA,59.6,68,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.0",58,NA,NA,45.2,69.7,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","42.8",42.8,NA,NA,31.8,54.4,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","35.6",35.6,NA,NA,24.2,48.8,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.6",63.6,NA,NA,50.4,75,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.7",59.7,NA,NA,48.5,70,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.5",68.5,NA,NA,60.9,75.2,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.1",61.1,NA,NA,49.7,71.4,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.7",59.7,NA,NA,47.3,71,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49.3",49.3,NA,NA,41.3,57.3,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.1",59.1,NA,NA,47.1,70.1,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.6",57.6,NA,NA,44,70.1,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.4",75.4,NA,NA,62.1,85.2,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","47.7",47.7,NA,NA,38.5,56.9,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","42.8",42.8,NA,NA,35.7,50.2,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.4",72.4,NA,NA,63.8,79.5,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","38.0",38,NA,NA,25.9,51.7,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.1",53.1,NA,NA,41.1,64.7,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.5",53.5,NA,NA,46.5,60.3,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49.9",49.9,NA,NA,33.8,66.1,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.7",68.7,NA,NA,56.5,78.8,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.0",65,NA,NA,51,76.8,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","43.2",43.2,NA,NA,34.6,52.2,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.9",54.9,NA,NA,42.8,66.4,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.7",57.7,NA,NA,47.8,67,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.1",58.1,NA,NA,47.5,68,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.8",65.8,NA,NA,58.9,72.1,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.5",68.5,NA,NA,54,80.1,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.9",56.9,NA,NA,41.4,71.1,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","34.7",34.7,NA,NA,29.1,40.9,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.3",54.3,NA,NA,35.6,71.9,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.3",66.3,NA,NA,55.6,75.6,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.8",55.8,NA,NA,41.5,69.3,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.7",74.7,NA,NA,55.5,87.5,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.7",63.7,NA,NA,58.2,68.8,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","47.8",47.8,NA,NA,32.1,63.9,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","53.0",53,NA,NA,35.8,69.5,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.3",54.3,NA,NA,41.6,66.5,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.7",67.7,NA,NA,50.8,81,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,50.9,80.8,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.9",68.9,NA,NA,54.3,80.6,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.4",58.4,NA,NA,46.6,69.3,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.2",51.2,NA,NA,36.9,65.2,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","26.7",26.7,NA,NA,17,39.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.7",59.7,NA,NA,43.9,73.6,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","59.3",59.3,NA,NA,44.1,72.8,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.0",65,NA,NA,50.5,77.2,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.8",63.8,NA,NA,49.6,76,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.3",48.3,NA,NA,40,56.7,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.1",50.1,NA,NA,41.8,58.5,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.2",48.2,NA,NA,33.8,62.9,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","50.9",50.9,NA,NA,35.3,66.2,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.0",61,NA,NA,49.4,71.5,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.3",51.3,NA,NA,36.6,65.7,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","MRC"
2012,2012,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.0",64,NA,NA,49.6,76.3,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.1",68.1,NA,NA,58.9,76,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.7",54.7,NA,NA,41,67.7,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.4",75.4,NA,NA,57.9,87.2,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.5",64.5,NA,NA,59.1,69.5,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.3",50.3,NA,NA,38.4,62.2,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.9",57.9,NA,NA,43.7,70.9,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","53.8",53.8,NA,NA,42.4,64.8,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.5",62.5,NA,NA,49.4,73.9,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.8",66.8,NA,NA,52.1,78.9,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.6",68.6,NA,NA,55.9,79,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.8",57.8,NA,NA,46.5,68.4,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.4",52.4,NA,NA,38,66.3,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","31.0",31,NA,NA,21,43.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.6",61.6,NA,NA,47.3,74.2,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.3",55.3,NA,NA,41.8,68.1,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.9",61.9,NA,NA,48.1,74,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","61.0",61,NA,NA,48.2,72.4,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","49.2",49.2,NA,NA,41.3,57.1,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","51.7",51.7,NA,NA,43.9,59.4,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","47.6",47.6,NA,NA,33.9,61.6,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","52.3",52.3,NA,NA,38.6,65.7,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.0",63,NA,NA,51.7,73,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.4",54.4,NA,NA,40.6,67.7,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2012,2012,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.3",77.3,NA,NA,74.2,80.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.8",85.8,NA,NA,83.5,87.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.7",77.7,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",76,85.8,"Overall","Overall",NA,"59","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.2",79.2,NA,NA,76.9,81.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","81.1",81.1,NA,NA,78.8,83.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.2",77.2,NA,NA,72,81.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.0",76,NA,NA,72.9,78.9,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","77.7",77.7,NA,NA,75.9,79.4,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","OVERALL","OVR"
2015,2015,"US","United States","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.7",77.7,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",75.9,85.9,"Overall","Overall",NA,"59","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.5",77.5,NA,NA,74.3,80.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,83.6,87.9,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.0",79,NA,NA,76.7,81.1,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.3",81.3,NA,NA,78.8,83.5,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.1",76.1,NA,NA,70.8,80.7,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","75.9",75.9,NA,NA,72.7,78.9,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.7",77.7,NA,NA,75.9,79.4,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","73.9",73.9,NA,NA,70,77.5,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.3",79.3,NA,NA,74.8,83.1,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","76.8",76.8,NA,NA,74,79.3,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","80.9",80.9,NA,NA,78.4,83.1,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.7",79.7,NA,NA,74.6,84,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","74.4",74.4,NA,NA,71,77.6,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.3",78.3,NA,NA,76.6,80,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","73.8",73.8,NA,NA,69.8,77.6,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","79.4",79.4,NA,NA,74.8,83.3,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.6",76.6,NA,NA,73.9,79.2,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","81.0",81,NA,NA,78.4,83.4,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,72.6,82.8,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","74.1",74.1,NA,NA,70.5,77.5,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","78.1",78.1,NA,NA,76.2,79.9,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.6",86.6,NA,NA,80.9,90.8,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.1",86.1,NA,NA,80.7,90.1,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","85.4",85.4,NA,NA,76.6,91.2,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","86.6",86.6,NA,NA,80.2,91.2,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","78.7",78.7,NA,NA,60.8,89.8,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.9",86.9,NA,NA,81.4,90.9,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","85.9",85.9,NA,NA,80.6,90,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.6",86.6,NA,NA,78.8,91.8,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","86.1",86.1,NA,NA,79.7,90.7,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","76.6",76.6,NA,NA,62.1,86.7,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.9",82.9,NA,NA,69.9,91,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","88.1",88.1,NA,NA,80.6,93,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","82.5",82.5,NA,NA,73.3,89,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.5",83.5,NA,NA,71.9,90.9,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","88.2",88.2,NA,NA,81.4,92.7,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","83.4",83.4,NA,NA,75,89.4,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","90.8",90.8,NA,NA,87.6,93.3,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","79.9",79.9,NA,NA,66.1,89,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","71.0",71,NA,NA,60.6,79.6,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","91.3",91.3,NA,NA,88.1,93.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","77.2",77.2,NA,NA,64.7,86.2,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","71.6",71.6,NA,NA,62,79.6,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","84.3",84.3,NA,NA,79.4,88.3,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence","66.9",66.9,NA,NA,50.1,80.3,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","CrdPrev","RACE","MRC"
2015,2015,"AL","Alabama","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","84.4",84.4,NA,NA,79.5,88.3,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence","70.7",70.7,NA,NA,57,81.5,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Mammography use among women aged 50-74 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN1_0","AgeAdjPrev","RACE","MRC"
2015,2015,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",79.4,84.3,"Overall","Overall",NA,"59","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.1",80.1,NA,NA,76.5,83.3,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,77.6,82.8,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.3",84.3,NA,NA,82.1,86.3,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.2",83.2,NA,NA,80.6,85.4,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","80.4",80.4,NA,NA,75.1,84.9,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.4",79.4,NA,NA,75.7,82.7,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.8",81.8,NA,NA,80.1,83.5,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","OVERALL","OVR"
2015,2015,"US","United States","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.7",80.7,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",79.9,84.3,"Overall","Overall",NA,"59","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.7",80.7,NA,NA,77.3,83.7,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.2",80.2,NA,NA,77.5,82.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.3",84.3,NA,NA,82.3,86.2,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","83.6",83.6,NA,NA,81.1,85.9,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,74.9,84.1,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,76.6,82.8,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.2",82.2,NA,NA,80.4,83.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.6",78.6,NA,NA,73.9,82.6,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","81.2",81.2,NA,NA,75.9,85.5,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","85.0",85,NA,NA,82.4,87.3,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.3",83.3,NA,NA,80.5,85.8,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.4",79.4,NA,NA,73.4,84.3,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.4",79.4,NA,NA,75.8,82.7,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.7",83.7,NA,NA,82,85.3,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","78.8",78.8,NA,NA,73.9,83,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,73.6,85,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.1",84.1,NA,NA,81,86.7,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.0",84,NA,NA,81.3,86.5,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.1",79.1,NA,NA,73.2,84,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","79.9",79.9,NA,NA,76.3,83,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.5",84.5,NA,NA,82.8,86.1,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.0",83,NA,NA,75.8,88.4,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.5",84.5,NA,NA,78.6,89,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","89.6",89.6,NA,NA,81.3,94.5,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","84.9",84.9,NA,NA,74.5,91.6,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.4",86.4,NA,NA,70.5,94.4,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.1",84.1,NA,NA,78.2,88.7,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.0",87,NA,NA,83,90.2,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.0",89,NA,NA,80.7,94,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","84.8",84.8,NA,NA,75.5,91,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","87.3",87.3,NA,NA,74.4,94.2,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","83.4",83.4,NA,NA,71.7,90.9,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","86.1",86.1,NA,NA,81.2,89.8,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","79.2",79.2,NA,NA,72.7,84.5,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.3",82.3,NA,NA,72.3,89.2,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","85.8",85.8,NA,NA,80.9,89.5,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.4",80.4,NA,NA,74.5,85.2,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","78.0",78,NA,NA,73.3,82,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","75.8",75.8,NA,NA,63.5,84.9,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","70.3",70.3,NA,NA,62.1,77.4,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","77.8",77.8,NA,NA,73.3,81.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","80.4",80.4,NA,NA,71.6,87,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,63.1,77.5,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","82.7",82.7,NA,NA,77.9,86.6,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence","88.5",88.5,NA,NA,78.3,94.3,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","CrdPrev","RACE","MRC"
2015,2015,"AL","Alabama","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","82.2",82.2,NA,NA,77.3,86.2,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence","89.1",89.1,NA,NA,80.1,94.3,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Papanicolaou smear use among adult women aged 21-65 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_1","AgeAdjPrev","RACE","MRC"
2015,2015,"US","United States","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.4",82.4,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",78.9,84.9,"Overall","Overall",NA,"59","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.5",79.5,NA,NA,73.9,84.2,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.5",79.5,NA,NA,75.4,83.1,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.5",82.5,NA,NA,78.7,85.7,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.9",84.9,NA,NA,81.1,88.1,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.9",78.9,NA,NA,70.3,85.5,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.8",83.8,NA,NA,78.3,88.1,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.4",82.4,NA,NA,79.7,84.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.7",78.7,NA,NA,70.8,84.9,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","79.2",79.2,NA,NA,69.6,86.3,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","83.7",83.7,NA,NA,78.3,87.9,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.4",85.4,NA,NA,81.1,88.8,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","78.4",78.4,NA,NA,68.3,85.9,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","84.5",84.5,NA,NA,79.4,88.6,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","86.3",86.3,NA,NA,83.5,88.6,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","81.6",81.6,NA,NA,70.7,89.1,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.5",82.5,NA,NA,73.4,88.9,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","89.1",89.1,NA,NA,75.5,95.5,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.7",85.7,NA,NA,68.8,94.2,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","85.8",85.8,NA,NA,79.3,90.5,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","77.9",77.9,NA,NA,70,84.2,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","75.5",75.5,NA,NA,68.2,81.6,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","70.0",70,NA,NA,53.7,82.4,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","65.1",65.1,NA,NA,53.8,74.9,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","82.6",82.6,NA,NA,75.8,87.8,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence","88.5",88.5,NA,NA,74.7,95.2,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Recent Papanicolaou smear use among women aged 21-44 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN2_2","CrdPrev","RACE","MRC"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.5",68.5,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",65.1,71.9,"Overall","Overall",NA,"59","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.0",70,NA,NA,68,72,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.7",66.7,NA,NA,63.8,69.4,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.6",72.6,NA,NA,70.5,74.7,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.9",71.9,NA,NA,70.1,73.6,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.4",61.4,NA,NA,58.9,63.9,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.1",65.1,NA,NA,63.5,66.6,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.8",62.8,NA,NA,58.3,67,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.5",74.5,NA,NA,72.6,76.4,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,63.2,67.5,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,67.9,72.8,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.0",67,NA,NA,64.8,69.2,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.2",70.2,NA,NA,68.7,71.6,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","OVERALL","OVR"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",64.5,71.2,"Overall","Overall",NA,"59","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,67.4,71.3,"Overall","Overall","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,63.5,68.8,"Overall","Overall","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.5",71.5,NA,NA,69.2,73.6,"Overall","Overall","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.2",71.2,NA,NA,69.4,72.8,"Overall","Overall","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.7",60.7,NA,NA,58.2,63.1,"Overall","Overall","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.5",64.5,NA,NA,62.9,66,"Overall","Overall","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.3",62.3,NA,NA,57.9,66.5,"Overall","Overall","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.1",74.1,NA,NA,72.1,76,"Overall","Overall","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.3",65.3,NA,NA,63.1,67.4,"Overall","Overall","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,67.5,72.3,"Overall","Overall","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.2",66.2,NA,NA,63.9,68.4,"Overall","Overall","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.4",69.4,NA,NA,67.9,70.8,"Overall","Overall","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Overall","Overall","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","OVERALL","OVR"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.4",68.4,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",63.6,70.4,"Gender","Male",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.3",69.3,NA,NA,66.1,72.3,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.4",67.4,NA,NA,62.8,71.7,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.1",72.1,NA,NA,69,75,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,67.7,73,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.0",60,NA,NA,55.8,63.9,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","63.6",63.6,NA,NA,61.2,66,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.8",64.8,NA,NA,58.1,71,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","75.1",75.1,NA,NA,72,78,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.3",62.3,NA,NA,58.8,65.7,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.4",69.4,NA,NA,65.5,73.1,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,62.9,69.8,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.0",70,NA,NA,67.8,72.1,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENM"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",63.2,69.9,"Gender","Male",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.4",68.4,NA,NA,65.2,71.4,"Gender","Male","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.2",67.2,NA,NA,63,71.2,"Gender","Male","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.9",70.9,NA,NA,67.8,73.9,"Gender","Male","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,67.2,72.4,"Gender","Male","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.0",59,NA,NA,54.8,63,"Gender","Male","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.2",63.2,NA,NA,60.8,65.6,"Gender","Male","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,59.4,71.5,"Gender","Male","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.6",74.6,NA,NA,71.4,77.5,"Gender","Male","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.4",62.4,NA,NA,58.9,65.8,"Gender","Male","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.5",69.5,NA,NA,65.6,73.1,"Gender","Male","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,62.6,69.5,"Gender","Male","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.2",69.2,NA,NA,67,71.3,"Gender","Male","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Male","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENM"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","69.2",69.2,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",66,73.1,"Gender","Female",NA,"59","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.7",70.7,NA,NA,68.1,73.1,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.0",66,NA,NA,62.4,69.5,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.1",73.1,NA,NA,70,76,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.2",73.2,NA,NA,70.9,75.4,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.6",62.6,NA,NA,59.6,65.6,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.4",66.4,NA,NA,64.4,68.3,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.2",61.2,NA,NA,55.1,66.9,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.0",74,NA,NA,71.5,76.4,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.1",68.1,NA,NA,65.4,70.7,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.2",71.2,NA,NA,68,74.2,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.6",67.6,NA,NA,64.8,70.2,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,68.4,72.2,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","GENDER","GENF"
2015,2015,"US","United States","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.8",68.8,"***","US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%",65.1,72.1,"Gender","Female",NA,"59","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,67.8,72.7,"Gender","Female","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,61.6,68.4,"Gender","Female","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.1",72.1,NA,NA,68.8,75.1,"Gender","Female","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.3",72.3,NA,NA,70.1,74.5,"Gender","Female","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.1",62.1,NA,NA,59.1,64.9,"Gender","Female","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.7",65.7,NA,NA,63.7,67.7,"Gender","Female","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","59.9",59.9,NA,NA,53.8,65.8,"Gender","Female","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","73.7",73.7,NA,NA,71.1,76.1,"Gender","Female","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.9",67.9,NA,NA,65.3,70.4,"Gender","Female","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,67.2,73.3,"Gender","Female","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.4",66.4,NA,NA,63.5,69.1,"Gender","Female","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.6",69.6,NA,NA,67.7,71.5,"Gender","Female","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Gender","Female","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","GENDER","GENF"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.4",70.4,NA,NA,68,72.6,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.6",66.6,NA,NA,63.2,69.8,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","75.3",75.3,NA,NA,71.8,78.5,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,70.9,74.5,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.6",64.6,NA,NA,61.6,67.5,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.9",66.9,NA,NA,65.3,68.4,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.2",68.2,NA,NA,63.7,72.4,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","74.9",74.9,NA,NA,72.9,76.8,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.3",67.3,NA,NA,65,69.5,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,70,75.1,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.5",67.5,NA,NA,65.2,69.7,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.0",72,NA,NA,70.6,73.5,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.1",69.1,NA,NA,66.7,71.4,"Race/Ethnicity","White, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.4",65.4,NA,NA,62.2,68.4,"Race/Ethnicity","White, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.8",72.8,NA,NA,69,76.4,"Race/Ethnicity","White, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","71.8",71.8,NA,NA,69.9,73.6,"Race/Ethnicity","White, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","63.3",63.3,NA,NA,60.3,66.3,"Race/Ethnicity","White, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.0",66,NA,NA,64.4,67.6,"Race/Ethnicity","White, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.3",67.3,NA,NA,62.5,71.7,"Race/Ethnicity","White, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","74.4",74.4,NA,NA,72.3,76.3,"Race/Ethnicity","White, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.7",66.7,NA,NA,64.5,68.9,"Race/Ethnicity","White, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.1",72.1,NA,NA,69.4,74.6,"Race/Ethnicity","White, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.3",66.3,NA,NA,64,68.6,"Race/Ethnicity","White, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.8",70.8,NA,NA,69.3,72.3,"Race/Ethnicity","White, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","White, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","WHT"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","70.1",70.1,NA,NA,65.7,74.2,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.3",67.3,NA,NA,61.4,72.6,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.1",71.1,NA,NA,64.9,76.7,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","55.6",55.6,NA,NA,51,60.1,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","68.9",68.9,NA,NA,57.9,78.1,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.9",65.9,NA,NA,58.8,72.4,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","76.9",76.9,NA,NA,69.6,82.8,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","67.5",67.5,NA,NA,58.1,75.7,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","66.6",66.6,NA,NA,54.4,77,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.7",70.7,NA,NA,66.5,74.5,"Race/Ethnicity","Black, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.7",67.7,NA,NA,62.1,72.9,"Race/Ethnicity","Black, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.4",70.4,NA,NA,64.3,75.9,"Race/Ethnicity","Black, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.1",56.1,NA,NA,51.6,60.4,"Race/Ethnicity","Black, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","70.3",70.3,NA,NA,59.9,78.9,"Race/Ethnicity","Black, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.0",67,NA,NA,60.8,72.7,"Race/Ethnicity","Black, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","75.8",75.8,NA,NA,68.8,81.7,"Race/Ethnicity","Black, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","68.8",68.8,NA,NA,60,76.5,"Race/Ethnicity","Black, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.1",67.1,NA,NA,55.8,76.8,"Race/Ethnicity","Black, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Black, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","BLK"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","71.5",71.5,NA,NA,62.3,79.3,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","61.0",61,NA,NA,45.4,74.6,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","38.6",38.6,NA,NA,28.6,49.7,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","30.2",30.2,NA,NA,19.6,43.4,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","57.3",57.3,NA,NA,49.2,65.1,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","62.5",62.5,NA,NA,53.9,70.3,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.9",54.9,NA,NA,46.6,62.9,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","69.9",69.9,NA,NA,61.2,77.3,"Race/Ethnicity","Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.4",64.4,NA,NA,51.9,75.2,"Race/Ethnicity","Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","41.1",41.1,NA,NA,31,52.1,"Race/Ethnicity","Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","36.8",36.8,NA,NA,26.4,48.7,"Race/Ethnicity","Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","58.8",58.8,NA,NA,51.7,65.6,"Race/Ethnicity","Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","62.8",62.8,NA,NA,54.4,70.5,"Race/Ethnicity","Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","56.5",56.5,NA,NA,48.2,64.5,"Race/Ethnicity","Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","HIS"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.3",60.3,NA,NA,43.7,74.9,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","73.4",73.4,NA,NA,69.9,76.7,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","58.7",58.7,NA,NA,44,72,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","40.2",40.2,NA,NA,26.8,55.2,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","51.9",51.9,NA,NA,30.5,72.6,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","72.7",72.7,NA,NA,57,84.2,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","60.5",60.5,NA,NA,48.5,71.3,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","54.2",54.2,NA,NA,39.3,68.5,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.4",65.4,NA,NA,58.2,71.9,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","57.8",57.8,NA,NA,43.4,71,"Race/Ethnicity","Other, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","72.8",72.8,NA,NA,69.2,76.1,"Race/Ethnicity","Other, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.1",65.1,NA,NA,53,75.4,"Race/Ethnicity","Other, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","45.7",45.7,NA,NA,34.2,57.8,"Race/Ethnicity","Other, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","50.4",50.4,NA,NA,33.7,67,"Race/Ethnicity","Other, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","67.8",67.8,NA,NA,53.5,79.4,"Race/Ethnicity","Other, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","60.1",60.1,NA,NA,48,71.1,"Race/Ethnicity","Other, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","55.0",55,NA,NA,41.9,67.5,"Race/Ethnicity","Other, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.1",66.1,NA,NA,59.4,72.2,"Race/Ethnicity","Other, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Other, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","AgeAdjPrev","RACE","OTH"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.9",65.9,NA,NA,60.8,70.6,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","65.0",65,NA,NA,48.6,78.5,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","48.9",48.9,NA,NA,31.8,66.3,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence","64.9",64.9,NA,NA,51.8,76,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"VI","Virgin Islands","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Crude Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.335765, -64.896335)","78","CAN","CAN3_0","CrdPrev","RACE","MRC"
2015,2015,"AL","Alabama","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)","01","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AK","Alaska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)","02","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AZ","Arizona","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)","04","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"AR","Arkansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)","05","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CA","California","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)","06","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CO","Colorado","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)","08","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"CT","Connecticut","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)","09","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"DE","Delaware","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)","10","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"DC","District of Columbia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.907192, -77.036871)","11","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"FL","Florida","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)","12","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"GA","Georgia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)","13","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"HI","Hawaii","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","65.9",65.9,NA,NA,60.9,70.6,"Race/Ethnicity","Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)","15","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ID","Idaho","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)","16","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IL","Illinois","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)","17","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IN","Indiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)","18","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"IA","Iowa","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)","19","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"KS","Kansas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)","20","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"KY","Kentucky","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)","21","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"LA","Louisiana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)","22","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ME","Maine","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)","23","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MD","Maryland","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)","24","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MA","Massachusetts","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)","25","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MI","Michigan","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","66.9",66.9,NA,NA,53.2,78.1,"Race/Ethnicity","Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)","26","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MN","Minnesota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)","27","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MS","Mississippi","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)","28","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MO","Missouri","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)","29","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"MT","Montana","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)","30","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NE","Nebraska","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","54.3",54.3,NA,NA,40.5,67.5,"Race/Ethnicity","Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)","31","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NV","Nevada","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)","32","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NH","New Hampshire","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)","33","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WY","Wyoming","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)","56","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NJ","New Jersey","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)","34","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NM","New Mexico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)","35","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NY","New York","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)","36","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"NC","North Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)","37","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"ND","North Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)","38","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OH","Ohio","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)","39","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OK","Oklahoma","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)","40","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"OR","Oregon","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)","41","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"PA","Pennsylvania","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)","42","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"RI","Rhode Island","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)","44","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"SC","South Carolina","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)","45","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"SD","South Dakota","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)","46","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"TN","Tennessee","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)","47","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"TX","Texas","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)","48","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"UT","Utah","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)","49","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"VT","Vermont","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)","50","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"VA","Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)","51","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WA","Washington","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence","64.8",64.8,NA,NA,51.8,76,"Race/Ethnicity","Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)","53","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WV","West Virginia","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)","54","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"WI","Wisconsin","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)","55","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"GU","Guam","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(13.444304, 144.793731)","66","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
2015,2015,"PR","Puerto Rico","BRFSS","Cancer","Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years","%","Age-adjusted Prevalence",NA,NA,"-","No Data Available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic","(18.220833, -66.590149)","72","CAN","CAN3_0","AgeAdjPrev","RACE","MRC"
